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Abstract of the Thesis 
Polymeric Scaffolds as Building Blocks for Nanomaterials  
with Biomedical Applications 
Daniel N. Crisan 
Functional polymers are emerging as strong candidates for a variety of biomedical 
applications, but progress in this field is slow due to the difficulties associated with 
the synthesis of libraries of polymers. Polymeric scaffolds facilitate the rapid 
synthesis of such functional polymers by employing Click chemistries as a tool for 
post-polymerisation modification. Acrylic and acetylene based polyhydrazides have 
been explored as potential scaffolds for the in situ screening of functionalised 
polymers for biomedical applications. Poly(acryloyl hydrazide) was prepared from 
commercially available starting materials using RAFT polymerisation in a three step 
synthesis, and its post-polymerisation modification using a variety of hydrophilic and 
hydrophobic aldehydes was investigated. Biocompatible solvents and reaction 
conditions were determined such that the post-polymerisation modification could be 
achieved with good yields or better. The applicability of the scaffold was shown 
during the in situ screening of functional polymers for siRNA delivery, which required 
no isolation or purification of candidate polymers. Poly(4-ethynylbenzohydrazide) was 
synthesised using Rh catalysed polymerisation conditions, towards achieving a 
helical polymer scaffold. Despite the lack of solubility in aqueous solvents, the 
stability and post-polymerisation modification was analysed in a variety of conditions, 
opening the possibility of synthesising biodegradable mimics to naturally occurring 
helical moieties (e.g. anti-microbial peptides).  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 The beginning of the 21st century poses a diversity of challenges but also 
many opportunities from a healthcare and biomedical point of view. Infections with 
antimicrobial-resistant bacteria are predicted to be the main cause of death by 2050.1 
Furthermore, these are also expected to complicate treatments for currently 
manageable diseases like HIV, Tuberculosis and Malaria. As longevity is increasing 
worldwide, so are the rates of cancer incidence and new types of cancer. Moreover, 
the threat of existent and new viruses is omnipresent, which in a globalised world 
makes an epidemic scenario a matter of when rather than if. These human cost is 
predicted to be accompanied by considerable economic costs, which could cost up to 
$100 trillion just due to antimicrobial resistance. 
 All is not bleak however, as research and progress into such fields as gene 
therapy,2-4 siRNA delivery,5-9 novel antibiotics based on mimics of antimicrobial 
peptides (AMPs),10-18 antimicrobial surfaces and anti-adhesion coatings,19-23 is 
advancing rapidly with promising and exciting results. Among these fields, materials 
based around functionalised polymers are emerging as possible solutions.4,16,20 
 Polymers are macromolecules that can be synthesised in a variety of sizes 
and shapes. Their physical and chemical properties can be adjusted to suit multiple 
applications, can be used to produce mimics of naturally occurring biomolecules in a 
cheap and facile way, and can be combined in such ways to obtain powerful 
synergistic effects, especially in biomedical applications. Historically, the use of 
polymers in biomedical applications has been limited, mainly due to the drawbacks of 
“traditional” (e.g. uncontrolled free radical, condensation etc.) polymerisations, which 
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do not readily support the high-throughput synthesis required for libraries of 
compounds that need to be tested. Although these techniques are industrially 
mainstream, their limitation towards wide-spread use for exploring functional 
polymers for biological applications, originates from several synthesis related 
drawbacks.24-26 
 Firstly and most importantly, these techniques can be highly substrate specific 
and they can be difficult to carry out with monomers that contain multiple functional 
groups. This is a key requirement for synthesising libraries of functionalised 
polymers. Furthermore, experimental conditions are often not interchangeable 
between different monomers and optimisation for each new reaction would normally 
be required. This is an expensive and time consuming process. Secondly, 
uncontrolled polymerisations exhibit poor control over the key features required for 
the preparation of materials with well-defined molecular weights, dispersities (ratio 
between weight-average and number-average molar mass) and structures. To 
evaluate the structure-activity of a library of functionalised polymers,27,28 it is desired 
that the sizes of the members are within the same range of each other, in order to 
observe trends related to their functionality not molecular weight. Furthermore, a 
narrow dispersity is more desirable in order to determine if an active polymer (e.g. a 
polymeric antimicrobial) is active over a wide range of sizes or only within a narrow 
molecular weight range. This should also facilitate approval from regulatory agencies 
(i.e. EMA, FDA) if a product were to be marketed, as their stringent regulations 
usually require a thorough knowledge of the structure of the active molecule. Finally, 
the synthesis of hundreds, if not thousands, of functional polymers would generally 
be considered highly time consuming and economically prohibitive. 
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 Two scientific breakthroughs at the end of the 1990’s lead to a “revolution” in 
thinking about the use functional polymers for biomedical applications. These 
breakthroughs were the advances in controlled polymerisation techniques29-32 and 
the development of “click chemistry” reactions.33,34 
 Controlled polymerisation techniques such as Ring-Opening Metathesis 
(ROMP),35-40 Atom-Transfer Radical (ATRP)41-46 and Reversible Addition-
Fragmentation Chain-Transfer (RAFT)47-53 (Fig. I.1) have paved the way towards the 
synthesis of polymers incorporating a range of functionalities. They are normally 
distinguished by their high tolerance of many functional groups, ability to polymerise 
cheap monomers, using inexpensive catalysts, to produce valuable products or 
intermediates, and ability to produce well-defined polymers, of different architectures 
(i.e. linear, block co-polymers, polymer brushes or combs, star) with narrow 
dispersities and molecular weights that can be controlled by adjusting the ratio 
between monomer and catalyst or by quenching the reactions at different times. 
Furthermore, reaction conditions are generally quite compatible across substrates 
with similar chemical properties. Although these features solve some of the 
fundamental drawbacks of “traditional” polymerisation techniques and allow the 
synthesis of complex and well-defined polymeric molecules, one key drawback 
remains unaddressed. The synthesis and characterisation of libraries of hundreds of 
such complex polymers remains time-consuming, which is detrimental to the 
identification of targets with useful biological properties. However, by providing the 
tools to incorporate a variety of functional groups as side-chains of these polymers, 
the solution to rapidly produce large numbers of functional polymers was achieved in 
the form of polymer scaffolds. Polymer scaffolds are functional polymers that use 
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auxiliary functional groups (Fig. I.2) for modification post-polymerisation, to quickly 
synthesise many new functional polymers without having to synthesise and 
polymerise the “equivalent” monomers. This is achieved by reacting the side-chain’s 
functional group with small, multi-functional molecules (usually orthogonal to each 
other). Importantly, this allows the incorporation of functional groups that are still 





















































Figure I.1: Schematic diagrams showing controlled polymerisation processes: 
ROMP (A), ATRP (B) and RAFT (C).
M denotes metal catalysts similar to catalysts used in olefin metathesis (W, Sn, Ti, Mo, Re, Ru) 
M denotes monomer
M denotes monomer
reacting the scaffold with multiple decorating molecules, at the same time or 
sequentially, polymers with multiple functional groups can be synthesised. These are 
particularly useful in biological applications such as, but not restricted to, siRNA 
delivery (see Chapter 3) or mimics of antimicrobial peptides that normally require a 
mixture of cationic and hydrophobic residues. Aside from these evident advantages, 
another key aspect is that all polymers in these libraries will have stemmed from the 
same parent scaffold. As such, the size of the polymer (degree of polymerisation, DP) 
and the dispersity (!) will remain constant throughout. Any significant differences in 
biological activity between members of the library will have resulted from structural 
differences only (and the physicochemical properties imparted as a consequence) 











Figure I.2: Schematic representation of the synthesis of a polymer scaffold and 
post-polymerisation modification to synthesise libraries of functional polymers.
DPs has been reported to show different biological activity.27,54,55 In addition to 
providing a faster synthetic pathway to libraries of functional polymers, polymer 
scaffolds also simplify and reduce the number of characterisation steps required (i.e. 
SEC/GPC, on the polymer scaffold is sufficient to determine DP and Đ for the whole 
population, or 1H NMR spectroscopy and mass spectrometry for determination of 
DP), saving time and resources. Very often, these characterisation steps will not work 
efficiently for particular polymers (e.g. sample may not fly in mass spectrometry, 
special columns and solvent conditions may be required for SEC/GPC, etc.). As 
such, the one key element of characterisation for functional polymers, synthesised 
via polymer scaffolds, is the determination of percentage loading (i.e. how many of 
the scaffold’s side-chains have reacted with the “decorating” functional small 
molecules). One of the shortfalls of functional polymers derived from scaffolds versus 
direct polymerisation of functional monomers is that in the latter, it is known as a 
certainty that all side-chains contain the target functional group, whilst in the former, it 
has to be determined and it is highly dependent on the efficiency of the chemistry 
used to decorate the scaffold’s side-chains. 
 As a consequence of the aforementioned, a key necessity of polymer scaffolds 
is to use very efficient chemistries such as “click chemistry” reactions (but not 
restricted to) in the post-polymerisation modifications. Click chemistry33,56 represents 
a whole class of reactions defined by the linking of small units thorough the formation 
of heteroatom links (C-X-C) and which abide to a set of criteria. Among the criteria, 
click chemistry reactions have to be modular (i.e. bringing different “building blocks” 
together) and wide in scope (i.e. applicable to diversity of substrates containing the 
same functional group), they must be high yielding, and ideally generate zero or 
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inoffensive byproducts that can be removed by non-chromatographic purification 
techniques (i.e. by recrystallisation, distillation, liquid-liquid extraction). Furthermore, 
the reactions should be carried out under simple conditions (i.e. insensitive to oxygen 
and water, ideally in the absence of solvents, in water or solvents that are easily 
removed). Click chemistry reactions are considered “spring-loaded”, or highly 
selective towards a single product. This is due to a high thermodynamic driving force, 
which also leads to processes that reach completion quickly. Often, reactions 





















































1 Aziridination via nitrene addition 
2 Epoxidation via olefin oxidation 
3 Dihydroxylation 
4 Hydroxyamination (Oxyamination) 
5 Nucleophilic ring opening 
6 Aminolysis of epoxides 
7 Thiolysis of epoxides 
8 Aziridination via Wenker synthesis 







Figure I.3: Representative “click chemistry” reactions involving several 
transformations of olefin bonds.
reactants are or appear insoluble in the medium. This is believed to be due to the 
organic molecules having more free energy when poorly solvated, imparting 
increased reactivity and resulting in a higher rate constant, which compensates for 
the low concentration of the reactants in solution.  
 Common examples of chemical transformations that broadly fall under the 
classification of “click chemistry” include additions to C=C bonds / olefin oxidation to 
form ring strained epoxides or aziridines, dihydroxylation and oxyamination (Fig. I.3). 
The ring strained epoxides and aziridines can then be easily opened with a range of 
nucleophiles to form libraries of 1,2-difunctionalised compounds. A wide variety of 
thiol chemistry can also be considered as click chemistry such as thiol-ene/yne 
addition, disulfide formation, alkyl halide substitution, reaction with isocyanates to 
form thiocarbamates and thiol-Michael addition (Fig. I.4). Carbonyl chemistry of the 
non-aldol type is frequently used as click chemistry in reactions such as isocyanate 

































1 Thiol-ene addition 
2 Thiol-yne addition 
3 Thiol-disulfide exchange 
4 Thiol-alkyl halide substitution 








Figure I.4: Representative “click chemistry” reactions involving several 
transformations using thiol derivatives.
aldehydes or ketones with amines, hydrazines, hydroxylamines to form imines,
hydrazones and oximes respectively, or aldehydes / imines reactions with dienes in 
hetero-Diels-Alder reactions (oxo-Diels-Alder and aza-Diels-Alder respectively) to 
form heterocyclic compounds (Fig. I.5). Lastly, “the cream of the crop” of “click 
chemistry” as referred to by Barry Sharpless33 is the Copper (I) catalysed Azide-
Alkyne Huisgen cycloaddition (CuAAC). 
 In the context of polymer scaffolds,57-63 many of these click chemistry 










































R1 R2 R1 R2
Figure I.5: Representative “click chemistry” reactions involving carbonyl chemistry 







2 Hydrazone formation 
3 Imine formation 
4 Oxime formation 
5 Aza-Diels-Alder 
6 Urea formation 
7 Thiocarbamate formation 2
esters, anhydrides) have been used successfully for the synthesis of functional 
polymers each with their own advantages and disadvantages. These scaffolds were 
analysed from the point of view of suitability towards synthesis of functional polymers 
for biological applications. It is the author’s belief that the best system for high-
throughput screening should ideally involve a one-pot, or in-situ approach between 
post-polymerisation modification and biological testing. For this to be possible, 
functionalisation reactions would need to be carried out in water or biocompatible 
solvents (i.e. DMSO) and require no purification steps. The scaffold should be soluble 
and stable under aqueous conditions. The reaction should ideally proceed with no by-
products at all, or water as a by-product. Other non-toxic molecules as by-products 
would not be to far from ideal, but would require additional control studies (i.e. does 
the by-product play a role in any biological effect observed for the functional 
polymer?). Finally, the reagents should be non-toxic or react in a 1:1 stoichiometry 
with the scaffold (i.e. full consumption so no free reagents in biological testing to 
account for); any catalysts used in the reaction should similarly be bio-compatible. As 
such, metal catalysed reactions would not be considered ideal for high-throughput 
screening due to their usual cell toxicities. 
1) Scaffolds containing epoxide side-chains 
 Although there are many tools available in the olefin oxidation click chemistry 
arsenal, their use in polymer scaffolds is mostly represented by epoxide chemistry. 
Poly(glycidyl methacrylate)64-67 (poly(GMA)) and poly(epoxystyrene)68 are the best 
examples (Fig. I.6) in this category. These polymers were synthesised using a variety 
of techniques including free radical, ATRP and RAFT polymerisation. 
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Poly(GMA) was used as a reactive coating for silica nanoparticles64 in order to attach 
fluorescent tags and ATRP initiators for grafting polymer layers such as 
oligo(ethylene glycol) methyl ether methacrylate. Another exemplification of the use 
of poly(GMA) as a scaffold is in brushes on silicon wafers65 and their subsequent 
chemical modification. In these examples, the modification of the oxirane group was 
carried out in solvents such as methyl ethyl ketone and ethanol and also exposed 
during the polymer synthesis and purification to solvents such as methanol, diethyl 
ether, DCM and even water without affecting the functional group. The modifications 
were carried out successfully with compounds containing carboxylic acid or amine 
functional groups. Amines, however, were found to react with multiple oxirane side-
chains resulting in cross linking. Despite stability and reactivity in a diversity of 
solvents, there has been very little investigation into the functionalisation of such 
scaffolds in water or with a diversity of different substrates to produce libraries of 
functional polymers. The chemistry is elegant in that it produces no by-products so 
requires no post-functionalisation purification, but there is currently no information if 
complete functionalisation can be achieved and if the reaction is stoichiometric. A 
further negative aspect of the reaction is the reactivity of an amine functional group 






Figure I.6: Representative examples of polymer scaffolds containing epoxide 
functional groups.
which deviates from the idea of functionalised chains and leads into the territory of 
single chain nanoparticles and extensive cross linked systems. 
2) Scaffolds containing alkene side-chains 
 There are many diverse examples of polymeric systems containing reactive 
alkenes69-78 as part of their side-chains or backbone (Fig. I.7). Most often, these 
scaffolds have been used to form functional polymers by photo or thermal thiol-ene 
click chemistry additions. Homo- and co-polymers were synthesised mainly via 
different (anionic, cationic, metal-catalysed, enzymatic) ring-opening polymerisation 
techniques, but there are also examples of RAFT polymerisation77 despite the risk of 
cross-linking dienes. Efficient functionalisation has been reported in most cases, 
including reported cases of close to 100% conversion regardless of the alkene 
content in the polymer. Thiols containing other different functional groups have been 
successfully reacted, including amino, hydroxyl, carboxyl group as well as short 
amino acid sequences. One potential issue with these systems is the potential for 
cross-linking and cyclisation between the thiol and alkene groups when exposed to 
the conditions required for radical thiol-ene addition. Studies have been carried out to 
determine reaction conditions which suppress this cross-linking, however these 
generally involve using a large excess of the thiol reactant. Full thiol consumption 
without side-reactions has also been shown when sub-stoichiometric amounts of 
thiols were used, with a view to use the remaining alkenes for further 
functionalisation. Reported functionalisation conditions are varied both in temperature 
(-35 ℃  up to 90 ℃) and time (0.5 h up to 24 h). However, because of the poor 
solubility of the scaffolds in water, most reported functionalisations were in solvents 
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(usually dry and under an argon or N2 atmosphere) such as DMF, THF, chlorinated 
solvents, dioxane, or toluene. 
Overall, the efficiency of this chemistry, lack of by-products and achievement of full 
conversion with a variety of thiols containing other diverse functional groups make 
this a powerful tool towards the synthesis of functional polymer. However, the solvent 
requirements and the apparent need for excess thiol reagents impose the need for a 
post-functionalisation purification step, which is a major disadvantage when 
considering high-throughput screening. 
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3) Scaffolds containing disulfide side-chains 
 An alternative reactive scaffold for thiols instead of addition to alkene bonds, is 
the use of disulfide exchange bonding. A key difference between these two 
chemistries is the reversible nature of the disulfide under redox conditions. This 
makes this bonding particularly useful for drug release or dynamic systems. 
Significant examples (Fig. I.8) of scaffolds using this chemistry include polymers and 
co-polymers synthesised via free radical and RAFT polymerisation. In these 
examples,79-83 the thiol exchange group is represented by a pyridyldisulfide group. 
The advantages of this group is that the exchange results in 2-pyridinethione as a 
by-product, which is both inert and it also has a characteristic UV-Vis absorption that 
has been successfully used to determine the percentage functionalisation. Co-
polymers and ter-polymers containing up to 10% mole of the pyridyldisulfide were 
functionalised either in DMF or in aqueous buffers. Up to 100% functionalisation has 




























Figure I.8: Representative examples of polymer scaffolds containing disulfide 
groups for thiol exchange.
excess reagent was used and post-functionalisation purification was carried out as a 
consequence. One complication of carrying out the functionalisation in water is the 
hydrolysis of the disulfide bonds, the rate of which increases with increased pH, 
however water soluble polymers have been shown to be stable in solution for long 
term at -20 ℃. The extent of functionalisation in aqueous conditions is also highly 
dependent on the pH with rates of reaction decreasing with decreasing pH (from pH 
8 to 3). Functionalisation of water-insoluble homo-polymers in DMF or DMSO have 
shown that these scaffolds are wide in scope, and suitable towards a diversity of 
thiols. Generally, when up to 60% of the side-chains are targeted with stoichiometric 
amounts of thiols, a linear relationship is observed, however beyond that its has been 
reported that up to two-fold excess reagent is required for full conversion. Generally, 
values around 90% conversion are reported for a variety of thiols but with clearly 
significant variations in the rate of reactions (30 min to 14 h) due to increased steric 
hindrance (i.e. small molecules will react much faster than larger bulkier thiols). 
Another interesting example of a scaffold, involves the ATRP co-polymerisation of 
methacrylate monomers containing N-hydroxysuccinimide (NHS) and pyridyldisulfide 
reactive handles. The NHS ester is an active easter, reactive towards amines and 
orthogonal to the thiol-disulfide exchange chemistry. This co-polymer is a prime 
example of scaffolds using orthogonal chemistries reactive towards amines and 
thiols. As a whole, scaffolds using disulfides as the reactive handle have been shown 
to be wide in scope with high efficiency of functionalisation with a large variety of 
thiols. Although polymers tend to be water-insoluble, derived products can become 
soluble depending on the nature of the thiols attached. Co- and ter-polymers have 
been shown to be stable water soluble scaffolds that can be functionalised under 
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aqueous conditions. A negative aspect is the necessity to use excess reagents to 
achieve maximum conversion possible (~90%), so post-functionalisation purifications 
may be required. 
4) Scaffolds containing isocyanates side-chains 
 Isocyanates can be considered as one of the best tools for click chemistry 
reactions. They are reactive towards a large variety of nucleophiles particularly 
amines, thiols and alcohols. Polymer scaffolds, in solution or as polymer brushes, 
with isocyanate side-chains84-86 (Fig. I.9) have been synthesised via radical or RAFT 
polymerisation, and their functionalisation with nucleophiles has been carefully 
investigated. It has been found that the reaction with equimolar amounts of primary 
and secondary amines proceeds quantitatively and rapidly, a feature observed also 
for thiols but in the presence of a base catalyst. The reaction with alcohols has been 
shown to be slower and requires dibutyltin dilaureate as a catalyst, however, 
quantitative functionalisation was reported.84 Because of the different alcohol/thiol 
catalyst conditions, selectivity can be tuned with regards to bifunctional reagents. 
Aminoalcohols will react selectively via the amine functional group due to its 
increased nucleophilicity. Selectivity in mercaptoalcohols can adjusted by increasing 
the amount of dibutyltin dilaureate to favour the reaction via the alcohol group. Under 
base catalysed conditions the reaction proceeds rapidly via the thiol group. Key 
advantages of using isocyanates as reactive handles is the lack of byproducts 
formed and quantitative functionalisation with equimolar amounts of reagents. This 
means that post-functionalisation purification is required only for removal of the 
dibutyltin dilaureate catalyst when functionalisation with alcohol is desired, or the 
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base catalyst when functionalisation via thiols is carried out (although this should be 
synthetically much easier, or not required at all). The main negative aspects of 
isocyanates scaffolds in the context of high-throughput testing for biomedical 
applications is the inability to carry out the functionalisation in water. Water itself 
reacts with isocyanates to release carbon dioxide and form a primary amine. 
Reported functionalisations have been carried out in chloroform, DMF or THF, which 
are not biocompatible and need to be removed, however, perhaps functionalisations 
in DMSO would be a suitable solution in the future to allow in-situ functionalisation 
and biological testing without purification and solvent removal.  
5) Scaffolds containing alkynes or azide side-chains 
 The copper(I) catalysed azide-alkyne cycloaddition to produce a 1,2,3-triazole 
has been widely incorporated into many polymer scaffolds (Fig. I.10), ranging from 
methacrylates via ATRP87,88 or RAFT polymerisation,89,90 to polycarbonates,91,92 
glycopolymers,93,94 polymer brushes88 and modified cyclodextrins.95 This modular 
reaction has been shown to be generally quantitative, and can be carried out in a 
variety of solvents (e.g. THF, DMF, DMSO) including aqueous conditions, which is a 
key advantage. There are however several drawbacks that disqualify these systems 
according to the parameters desired for an optimum system. First, and most 










Figure I.9: Representative examples of polymer scaffolds containing isocyanate 
functional groups.
are known for their cytotoxicity96 and as such would require thorough removal from 
the system before the polymers can be tested. Furthermore, although many 
examples have shown the reaction to be wide in scope and quantitative, usually the 
reactions have been carried out with excess reagent (1.1 - 2.0 equiv.), which 
enforces the requirement for post-functionalisation purification. 
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Figure I.10: Copper(I) catalysed azide-alkyne cycloaddition (top). Representative 
examples of polymer scaffolds containing azide or alkyne functional groups 
(bottom).
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6) Scaffolds containing activated ester side-chains 
 Polymers containing activated ester side-chains have featured prominently in 
the research on polymeric scaffolds. This is in part due to the high control and 
efficiency in polymerising monomers containing activated ester side-chains such as 
(but not limited to) NHS,97-100 fluorophenyl101-106 and nitrophenyl-groups107,108 (Fig. I.
11). The reactivity of activated esters scaffolds such as acrylates and methacrylates 
obtained via ATRP or RAFT polymerisation, or norborenes from ROMP, with amines 
has been throughly investigated. It has been shown that both the steric bulk and the 
reactivity of the amine group play an important role in the percentage conversion. 
Primary amines, such as tert-butyl amine, benzyl amine and cyclohexylamine were 
shown to react quantitatively with a tetrafluorophenyl methacrylate scaffold (2 equiv. 
amine), however aromatic amines were shown to be completely unreactive. The 
reactivity of pentaflurophenyl methacrylate with a library of nine water soluble amines 
with different steric bulk was investigated by Gibson et al.106 to show conversions 
between 60-80% when 2 equiv. amine was used. Complete conversion has been 
reported by Hu et al.99 in the reaction between poly(N-acryloxysuccinimide) and 0.2 
equiv. galactosamine followed by 1.6 equiv. ethanolamine. Similarly pegylated 
poly(N-acryloxysuccinimide) copolymers were fully functionalised with mixtures of 
amines towards forming complexes with plasmid DNA and functional polymers. The 
functionalisation reactions were commonly carried out in dry solvents (e.g. THF, DMF 
or DMSO) under an inert atmosphere at 50 ℃. These conditions are required to 
minimise ester hydrolysis. Under open air, ~3% hydrolysis was observed in DMSO at 
50 ℃  for poly(N-acryloxysuccinimide), while complete hydrolysis was reported for 
poly(p-nitrophenyl methacrylate) under reflux for 24 hours with 4 equiv. hydroxide. 
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The rate of hydrolysis was shown to increase with increased pH (7.4 to 8.5) but 
overall aminolysis is normally faster than hydrolysis at the reported pH range. With 
regards to post-functionalisation purification, the requirement of excess amine and 
the release of alcohols as by-products, as well as the use of non-aqueous solvents, 
suggests that purification would be required before the biological testing could be 
carried out. 
7) Scaffolds containing aldehyde or ketone side-chains 
 Aldehydes and ketones can readily react with amines, hydrazines and 
hydroxylamines to form imines, hydrazones and oximes.109 These are reversible and 
pH dependent reactions, which make them ideal for dynamic systems and delivery 


























































are hydrolytically stable between pH 5-7 and pH 2-7 with rapid decomposition 
occurring above pH 9.110,111 Polymers containing aldehyde or ketone side-chains 
(Fig. I.12) have been synthesised via RAFT, ATRP or ROMP and their 
functionalisation properties have been investigated.107,112-123 Functionalisation of 
benzylaldehydes with hydroxylamines and hydrazides has been shown to be 
quantitative in THF at 25 ℃  with an excess of reagent. Fulton et al.113 showed the 
dynamic character of the system by reacting a benzaldehyde scaffold with short, 
medium and long alkyl chain hydrazides and showing that a mixture of two functional 
polymers re-equilibrates into a single polymer species by interchanging hydrazone 
bonds between the scaffolds. Co- and ter- polymer scaffolds containing aliphatic 
aldehyde/ketone side-chains and other chemo-selective handles such as azide and 
maleimides have been successfully developed115,123 for orthogonal multi-
functionalisation. Quantitative yields have been observed in the reaction between 
these scaffolds and different hydrazides in DMF or THF, at different temperatures but 
again with excess reagents. Poly(methyl vinyl ketone) has been functionalised with 
oligosaccharides under aqueous conditions.116 Although long reactions times (96 
hours), relatively high temperatures (95 ℃) and 2-3 equiv. modified oligosaccharides 
were used, quantitative functionalisation was achieved. The reaction between 
aldehyde/ketones and amines, hydrazines, hydrazides or hydroxylamines produces 
water as a by-product, which is a great advantage in terms of requirement for post-
functionalisation purification. However, most scaffolds explored are not soluble in 
water. Very few commercially available hydrazides or hydroxylamines with multiple 
functional groups exist, limiting the rapid screening of large libraries of functional 
 22
polymers. Whilst amines can be widely used, the labile nature of imines under 
aqueous conditions suggests they are not ideal for biological applications.  
8) Scaffolds containing hydrazide or hydroxylamine side-chains 
 The advantages of the previously described system (i.e. quantitative yields, 
water by-product, reactivity in water and pH dependent stability under aqueous 
conditions) can be maintained and the disadvantages of aldehyde/ketone containing 
polymeric scaffolds (i.e. scaffold insolubility in water, a general lack of commercially 
available hydrazide, hydrazine or hydroxylamine building blocks to use for 
functionalisation) can be solved by reversing the chemo-selective handle such that a 
polyhydrazide or a polyhydroxylamine scaffold is used instead. The water solubility of 


































Figure I.12: Representative examples of polymer scaffolds containing aldehyde or 
ketone functional groups.
backbone involved) due to the favourable H-bonding interactions possible when side-
chains rich in N and O atoms are present. Furthermore, aldehyde/ketone building 
blocks are widely commercially available and a key aspect is that usually, aldehyde 
and ketones are less toxic and easier to handle compared to their amine equivalents 
that would be used with many of the aforementioned scaffolds. Scaffolds containing 
hydroxylamine (Fig. I.13) side-chains have been synthesised via RAFT in the form of 
poly(O-(4-vinylbenzyl)-hydroxylamine)124 via a protected phthalamide precursor. 
Functionalisation studies were carried out with a few aldehydes and ketones in THF. 
Near-quantitative conversions have been observed with 1 equiv. reagent, while with 
0.5 equiv. conversions of 98% are reported. Importantly, conversions were not 
improved upon using an excess of reagent (2 equiv.) suggesting a limitation based on 
steric hindrance. Reactions were carried out at 60 ℃  with maximum conversion 
obtained in a 3-5 hour timeframe, but the same conversion could be achieved at 
room temperature albeit after 24 hours. The incorporation of hydrazide side-chains 
into polymers towards libraries of functionalised polymers had been relatively little 
explored. Bertozzi’s group synthesised poly(acryloyl hydrazide) via the RAFT 
polymerisation of acetoxime acrylate followed by reaction with excess hydrazine.125 
The scaffold was successfully functionalised with eighteen saccharides of different 
complexities to form glycopolymers for microarray applications. The coupling reaction 
was carried out in an acetate buffer at 50 ℃ with 1.1 equiv. of glycan, with most yields 
good and above after 24 hours. Improved yields were reported only in a minority of 
cases when 2.0 equiv. of glycan was used. The stability of the glycopolymers to 
hydrolysis was evaluated at pH values above 7. More recently poly(acryloyl 
hydrazide) was synthesised from poly(methyl acrylate)126 and its applicability towards 
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a wide-range of applications was shown using different hydrazide click-chemistries. 
The reaction between an aldehyde containing dye and the scaffold at a ratio of 1:75 
(CHO:CONH-NH2) was probed, which showed reaction completion in under 10 
minutes in aqueous conditions. Experiments with 2-hydroxy-1-napthaldehyde (0.5 
equiv.) showed complete conversion after overnight reflux in a mixture of MeOH:H2O 
(1:15). The reversibility of the reaction was investigated at pH 5.0 at 37 ℃  and 
revealed 75% release of the aldehyde over an 11 days period. This evidences both 
that the functional polymer is stable to hydrolysis in a pH dependent manner, enough 
for immediate use, testing and analysis, but also labile enough for drug-release or 
dynamic applications. In the past few months, the direct synthesis via RAFT 
polymerisation of poly(methacryloyl hydrazide) and poly(2-methacrylamidoethyl 
carbohydrazide) in aqueous conditions has been achieved with good control.127 This 
has been the first reported synthesis of polyhydrazides that didn’t require protecting 
groups, as in the past it was observed that the hydrazide side-chains attack and 














10 equiv. N2H4 
DMF, 0 ℃
Figure I.13: Representative examples of polymer scaffolds containing 
O-hydroxylamine or hydrazide side-chains.
functionalised with a diversity of saccharides with different conjugation efficiencies, 
however studies into the functionalisation of such systems with a wide array of 




 Considering the properties that are believed to be desirable by the author, for 
a scaffold that can be wide in scope and can be employed rapidly and easily towards 
functional polymers for biomedical applications, polymers incorporating 
hydroxylamine or hydrazide side-chains can be argued to be the candidates with 
most potential. Firstly, the available evidence shows that these scaffolds can be both 
soluble and inert in water. Secondly the reaction between these functional groups 
and aldehyde or ketones produces water as a by-product. Thirdly, functionalisation 
studies have shown that the coupling reaction is overall high yielding or near-
quantitative when equimolar amounts of reagents are used. There is no requirement 
for complex catalyst aside from the addition of an acid catalyst that could be easily 
neutralised. These properties suggest that these scaffolds could be functionalised 
and tested for biomedical application without the need for any post-functionalisation 
purification. However, due to the non-quantitative nature of the reaction, additional 
control studies may be warranted to amount for the effects of free reagents in 
solution (i.e. unconsumed aldehyde/ketone). Considering the reversible and dynamic 
character of the hydrazone and oxime bonds, such control studies would also 
acknowledge the effects of released molecules in situ.  
 Although, the discussion was condensed on the non-aldol carbonyl click-
chemistry it is worth mentioning that hydrazides and hydroxylamines can be used in 
the other click-chemistry type reactions where amines are used as chemical 
modulators (e.g. reaction with epoxides, isocyanates, active esters) to form non-
reversible covalent bonds. This could be potentially useful, if a permanent chemical 
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modification (e.g. attaching a dye or a receptor) is required, while still being able to 
synthesise subsequent combinatorial libraries.  
 The main differences between hydrazines, hydroxylamines and hydrazides are 
their basicity and the stability to hydrolysis of the resulting hydrazones and oximes. 
The basicity decreases in order, from hydrazines to hydroxylamines to hydrazides 
with some reported pKa values for protonated hydrazines (~ pKa 8), hydroxylamines 
(~pKa 6) and hydrazides (~ pKa 3.5).128-130 This would suggest that at neutral pH a 
hydrazine scaffold will be strongly protonated, a hydroxylamine scaffold would be 
less than 50% protonated while a hydrazide scaffold would be only weekly 
protonated. It is well established that cationic polymers are generally more cytotoxic 
than neutral polymers,15,131-133 and it is believed in the context of biological 
applications (e.g. mimics of antimicrobial peptides) that a non-cytotoxic scaffold is 
preferred. As such, polyhydrazides are potentially the better candidates out of the 
three categories with regards to decreased cytotoxicity. In terms of stability to 
hydrolysis, oximes are more stable over a larger pH range (pH 2-7) compared to the 
smaller range (pH 5-7) for hydrazones, but both are labile at basic pH (> pH 9). The 
smaller pH stability range in hydrazones would suggest that scaffolds based on this 
type of bonding would have a more dynamic character, and would open the avenue 
for template driven combinatorial libraries, as well as applications of targeted delivery 
(e.g. drugs, siRNA) based on pH differences (e.g. acidic pH in tumour cells). Given 
the properties described above, it is the author’s belief that polymeric scaffolds 
containing hydrazide side-chains for post-polymerisation functionalisation with 
aldehydes offer great promise for the discovery of functional polymers for biological 
applications. 
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 In this research the aims were to synthesise a set of polyhydrazide scaffolds, 
investigate the functionalisation of these polymers with aldehydes and evaluate the 
performance of libraries of functional polymers as carriers for siRNA delivery.  
 The initial target was to develop a direct synthetic route of poly(acryloyl 
hydrazide) via RAFT polymerisation (see Chapter 1), ideally in aqueous conditions, 
taking advantage of the good track of the polymerisation of polyacrylamides using 
RAFT. Although poly(acryloyl hydrazide) had been synthesised previously by Bertozzi 
et al.125 the reported route involved the use of an oxime monomer, transformed 
post-polymerisation into a hydrazide using rather harsh conditions in both steps (i.e. 
dioxane, hydrazine). 
 Following on, the metal catalysed polymerisations of alkynes134 was pursued 
to synthesise poly(acetylene hydrazide) and poly(phenylacetylene hydrazide) (see 
Chapter 2) to exploit their intrinsic helicity. Helical scaffolds would be of particular 
value for two reasons. Firstly, the functionalisation of such structures is predicted to 
be more efficient on entropic grounds compared to linear polymer scaffolds, which 
need to surrender considerable degrees of freedom during binding. Polyacetylene 
backbones have inherently less conformational freedom and should exhibit better 
template binding. Secondly, many naturally occurring biologically interesting motifs 
(e.g. antimicrobial peptides) exhibit helical conformations with segregated 
hydrophobic and hydrophilic faces.135 Libraries of synthetic mimics of such molecules 
via functional polymers could be accessed rapidly starting from a helical scaffold. 
 Finally, having analysed the functionalisation of these different scaffolds, the 
author pursued to prove the usefulness of poly(acryloyl hydrazide) to synthesise and 
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identify non-toxic amphiphilic polymers that can bind siRNA, transport the cargo 
across membranes and release the cargo inside cells (see Chapter 3).  
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Chapter 1 
Acrylic Polymer Scaffolds via 
 RAFT Polymerisation 
Extracts from this chapter can be found in the following article: 
D. N. Crisan, O. Creese, R. Ball, J. L. Brioso, B. Martyn, J. Montenegro and F. 
Fernández-Trillo, Polym. Chem., 2017, 8, 4576–4584  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1.1 Background 
 The reversible addition-fragmentation chain transfer (RAFT) process is a 
powerful tool in modern living/free radical polymerisation. Its wide versatility with 
regards to substrates, solvents and reaction conditions, has caused increased 
interest from both the academic and industrial sectors since the initial report in 19981. 
The process relies on the use of transfer agents to control the rate of polymerisation 
reactions, polymer chain lengths and polydispersity. These unsaturated compounds 
with general structure 1.1 act through a two-step addition-fragmentation mechanism 
shown below (Scheme 1.1). One of the essential components in these molecules is 
a C=X reactive double bond where X is most often a methylene group or a sulfur 
group. The Z group is chosen so that it can provide the optimum balance between 
reactivity with monomer and stability of the resulting intermediate. The R group must 
be a suitable good free radical leaving group but also a good initiating radical. An 
efficient RAFT process requires that the product of the chain transfer process to act 
as a chain transfer agent with activity similar to, or greater than, the initial transfer 
agent. As a consequence, group A is most commonly also a methylene or sulfur 
group and generally the same as X.  
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1.1
Scheme 1.1: Addition-Fragmentation mechanism.
Z










Kinetic RAFT polymerisation 
 RAFT polymerisations generally follow first-order kinetics, and as a 
consequence, the rate of polymerisation is proportional to the concentration of 
monomer in the reaction. From the integrated first order rate law: 
ln[M] = -kt +[M0] or 
 ln([M]/[M0]) = -kt or  
ln([M0]/[M]) = kt 
where [M] is the concentration of monomer at time t. Since [M] is inversely 
proportional to the percentage conversion, and in a controlled polymerisation, the 
molecular weight of polymer chains in the reaction increases proportionally to the 
consumption of monomer, it is expected that the molecular weight (Mw) follows a 
linear relationship with percentage conversion. Furthermore, controlled 
polymerisations like RAFT are characterised by low dispersity indexes throughout the 
reaction.  
 As observed in Scheme 1.1, radicals are neither formed nor destroyed as a 
consequence of the RAFT equilibria.2 The RAFT agent can behave as an ideal 
transfer agent once a steady state is established, thus, its presence in the 
polymerisation medium does not affect the rate of reaction. As long as the 
fragmentation of the RAFT adduct radical and subsequent re-initiation are rapid and 
not rate determining, the RAFT mechanism does not induce any inherent rate 
retardation. In the initiation step of the reaction, short chains are generated, which 
progressively increase in size as part of the subsequent RAFT equilibration, 
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reinitiation and chain equilibration steps (Scheme 1.2). The rate coefficients of the 
above steps are very often dependent on the chain length, particularly the 
termination and propagation steps. Because of this dependence, rate of 
polymerisations under RAFT agent control are often very different than those under 
normal radical polymerisation conditions. 
 Apart from the above-mentioned factors, addition of a RAFT agent to a 
polymerisation reaction can significantly influence its reaction kinetics, through either 
of two phenomena: 
- an inhibition period at the beginning of the reaction where little or no 
polymerisation is observed. 
- rate retardation, in which addition of the RAFT agent significantly decreases the 
rate of polymerisation compared to its analogous radical reaction for the duration 
of the entire process. 
 Inhibition phenomena are generally associated with the pre-equilibrium 
(initialisation) stage in which the original RAFT compound is converted to the 
polymeric RAFT agent. Other inhibition phenomena can be attributed to impurities in 
the RAFT agent or by-products of the polymerisation reaction. The effects of the 
former can be minimised or eliminated by an appropriate choice of stabilising group Z 
and leaving group R. Rate retardation and inhibition effects are most prone in RAFT 
agents carrying Z groups that most effectively stabilise the adduct radicals. Agents 
where the group is a phenyl or other aromatics are known to show strong inhibitory 
effects. To completely avoid inhibition phenomena associated with the pre-equilibrium 
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and initialisation stages, a macromolecular or polymeric RAFT agent can be 
employed. Alternatively, agents such as trithiocarbonates which have a more reactive 
C=S double bond can be used. 
 Another important observation in RAFT-mediated polymerisations is called 
hybrid behaviour. This manifests as a rapid increase in molecular weight and a broad 
initial polydispersity that narrows with increasing conversion, but it also displays 
significant rate retardation as the molecular weight approaches the calculated 
molecular weight based on full conversion. This behaviour is generally observed with 
macromonomer RAFT polymerisation and in the case of less active thiocarbonylthio 
compounds. The experimental observations and approximate trends can generally be 
summarised as follows: 
i. The RAFT process should not induce any rate retardation/inhibition effects if the 
RAFT adduct radicals are fast to fragment. 
ii. The more reactive the propagating radical (the less reactive the monomer), the 
higher the equilibrium constants in both the pre- and main equilibrium. 
iii. An increasing stability of the RAFT adduct radical and inability of the leaving 
group to reinitiate polymerisation increases the chances of inhibition/rate 
retardation occurrences for a given monomer. 
iv. Less reactive propagating radicals (derived from more reactive monomers) 
require RAFT agents with increased C=S double bond reactivity to minimise 
possibility of hybrid behaviour. 
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The Mechanism of the RAFT process 
 Mechanistically, the RAFT polymerisation (Scheme 1.2) is initiated (Step I) in 
the same manner as traditional radical addition polymerisations. The short polymeric 
chains formed are then transferred onto the RAFT agent that releases a new radical 
initiator (Step II). In this re-initiation step (Step III), new short polymeric chains are 
formed. An equilibrium (Step IV) is established wherein the “radical” is “passed” 
between polymeric chains via the RAFT agent. The chain holding the radical can 
react and grow with monomer still present in solution in the same fashion as radical 














































Scheme 1.2: The mechanism of RAFT polymerisations. Reaction control is highly 
dependent on the equilibrium constants associated with the two equilibria. 
react, resulting in a dead polymer, which cannot be reinitiated. Indeed, during RAFT 
polymerisation, termination through the formation of dead polymers is undesirable as 
it leads to increased dispersity. 
RAFT agents and their substrate compatibilities 
 The effectiveness of a RAFT agent depends strongly on the monomer 
polymerised and on the properties of the free radical leaving group R and the group 
Z3,4, which is tuned to activate or deactivate the thiocarbonyl double bond and to 
modify the stability of the intermediate radicals. RAFT agents (Fig. 1.1) can be 
classified with respect to the Z group into dithioesters, trithiocarbonates, xanthates, 
dithiocarbamates and other highly specific moieties.  
 Dithioesters that display an aromatic Z group are amongst the most active 
RAFT agents. In the presence of a suitable R group they form the class of agents 
most suited for (meth)acrylic (MMA, MA) and styrenic (S) monomers. A downside in 
their use is that when used in high-concentrations to afford low-molecular weight 
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Z: Ph >> SCH3 > CH3 - N >> N
O
> OPh > OEt - N(Ph)(CH3) > N(Et)2
MMA VAc, NVP































Ph- > > >> - - > -
MMA
S, MA, AM, AN
VAc, NVP
Figure 1.12: Guidelines for the selection of RAFT agents for a variety of monomers. 
From left to right: for Z, addition rates decrease and fragmentation rates increase; 
for R, fragmentation rates decrease. Dashed lines indicate partial control during 
polymerisation (i.e. control over molecular weight but poor polydispersity).
polymers, polymerisations suffer from rate-retardation. Additionally, they are 
susceptible to hydrolysis and decomposition in the presence of Lewis acids. RAFT 
agents based around trithiocarbonates, despite being less active than dithioesters, 
provide good control in the polymerisation of (meth)acrylic (MMA, MA) and styrenic 
(S) monomers whilst being less prone to degradation. Dithiocarbamates and 
xanthates are useful RAFT agents in polymerisations where the propagating radical 
is a poor homolytic leaving group. Monomers related to vinyl acetate (VAc) or 
N-vinylpyrrolidone (NVP) are suitable species that can be polymerised by the less 
active transfer agents.  
Solvent Selection 
 RAFT polymerisation remains in effect a radical polymerisation. As a 
consequence, it remains highly versatile in terms of reaction media. A large variety of 
solvents are tolerated including protic solvents such as alcohols and water. 
Furthermore, RAFT polymerisation can be also be carried out in unconventional 
media such as ionic liquids5. Ultimately, the choice of solvent has to be made with 
regards to the requirements of the chain transfer agent used and the monomer 
polymerised. It also needs to be remembered that the more active dithioesters chain 
transfer agents are susceptible to hydrolysis.  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1.2 Objectives 
 The primary objective was to synthesise a simple acrylic polymer with a 
hydrazide side chain as the anchor for aldehydes. The target of choice was 
poly(acryloyl hydrazide) P1 (Scheme 1.3). 
 Initially, the development of a robust, efficient and clean synthesis to obtain 
monomer 1.2 was targeted. It was considered best, those synthetic pathways that 
rely on the use of safer chemicals and facile purification methods. By facile, it was 
generally meant purification techniques such as phase-separation, recrystallization 
and trituration while generally avoiding techniques such as chromatography. Once 
the initial step was achieved the synthesis and characterisation of poly(acryloyl 

















Scheme 1.3: Primary objective. The synthesis of poly(acryloyl hydrazide) P1 from 


























Scheme 1.4: Second objective. To investigate the coupling of P1 with aldehydes to 
afford functional polymers, and as a minor subsequent aim, investigate reducing 
conditions to immobilise the aldehyde.
Secondly, it was aimed to test the polymer’s reactivity through its hydrazide side-
chains with several aldehydes to determine hydrazone formation, binding efficiency, 
reaction conditions and polymer size effects on the chemistry investigated. The 
investigation into different chemistries suitable for the reduction of hydrazones to 
hydrazines (Scheme 1.4) to permanently immobilise aldehydes to the polymer 
scaffold was also planned. The final objective was to develop suitable pathways to 
attach fluorescent dyes using the polymer’s end group towards fluorescent 







Linker A Fluorescent dye











Linker A Fluorescent dye
Linker BFluorescent dye
Scheme 1.5: Final objective. To investigate suitable pathways to functionalise P1 
with fluorescent dyes through its end groups.
P1
1.3  Results and Discussion 
Synthesis of poly(acryloyl hydrazide) P1 
 To synthesise acryloylhydrazide 1.2 reactions involving the formation of similar 
molecules were looked into, especially the formation of amides. The most frequent 
approaches6-8 involve the reaction of an amine with an acid chloride or with an 
activated carboxylic acid. The immediate equivalent would have been to react 
acryloyl chloride directly with hydrazine, but in retrospect to the synthetic guidelines 
detailed in the objectives, hydrazine had two main shortfalls. Firstly, the safety 
hazards associated with hydrazine make it unattractive to use, but also, its ability to 
react at both ends meant that di-substitution side reactions were possible, resulting in 
the requirement for more complex purification methods such as chromatography. As 
a consequence, a Boc-protected hydrazine in the form of tert-butyl carbazate was 
chosen. The reaction (Scheme 1.6), which produced the target tert-butyl 2-
acryloylhydrazine-1-carboxylate 1.3, was carried out in a THF/NaOH(aq) emulsion to 
neutralise the HCl produced as the reaction by-product. 
 
Although the reaction was efficient in the sense that the product could be obtained 
using facile work-up procedures, the relatively poor overall yield (<35%) correlated to 
long reaction times (>4 hours) made it unattractive for larger scale synthesis. 
Additionally, during attempts to scale-up the reaction, new unidentified side-products 















0 ℃ to r.t., 35%
1.3
Scheme 1.6: Reaction scheme showing the initial synthesis of the target precursor 
tert-butyl-2-propiolohydrazine-1-carboxylate (1.3).
techniques. Consequently, an alternative conjugation pathway9 was explored and 
adapted so that tert-butyl carbazate was reacted with acrylic acid activated using 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (Scheme 1.7). 
 
Modifications from the original reported conditions9 were made to accommodate the 
product’s poor solubility in water. As a consequence, THF was added as a co-solvent 
in a 1:2 mixture with water. An unknown minor side-product seems to be produced in 
this reaction, which required the introduction of a recrystallization step after work-up. 
With an average percentage yield of ~65% after two recrystallization cycles, this 
method was deemed suitable, especially since it could be performed on larger scales 
(i.e. 8 g starting material). 
Characterisation data obtained via 1H and PENDANT 13C NMR spectroscopies for 
the isolated product (Fig. 1.2) showed proton environments consistent with two 
amide, two alkene (no distinguishable difference in chemical shift between the cis/
trans protons was observed) and one alkyl proton environment, as well as carbon 
environments consistent with two 4° carbonyls, a 2° alkene and a 3° alkene, a 4° 
alkyl and a 1° alkyl carbon environment. This was in agreement with the expected 
results and the results in the literature.41 Mass spectra obtained were difficult to 
elucidate as they showed a high degree of fragmentation and recombination to afford 
ions with molecular weight higher. Although the molecular ion peak [M+Na]+ is 


















Scheme 1.7: Optimised synthetic route to tert-butyl-2-acryloylhydrazine-1-
carboxylate (1.3).
trimers and tetramers and fragmentation products of these higher molecular species. 
It is believed that these substrates could be relatively reactive in the gas phase and 
as a consequence, they are prone to form higher molecular weight ions via repeated 
fragmentations and recombinations. Tandem mass spectrometry was carried out in 
which the molecular ion peak was selected for the second stage of mass 
spectrometry. This showed the same pattern of peaks where the higher molecular 
weight peaks had a higher intensity compared to the molecular ion peak. 
 Deprotection of hydrazide 1.3 (Scheme 1.8) was performed using 1M HCl(aq)
and relatively long reaction times (48 hours) to afford the hydrazide hydrochloride 






Figure 1.2: (Top) 1H and PENDANT 13C NMR spectra of hydrazide 1.3 in DMSO-
d6. (Bottom) TOF MF ES+ spectrum of hydrazide 1.3 showing the molecular ion 














reaction temperatures had to be kept at room temperatures or below, especially 
when the excess HCl was removed under reduced pressure. The product was 
isolated in quantitative yields by freeze-drying the remaining water. The 1H NMR 
spectrum (Fig. 1.3) confirmed that the deprotection was successful due to the 
absence of the (CH3)3 peak at 1.40 ppm. Alternative deprotection strategies were 
attempted including treatment with TFA, but the compound was never isolated pure 
due to difficulties in removing residual TFA and formation of impurities at that stage. 
In order to polymerise the acryloylhydrazide monomer 1.4, under aqueous buffer 
conditions, a suitable water soluble RAFT had to be chosen. Trithiocarbonate CTA1 
was opted for, as there is a good track record8,10,11 of polymerisation of acrylamides 
and methacrylamides with this family of agents and there was previous experience in 
the laboratory with this molecule. This bright yellow compound was synthesised 






























Scheme 1.9: Synthesis of trithiocarbonate CTA1, the chosen RAFT agent for the 
polymerisation of the alkene monomer.
Having designed a synthetic route to the target monomer and a suitable RAFT agent, 
the investigation of the polymerisation under aqueous buffer conditions was carried 
out. Reactions were carried out in 1 M AcOH buffer at pH 5 to ensure that the RAFT 
agent was deprotonated to enhance its solubility (Scheme 1.10). At pH 5 the 
hydrazide functionality should also be partially protonated13,14 thus decreasing its 
nucleophilicity with respect to the carbonothioyl group. This was considered important 
to avoid destruction of the RAFT agent. 
 Despite observing almost complete monomer consumption by 1H NMR 
spectroscopy within four hours, the expected broad proton signals for the polymer in 
the alkyl region (1.8 - 1.2 ppm) were not observed (Fig. 1.3). Instead two broad 

















1 M AcOH(aq), 




Scheme 1.10: Proposed polymerisation conditions of the deprotected monomer 1.4 
in aqueous conditions. 
Figure 1.3: 1H NMR spectra of the polymerisation reaction of monomer 1.4 in the 
presence of RAFT agent CTA1 at the beginning (left) and end of the reaction (right). 












suggesting formation of polyethylenimine type bonds through nucleophilic conjugate 
addition. Furthermore, after purification by dialysis and lyophilisation to remove the 
water, only a very small amount of a mixture of grey and white precipitate was 
isolated. Based on the visual observation that the initial yellow solution turned murky 
within an hour of starting the reaction, it was hypothesised that RAFT agent 
degradation was occurring.15 Radical polymerisation reactions in the absence of a 
chain transfer agent or in the presence of a non-degradable chain transfer agent 
were carried out. The latter showed very poor monomer consumption while the 
former despite exhibiting over 60% consumption after eighteen hours, did not display 
the expected polymer characteristics. The trace amount of sample isolated after 
dialysis proved to be similar to the product isolated from the RAFT polymerisation.  
 Research conducted by Julia Lipecki under the guidance of the author of this 
thesis, investigated the polymerisation of the deprotected monomer by using a 
different RAFT agent. Dithiocarbamate CTA2 has been shown by Keddie et al.16 to 
be a pH switchable CTA in the sense that in the presence of two distinct monomers, 
each can be selectively polymerised by changing the pH of the aqueous solution. 
Furthermore, the agent was shown to be very robust under strong acidic conditions. 
























Scheme 1.11: Alternative conditions attempted for the polymerisation of the 
deprotected monomer 1.4 in aqueous conditions using a dithiocarbamate CTA.
(Scheme 1.11), starting from the original reported conditions16 (100/1/1/) going as far 
as 100/1/200 to ensure full protonation of the hydrazide monomer. In those 
experiments, similar polymerisation products as those under trithiocarbamate CTA1 
were observed. Reactions between monomer 1.4 and RAFT agent CTA2 under 
acidic conditions in the absence of a radical initiator confirmed that reactions 
between the hydrazide and thiocarbonyl groups are occurring and are competing with 
the polymerisation process. Recent work38 on the polymerisation of a couple of 
methacryl hydrazides, investigated and confirmed the observed nucleophilic attack 
by the hydrazide on the CTA. This was successfully prevented at pH 0 when a 
hydrazide monomer with a acyl side-chain was used.  
 Having analysed that the deprotection step was cumbersome and the 
polymerisation of the deprotected monomer required further investigation, it was 
decided to attempt the polymerisation of the protected hydrazide monomer 1.3 in 
organic solvents with a view to remove the Boc protecting group post-polymerisation. 
In choosing an appropriate organic solvent for the reaction, three conditions had to 
be satisfied. The first condition was that all three reagents (i.e. the protected 
monomer, the RAFT agent and the radical initiator) had to be soluble. The second 
was that solvent had to dissolve the monomer at a concentration of at least 0.9 M or 
above for good reaction times and conversion. The last condition was that the 
solvent’s boiling point had to be above that of the reaction temperature required for 
the efficient thermal decomposition of the radical initiator (70 ℃). Polar solvents like 
THF and MeOH showed good potential in terms of solubility, but their low boiling 
point and volatility upon degassing with argon gas meant they were unreliable to 
maintain the same constant concentration during the reaction. Ethyl acetate satisfied 
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the above conditions but it was found that upon cooling down, from 70 ℃, immediate 
precipitation of Boc-P1 was occurring. This made it difficult to investigate the kinetics 
of the reaction as the polymer precipitated in the syringe during aliquot sampling. 
Ultimately, DMSO was chosen (Scheme 1.12) as it not only satisfied all the 
conditions better than other common organic solvents, but its solubility in water, 
meant that it could be easily removed during dialysis. 
 To test the reaction conditions, a series of kinetic experiments were carried out 
to evaluate the optimum reaction time for different molecular weights. Monomer 
conversion was monitored by 1H NMR spectroscopy at different time intervals (Fig. 
1.4) and the aliquots were further analysed by SEC/GPC. Syringic acid was added to 
1H NMR spectroscopy samples as an internal standard, and the integration of the 
aromatic proton signal at 7.20 ppm was compared against the vinyl proton signals 
from the monomers (6.18 and 5.68 ppm). Two sets of kinetic experiments were 
carried out to verify the observed findings. According to literature,2 polymerisations 
under the influence of a RAFT agent should follow first order kinetics. In both cases a 
deviation from this expected relationship was observed (Fig. 1.5). The plateauing 
feature observed, after reacting for five hours, is consistent with hybrid behaviour of 

























Scheme 1.12: RAFT Polymerisation conditions of the Boc-protected acryloyl 
hydrazide monomer 1.3 to afford Boc-P1.
approaches higher monomer consumption. Nonetheless, optimisation of the process 
was carried out to achieve monomer conversions between 80-90% and polymers 
with degrees of polymerisation (DPs) ranging from DP 43-127 and dispersities (Đ) 
ranging between 1.38-1.52. 
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Figure 1.5: A) Representative linear plot of ln[M]0/[M]t vs. time. Conditions: squares 
[M]=0.9 M, [M]/[CTA]/[ACVA]=100/1/0.2; circles [M]=0.9 M, [M]/[CTA]/
[ACVA]=100/1/0.11. 
B) Representative plot of measured Mw vs. conversion (solid) and Đ vs. conversion 
(hollow). Mw were obtained using SEC/GPC carried out by the Gibson Laboratory 
(Prof. Matt Gibson) at the University of Warwick.
Figure 1.4: 1H NMR spectra of representative aliquots from a polymerisation 
reaction of monomer 1.3 with CTA1 in DMSO-d6 at 70 ℃. The NMR samples were 
spiked with syringic acid as an internal standard. The integration of the monomer’s 
vinyl peaks (6.18 and 5.68 ppm) was compared against the integration of the 















 To extract and purify polymer Boc-protected poly(acryloyl hydrazide) Boc-P1, 
the unreacted monomer was removed alongside the DMSO solvent and other by-
products by dialysis. The polymer was isolated as a white powder after lyophilisation. 
Boc-P1 was characterised by 1H NMR, IR, and UV-Vis spectroscopies for structural 
determination and SEC/GPC for molecular weight determination.  
 The 1H NMR spectrum (Fig. 1.6) showed broad amide peaks at 9.24 and 8.51 
ppm instead of the previously sharp peaks at 9.74 and 8.84 ppm for the monomer. 
The differences in chemical shift could be attributed to the changes in electronic 
effects in going from the alkene to the alkyl-polymer backbone. Broadness was 
expected as a consequence of tacticity. New broad peaks were also observed in the 
alkyl region between 2.20 and 0.90 ppm where the alkyl backbone was expected, 
however some broad peaks were obstructed by a broadened (CH3)3 from the Boc 
group. The FT-IR spectrum (Fig. 1.6) showed significant broadening in most peaks, 
but most relevantly in the amide N-H stretches at 3250 cm-1, the C-H stretches at 



















   
   
   
   
   









Figure 1.6: 1H NMR spectrum of a representative sample of polymer Boc-P1 in 
DMSO-d6 (left). FT-IR spectra of monomer 1.3 and polymer Boc-P1 showing the 








 UV-Vis spectroscopy was used to investigate the presence of the 
trithiocarbonyl group from the CTA, which should be incorporated at the end of the 
polymer chains. CTA1 has a characteristic strong absorbance with ƛmax at 310 nm 
(Fig. 1.7) and its presence in the polymer would be predicted by a similar 
absorbance peak. Indeed, it was observed that Boc-P1 showed a peak with a 
blueshift in the ƛmax (Fig 1.8). By measuring the absorbance of known concentrations 
of CTA1 a calibration curve was plotted (Fig. 1.7) that was used to extrapolate the 
percentage weight contribution of the trithiocarbonyl group to the mass of a weighed 
sample of Boc-P1. Using this technique the molar ratio of monomers to 
trithiocarbonyl group was caluculated, which would give an approximate value of DP. 
This assumed that all polymer chains are terminated with the carbonothioyl group, 
which is not necessarily true. It was hoped to observe DP values close to [M]:[CTA1] 
x percentage monomer conversion (c). Overall the values obtained (DPUV) (Table 
1.1) this way were lower than those predicted according to the percentage 
conversion (DPth). This suggested that there was more CTA1 incorporated than there 
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Figure 1.7: UV-Vis spectra of CTA1 in DMSO at different sample concentrations 
(main). Calibration curves plotted at ƛ300 (max. for Boc-P1), ƛ305 and ƛ310 (max for 
CTA1) (inset).
should have been. However we need to consider that the difference in ƛmax between 
CTA1 and Boc-P1 could lead to a degree of error when extrapolating from the 
calibration curve. Furthermore, there is no indication to differences in the extinction 
coefficient of the CTA1 compared to Boc-P1 containing the same trithio end group. 
As expected, polymer batches synthesised with a higher [M]:[CTA] ratio, so as to 
produce polymers with larger DPs, showed a weaker absorbance at 300 nm (Fig. 
1.8). Overall, this was an interesting attempt to calculate DPs by UV-Vis 
spectroscopy at a time when SEC/GPC was not available to the laboratory, and it 
was useful in showing that batches of polymer with different DPs could be produced. 
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Absorbance of Boc-P1 vs CTA1
Boc-P180
CTA1

















Absorbance of Boc-P1 with varying DPs
Boc-P1170 (1.95 mg/ml)
Boc-P1130 (1.33 mg/ml)
Boc-P140  (0.63 mg/ml)
Boc-P180 (0.74 mg/ml)
Figure 1.8: UV-Vis spectra of Boc-P180 (DP 80) and CTA1 in DMSO showing the 
difference in ƛmax (left). UV-Vis spectra of Boc-P1 with varying DPs (40, 80, 130, 
170) at different concentrations, showing a decrease in incorporated trithiocarbonyl 
groups at the end of the polymer chains (right).
Polymer [M]/[CTA] ca DPthb DPUVc Mnd Đd
Boc-P140 50 86% 43 16 9810 1.38
Boc-P180 99 79% 78 40 20306 1.52
Boc-P1130 151 84% 127 93 31552 1.51
Boc-P1170 195 87% 170 110 44826 1.95
Table 1.1: Boc-protected poly(acryloyl hydrazide)s (Boc-P1x) described in this 
research. acalculated from 1H NMR peak integration of alkene signals versus a 
known standard. b[M]/[CTA] x c. ccalculated by calibration to CTA content. 
dcalculated by SEC/GPC.
 Initially, the characterisation of Boc-protected poly(acryloyl hydrazide) Boc-P1 
by SEC/GPC using two PLGel columns and THF or acetone as eluents was 
attempted. Despite being soluble, no polymer peaks were visibly separated from the 
solvent front in either of the two solvents. Using DMF as an eluent resolved the 
separation problems but the observed Đ were suspiciously high (3.49-5.92). Indeed, 
addition of 0.05M LiBr to DMF lead to significant improvements to Đ values (Table 
1.1) as the salt suppresses sample-stationery phase interactions.39 SEC/GPC 
confirmed that the synthesis of polymers up to DP 130 with a fair degree of control 
over size and Đ (up to 1.52) (Fig. 1.9) was achieved. Polymers with around DP 170 
were also synthesised but the Đ values were higher (1.95). 
 Having accomplished this relatively rapid, reproducible and scalable route 
from starting materials to the protected polymer, possible deprotection and 
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Figure 1.9: SEC/GPC chromatograms of Boc-P1x. Eluent: DMF (0.05M LiBr) at 
60oC; Flow: 1.0 mL min-1; Columns: Polymer Labs PolarGel guard column (50 x 7.5 
mm, 5 µm),  2  x  PLGel  PL1110-6540  columns  (300  x  7.5  mm,  5 µm). 
Molecular weights were calculated based on a standard calibration method 
using PMMA.
purification strategies were explored. A sample of polymer was dissolved in 
trifluoroacetic acid (TFA, 1 ml to 100 mg polymer) and immediate gas evolution 
related to the emission of CO2 was observed as part of the Boc group removal. After 
precipitation in Et2O, the sample was dissolved in water, and two purification 
strategies were tested. One strategy involved direct lyophilisation to afford yellow 
coloured crystals (Fig 1.10), while in the second strategy, the sample was first treated 
with a saturated solution of NaHCO3 and dialysed against water. This was done to 
deprotonate the hydrazide TFA salt resulted as part of the deprotection reaction, and 
immediate bubbling consistent with the break down of carbonic acid was observed. 
After lyophilisation a white powder was isolated (Fig. 1.10), posing questions 
regarding the structural differences leading to different colours between the two 
samples. 
 Ultraviolet-visible spectrometry showed that the sample that was treated with 
sat. soln. NaHCO3 had lost its absorbance at 300 nm caused by the presence of the 
RAFT group (Fig. 1.11). Furthermore, the same sample gave a rapid coloured 
response when exposed to Ellman’s Reagent (DTNB, 5,5’-dithiobis-(2-nitrobenzoic 
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Figure 1.10: Photographs showing: A) Sample of Boc-P1 deprotected and 
lyophilised without basic treatment. B) Sample of Boc-P1 deprotected, treated with 
a sat. soln. NaHCO3, dialysed and lyophilised.
A B
acid), a common test for thiols) with a characteristic absorbance peak at ƛ435 nm. The 
non-dialysed sample still had its absorbance at 300 nm and tested negative in the 
presence of DTNB as evidenced by the absence of a peak at ƛ435 nm.  
 Since RAFT groups are unstable in basic media or in the presence of primary 
or secondary amines it is believed that the hydrazide side-chains could react with the 
trithiocarbonyl group as a side-reaction during their functionalisation with aldehydes. 
By combining the deprotection step with a NaHCO3 neutralisation step a cascade 
reaction (Scheme 1.13) was developed that would result in the target polymer 
scaffold P1. 
 Poly(acryloyl hydrazide) P1 was isolated as a white powder after purification 
via dialysis against water and lyophilisation, and characterised via 1H and 13C NMR 
spectroscopy and SEC/GPC. UV-Vis spectroscopy was used to confirm to 
transformation of the trithiocarbonyl group into a thiol. P1 was insoluble in all organic 
solvents, however dissolution could be achieved by first dissolving the sample in 
aqueous solvents and adding a miscible organic solvent. Solubility could be achieved 
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Figure 1.11: UV-Vis spectra showing of the absorbance of deprotected Boc-P1 
isolated via two different methods and its reaction with DTNB. P1 that was not 
treated with NaHCO3 still shows the characteristic peak at ƛ300 nm due to the 
trithiocarbonyl group (left). P1 treated with NaHCO3 no longer displays a peak at 
ƛ300 nm and the newly formed thiol is evidenced by its reaction with DTNB (right).
in systems with at least 5% H2O content in DMSO. As a consequence, all 1H NMRs 
spectrums with P1 and subsequent functionalisations were carried out in D2O or 
DMSO with D2O as co-solvent resulting in proton exchanges with the N-H protons so 
these were not visible. The alkyl polymer backbone represented by three broad 
peaks between 2.25-1.30 ppm closely resembles the same features displayed by 
poly(acryloyl hydrazide) synthesised by Bertozzi’s Lab.17 Furthermore, the two methyl 
groups from the carboxylic acid end at 1.00 and 0.94 ppm were also observed (Fig. 
1.12). By comparing the intensity of these peaks versus the broad alkyl signals, the 
DP of the polymer sample could be estimated. Because there are 6H from the two 
methyl groups at the terminus, and every repeating unit in the polymer chain has 3H, 



























Scheme 1.13: Cascade deprotection and neutralisation from Boc-P1 to achieve 








Figure 1.12: 1H NMR (left) and PENDANT 13C NMR (right) spectra of a sample of 
P140. 
Using this integration method, DP values for P1x were obtained, which were in 
accordance to the approximated values obtained for Boc-P1x in the previous step, 
and the difference between samples of different molecular weights was correctly 














Figure 1.13: 1H NMR spectra of four samples of P1 with different DPs and 
molecular weights.
Polymer DPNMRa Mnb Đb
P140 49 10918 1.37
P180 106 18446 1.33
P1130 136 —c —c
P1170 162 —c —c
Table 1.2: Poly(acryloyl hydrazide)s (P1x) described in this research. acalculated 
from 1H NMR peak integration of methyl signals versus alkyl backbone signals. 
bcalculated by SEC/GPC and calibrated against PEG standards, csamples were 
not soluble in DPBS.
 Aqueous SEC/GPC was carried out using two PL-aquagel-OH columns and 
LonzaTM DPBS (pH 7.4) as eluent. The molecular weights obtained were based on a 
calibration curve with PEG standards, however P1130 and P1170 were not soluble in 
this buffer and no data was obtained for them. In other buffer conditions no sample of 
P1 was visible regardless of molecular weight. 
The polymers were also analysed by SEC/GPC using two Shodex Asahipak 
columns, 100 mM AcOH as the eluent. The polymers were not detectable by neither 
the UV-Vis nor the RI detectors, however, it was decided to use the hydrazide side-
chain to attach an aldehyde with a strongly UV-Vis active group. The choice was 
made to react P1 (Scheme 1.14) with 4-imidazolecarboxaldehyde (A1) in the same 
solvent as the eluent and inject the crude. The resulting functionalised polymers 
P1A1 were detectable by SEC/GPC. 
Furthermore, it was also observed (Fig. 1.14) that there was limit to the number of 
aldehydes that could be attached to the scaffold. At levels above 0.75 equiv. 
unbounded imidazole A1 (31 min) was observed in the SEC/GPC spectra. The 



























Scheme 1.14: Functionalisation of P1 with imidazole A1 for SEC/GPC analysis.
was not unexpected, as it is believed the side-chains are becoming increasingly 
sterically hindered. Similar levels of functionalisation were reported by Bertozzi’s 
group during their synthesis of glycopolymers using a similar scaffold to P1.17 
Functionalisation of poly(acryloyl hydrazide) P1 with aldehydes 
 To investigate the functionalisation of poly(acryloyl hydrazide) under aqueous 
conditions we used 4-imidazolecarboxaldehyde A1 as a model hydrophilic aldehyde 
and P140 as the polymer scaffold. As reported before, by SEC/GPC the coupling of 
A1 in 100 mM AcOH(aq) was complete up to ~0.75 equiv. aldehyde. This was 
investigated further by 1H NMR spectroscopy in a 100 mM AcOH/D2O buffer. It was 
observed that the duration of the coupling was not dependent on the number of 
equivalents added, with 0.3 and 0.6 equiv. of A1 requiring one hour for complete 
coupling to be observed (Fig. 1.15). For 0.9 equiv., no full consumption of aldehyde 
was observed even after 24 h. (Table 1.3), however the amount of free aldehyde 
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P1 with varying amounts of A1
P1 + 1.00 equiv. A1
P1 + 0.75 equiv. A1
P1 + 0.50 equiv. A1
P1 + 0.25 equiv. A1
A1
P1
Figure 1.14: SEC/GPC chromatogram showing the functionalisation of P1 with 
imidazole aldehyde A1 at different equivalence values.
(~27%) was generally constant at measured time intervals, suggesting that ~66% of 
the hydrazide side-chains had reacted. For 0.6 equiv., despite initially observing full 
aldehyde consumption, it was observed that after 48 hours 7% of the aldehyde had 
been regenerated (Fig. 1.15) suggesting that the hydrazones formed are not 
completely stable under these conditions. 
Further coupling under aqueous conditions was investigated by reacting P140 with a 
series of hydrophilic aldehydes including glyceraldehyde (A2), anionic glyoxylic acid 
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A1
0.9 equiv. A1, t=1h
0.6 equiv. A1, t=1h
0.3 equiv. A1, t=1h
0.6 equiv. A1, t=1h
0.6 equiv. A1, t=4h
0.6 equiv. A1, t=48h
Figure 1.15: 1H NMR spectra of A1 (Top) and P140 in the presence of decreasing 
amounts of A1 (left). 1H NMR spectra of P140 in the presence of 0.6 equiv. A1 at 
different time intervals. 
Table 1.3: Percentage loading of P140 with 4-imidazolecarboxaldehyde (A1) 
















(A3) or aldehydes which contain biologically important motifs such as betaine 
aldehyde chloride (A4), pyridoxal-5’-phosphate (A5) and 5-formyluracil (A6) (Table 
1.4). As expected, the coupling was highly dependent on the solubility of both the 
aldehyde and functionalised polymer in the buffer used. When acidic conditions were 
used (5% AcOH, 24 h incubation time) only the neutral (A2) and the cationic 
aldehydes (A4) gave similar degrees of functionalisation to that reported for the 
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5% AcOH in 
D2O
1 P140A1 66 - 74
2 P140A2 65 13 20
3 P140A3 3 63 68
4 P140A4 80 - 30
5 P140A5 —a 86 —a
6 P140A6 —a —a 65
Table 1.4: Percentage loading in coupling reactions of P140 with different water 
soluble aldehydes under different aqueous conditions. All experiments 
characterised after 24 h incubation at 60 ℃. Percentage functionalisation 













































A1 A2 A3 A4 A5 A6
imidazole derivative (A1). The anionic phosphate aldehyde (A5) and the uracil 
derivate (A6) were insoluble in this acidic buffer while glyoxylic acid (A3) resulted in 
insoluble polymers that compromised the characterisation of the degree of 
functionalisation. Switching to a basic phosphate buffer (100 mM Na2HPO4) 
compromised the overall coupling, and in this case, only the anionic derivatives gave 
satisfactory degree of functionalisation. Indeed a good 63% coupling was observed 
for glyoxylic acid (A3) and a very good 86% coupling for pyridoxal-5’-phosphate (A5). 
5-Formyluracil (A6) remained insoluble in both acid and basic media so a polar 
organic solvent like DMSO was opted for, to carry out the coupling. However, due to 
the solubility properties of P1 mentioned before, the functionalisations of P1 in 100% 
DMSO could not be carried out, instead the polymer had to be dissolved in an 
aqueous AcOH buffer first and diluted in DMSO up to 95% DMSO content. Using a 
co-solvent like DMSO in the coupling reactions facilitated the comparison of 
percentage functionalisation between different aldehydes in the same solvent. 
Investigation of the kinetics of the reactions with our model aldehyde A1 revealed 
that although similar degrees of functionalisation could be achieved, often longer 
incubation times (24 h) and temperatures of 60 ℃  were required. This observation 
seems to be in accordance to one of the fundamental principles of click-chemistry, 
which states that when water is used in reactions as a solvent, it can act as a 
powerful catalyst.18 Using a 1:1 mixture of aqueous buffer (5% AcOH in D2O) and 
DMSO-d6, less than half of the imidazole (A1) had coupled after incubation for 24 h 
at 60℃ (Fig. 1.16). Surprisingly, however, using a 5% of the aqueous buffer and 95% 
DMSO-d6 solvent mixture, functionalisation of 74% of side-chains was achieved. In 
light of this observation, all coupling reactions with the remaining aldehydes (A2-A6) 
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were carried out in this solvent mixture (95% DMSO-d6 / 5% AcOH in D2O) and 
reaction conditions (24 h incubation time at 60 ℃). Under these conditions, P140 was 
successfully functionalised up to 65% with the uracil derivative (A6), which was 
previously not determined due to its insolubility in the aqueous buffers used. All 
aldehydes apart from pyridoxal-5’-phosphate (A5) were soluble and coupled with 
varying results. Glyceraldehyde (A2) showed a low degree of functionalisation (20%) 
as evidenced by the hydrazone peak at 7.38 ppm, mainly, believed to be, due to 
competing self-polymerisation reactions via cyclic ketal formation as evidenced by 
the disappearance of the aldehyde peak and the appearance of a new signal at 3.53 
ppm (Fig. 1.17). 
 In biological applications such as antimicrobial polymers and gene delivery 
vectors there is often the need for hydrophobic components.19-24 Using DMSO in the 
coupling reactions allowed the investigation of the coupling of a series of 
commercially available hydrophobic molecules ranging from aromatic to aliphatic 
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Figure 1.16: 1H NMR spectrum of the functionalisation of P140 with 












aldehydes. Among these, it was experimented with unsubstituted aromatics like 
benzaldehyde (A7) and naphthaldehyde (A8), hydroxy or fluoro-substituted 
aromatics such as 4-hydroxybenzaldehyde (A9), 2,3-dihydroxybenzaldehyde (A10), 
and 2,4,6-trihydroxybenzaldehyde (A11), 2,4,6-trifluorobenzaldehyde (A14) and 
2,3,4,5,6-pentafluorobenzaldehyde (A15), carboxylated aromatic aldehydes such as 
5-formylsalicylic acid (A12), heteroaromatic aldehydes such as 4-imidazole 
carboxaldehyde (A1) and indole-3-carboxaldehyde (A13), as well as aliphatic linear 
and branched aldehydes such as acetaldehyde (A16), isovaleraldehyde (A17), 
2-ethylhexanal (A18), octanal (A19) and decanal (A20). 
Initially the coupling was investigated in a 1:1 mixture of aqueous buffer (5% AcOH in 
D2O) and DMSO-d6 to mimic the conditions used in the work on siRNA delivery (see 
Chapter 3). The experiments were carried out by dissolving the aldehyde in DMSO 
and adding the polymer solubilised in the aqueous buffer. For most samples 
immediate precipitation of aldehyde or functionalised polymer was observed (Fig. 
1.18), but most samples dissolved after stirring and heating to 60 ℃  for 4 h. Upon 
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Figure 1.17: 1H NMR spectra of the glyceraldehyde (A2) control reaction (left). 1H 
NMR of P140 functionalisation with glyceraldehyde (A2) (right). Both samples were 
incubated for 24 h at 60 ℃ in 5% aqueous buffer (5% AcOH in D2O) 95% DMSO-






cooling, however, most samples precipitated out of solution. Interestingly, the 
precipitates formed did display different colours than the original precipitates 
suggesting that coupling to poly(acryloyl hydrazide) had occurred. Further evidence 
towards functionalisation is that the 1H NMR spectra showed complete absence of 
polymer but presence of free aldehyde, quantification of coupling was not obtained 
however. 
 The coupling reactions were repeated in 5% aqueous buffer and 95% DMSO-
d6 and overall the coupling efficiency for aromatic aldehydes was around the 70% 
expected benchmark regardless of the molecule size (Table 1.5, Entry 1 vs Entry 2) 
or substitution at the aromatic centre (Entry 3 vs Entry 4 vs Entry 6, vs Entry 8). 
Short aliphatic aldehydes showed very good coupling efficiencies (Entry 10 vs Entry 
11) while for the bulkier molecules (Entry 12 vs Entry 13 vs Entry 14) the couplings 
are estimative since turbid solutions were observed suggesting insoluble products or 
micelle formation. Percentage functionalisation was determined by 1H NMR 
spectroscopy signal integration (Fig. 1.19) by comparing the sharp aldehyde peak 
against the other peaks and the newly formed broad hydrazone peak (usually ~7.40 
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Figure 1.18: Photographs showing: Reactions of poly(acryloyl hydrazide) P140 with 
different aromatic and aliphatic aldehydes at t=0 (left) and t=4 h (right) in 1:1 
mixture aqueous buffer (5% AcOH in D2O) and DMSO-d6.
A (18, 7, 20, 12, 17, 8, 10, 13, 11, 1, 19, 16) A (13,10, 9, 18, 16, 8, 7, 12, 1, 17, 19, 20)
ppm, generally not clearly identified with aromatic aldehydes due to broadening of 
aromatic signals). The integration was compared against control reactions in which 











































A7 A8 A9 A10 A11 A12 A13
A14 A15 A16 A17 A18 A19 A20
Entry Polymer %loading Entry Polymer %loading
1 P140A7 64 8 P140A14 72
2 P140A8 73 9 P140A15 56
3 P140A9 71 10 P140A16 96
4 P140A10 85 11 P140A17 75
5 P140A11 50 12 P140A18 —a
6 P140A12 75 13 P140A19 62a
7 P140A13 52 14 P140A20 59a
Table 1.5: Percentage loading in coupling reactions of P140 with different 
hydrophobic aldehydes. All experiments characterised after 24 h incubation at 60 ℃ 
in 5% aqueous buffer and 95% DMSO-d6. Percentage functionalisation calculated 











(5% AcOH in H2O)











reaction and control were spiked with equimolar amounts of syringic acid prior to 
running 1H NMR spectroscopy. Furthermore, broadening of the signals belonging to 
the aldehyde was a clear indication that coupling was occurring. Several aldehydes 
(A11, A13, A15) displayed degrees of functionalisation visibly lower than the overall 
average. It is believed that 2,4,6-trihydroxybenzaldehyde (A11) has a less 
electrophilic carbonyl centre as a result of electron delocalisation due to the three 
hydroxy groups. Furthermore, in the control reaction, the peak at 5.80 ppm (Fig. 
1.20), which was assigned to the two aromatic protons, integrates to only 33% 












Figure 1.19: 1H NMR spectra of the reaction of P140 with isovaleraldehyde (A17) 
(top left) and 4-hydroxybenzaldehyde (A9) (bottom left) and their controls (top right, 
bottom right), showing the determination of percentage loading. Samples were 
incubated for 24 h at 60 ℃ in 5% aqueous buffer (5% AcOH in D2O) 95% DMSO-
d6. Samples were spiked with equimolar amounts of syringic acid (7.19 ppm).
be due to longer relaxation time of the aromatic protons, although 1H NMR 
spectroscopy experiments carried out with longer scans and longer relaxation times 
always resulted in similar results as the normal conditions. Alternatively, there is a 
possibility that in this acidic solvent mixture proton exchange with the aromatic 
protons could be occurring.25 This made the accurate determination of percentage 
loading more difficult. The pentafluorobenzaldehyde (A15) similarly displayed 
peculiarities in its 1H NMR spectra (Fig. 1.20). The spectra of the control displayed 
an unexpected singlet peak at 6.12 ppm which had an integration of 0.40 compared 













Figure 1.20: 1H NMR spectra of the reaction of P140 with 2,4,6- 
trihydroxybenzaldehyde (A11) (top left) and pentafluorobenzaldeyde (A15) (bottom 
left) and their controls (top right, bottom right) showing the determination of 
percentage loading and by-products. Samples were incubated for 24 h at 60 ℃ in 
5% aqueous buffer (5% AcOH in D2O) 95% DMSO-d6. Samples were spiked with 
equimolar amounts of syringic acid (7.19 ppm).
pentafluorophenylmethanediol due to the presence of strong electron withdrawing 
group (i.e. pentafluorobenzene). This could potentially mean that a longer reaction 
time is needed to achieve similar similar couplings efficiency to the other aldehydes. 
Furthermore, during the reaction with poly(acryloyl hydrazide) P1 two new sharp 
singlets were observed in the aldehyde region at 9.74 and 9.31 ppm suggesting 
additional by-products.  
 Especially in the case of reactions with aromatic aldehydes the formation of 
new impurities was observed. The 1H NMR spectra (Fig. 1.21) of these impurities 
bear resemblance to their aldehyde counterparts in the sense that they showed the 
same number of peaks and multiplicity. The major difference is that the impurities 
showed a characteristic sharp singlet between 9.0-8.5 ppm (Fig. 1.21) instead of the 
10.1-9.7 observed for the aldehyde peak. These impurities could be identified in all 
the functionalisations with aromatic aldehydes, but their overall content was generally 
around 1-3% of total amount of aldehyde used (Table 1.6). These chemical shift 
seemed to be consistent with H-C(R)=X environments where it was hypothesised 
that X could be N-R or N-NHR, meaning that the impurity observed would be as a 
result from imine or hydrazone formation. To prove this hypothesis, reactions were 
carried out in conditions similar to those used for functionalisation of P1, using 
ammonia and hydrazine monohydrate. None of the conditions tested with ammonia 
resulted in compounds whose NMR spectra matched that of the observed impurities. 
Coupling between hydrazine and benzaldehyde (A7) and between hydrazine and 
4-hydroxybenzaldehyde (A9), however, resulted in the formation of hydrazones with 
NMR spectra (Fig. 1.22) that matched those of the impurities observed. In the 
presence of only 1 equiv. of hydrazine, two distinct hydrazones could be formed with 
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Entry Polymer %Impurity Entry Polymer %Impurity
1 P140A7 1 8 P140A14 3
2 P140A8 2 9 P140A15 27
3 P140A9 3 10 P140A16 —
4 P140A10 1 11 P140A17 —
5 P140A11 2 12 P140A18 —
6 P140A12 3 13 P140A19 —
7 P140A13 16 14 P140A20 —
Table 1.6: Percentage impurity formed in coupling reactions of P140 with different 
hydrophobic aldehydes. All experiments characterised after 24 h incubation at 60 "


































Figure 1.21: 1H NMR spectra of the reactions of P140 with representative aromatic 
aldehydes, showing broad hydrazone signals from the functionalised polymer, 
signals from unreacted aldehydes [blue circles] and signals from small molecule 
hydrazone impurities (sharp hydrazone singlets between 9.0-8.5 ppm and sharp 
aromatic signals (some are concealed underneath the broad aromatic peaks) [red 
circles]. All samples were spiked with equimolar amounts of syringic acid (7.19 
ppm) [yellow circle]. The integration values of the aldehyde and hydrazone signals 
represent the percentage unreacted aldehyde and impurity formed.
benzaldehyde (Fig. 1.22, C), which were attributed to the mono- and di-hydrazone. 
This was confirmed by treating the aldehyde (A7) with excess amounts of hydrazine 
(4.0 equiv.) so that formation of the monohydrazone was favoured (Fig. 1.22, B). 
Conversely, 4-hydroxybenzaldehyde reacted with 1 equiv. hydrazine to form only the 
mono-hydrazone product (Fig. 1.22, F), while excess aldehyde (2.0 equiv.) lead to 
the formation of both the mono- and di-hydrazone products (Fig. 1.22, G). To further 
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Figure 1.22: 1H NMR spectra of (A) benzaldehyde (A7); (B) reaction between 
benzaldehyde and 4 equiv. hydrazine to afford monobenzylidenehydrazine; (C) 
reaction between benzaldehyde and 1 equiv. hydrazine to afford mostly 
dibenzylidenehydrazine; (D) the reaction of P140 with 1 equiv. A7; (E) 
4-hydroxybenzaldehyde (A9); (F) reaction between 4-hydroxybenzaldehyde and 1 
equiv. hydrazine monohydrate to afford mono(4-hydroxybenzylidenehydrazine); (G) 
reaction between benzaldehyde and 0.5 equiv. hydrazine monohydrate to afford a 
mixture of mono- and di (4-hydroxybenzylidenehydrazine; (H) the reaction of P140
with 1 equiv. A9 (D) All samples were incubated for 24 h in 95% DMSO-d6 / 5% 























































investigate the formation of the mono- and di-hydrazones, kinetic studies were 
carried out with substoichiometric (0.25 equiv.) amounts of benzaldehyde (A7) and 
P1 in the established conditions. It was observed that even before all the aldehyde 
had coupled to the polymer (~4 h) (Fig. 1.23, F), both the mono- and di-hydrazone 
impurities could be identified by 1H NMR spectroscopy. Following the full 
consumption of the aldehyde, a steady increase in the concentration of the mono-
hydrazone (benzylidenehydrazine) was observed, with up to 15% content (compared 
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Figure 1.23: 1H NMR spectra of the reaction of P140 with 0.25 equiv. benzaldehyde 
(A7) monitored at different time intervals (B-F). 1H NMR spectra of 
monobenzylidenehydrazine (A), dibenzylidenehydrazine (G) are shown for 










to original aldehyde content) after 12 days (Fig. 1.23, B). No significant increase in 
the concentration of the di-hydrazone (1,2-dibenzylidenehydrazine) (~3%) was 
observed even after 12 days. Mechanistically, this would suggest that the mono-
hydrazone forms first through the cleaving of the C-N bond from the polymer’s 
hydrazide chains. The di-hydrazone would then be formed through the subsequent 
reaction between the mono-hydrazone and any free aldehyde left in solution. As far 
as it was ascertained, there are no clear examples of such reactivity occurring in 
small molecule organic chemistry. Instead, it is believed that a macromolecular effect 
may be responsible, similar to a protease type mechanism26 (Fig. 1.24). It remains to 

















































































Figure 1.24: Aspartyl protease mechanism, one of many types of proteases (top); 
proposed mechanism responsible for mono-hydrazone formation driven by an 
external nucleophile (e.g. water) (middle); proposed mechanism responsible for 
mono-hydrazone formation driven solely by unreacted hydrazide side-chains 
(bottom).
take part in the formation of the impurity, or the whole process is driven 
intramolecularly by neighbouring, non-functionalised side-chains. Nonetheless, the 
data suggests that the larger the number of non-functionalised side-chains the higher 
the extent of impurities formed. This was evidenced by the lower amount of impurity 
formed when P140 was reacted with 1.0 equiv. compared to its reaction with 0.25 
equiv. benzaldehyde (A7). Attempts were made to identify the mechanism 
responsible through two means; one set of experiments attempted to disprove that 
water plays a role in the reaction which would indicate a mechanism driven solely by 
the free hydrazide side-chains. Solid-liquid coupling reactions were carried out, in 
which the solid poly(acryloyl hydrazide) P1 was stirred at 60 ℃ with solutions of A7 
or A9 in dry DMSO with AcOH. It was observed that eventually the functionalised 
polymer does dissolve in the solution, but the characteristic 1H NMR signals from the 
trace impurities were also observed (Fig. 1.25, red circles). However, since complete 
absence of water from the system could not be guaranteed (i.e. water content in dry 
DMSO is only as low as 100 ppm), the experiment did not prove with a certainty that 
water does not play a role in the formation of the impurity.  
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Figure 1.25: 1H NMR spectra of the reaction of P140 with 1.0 equiv. benzaldehyde 
(A7) (left) and 4-hydroxybenzaldehyde (A9) (rigtht). Both samples were incubated 
for 24 h in dry DMSO with 0.025% AcOH and spiked with DMSO-d6 for signal 
acquisition.
P140A7 P140A9
The purpose of the second set of experiments was to see if other nucleophiles in the 
reaction would be incorporated into the polymer as part of the cleaving process. In 
three separate experiments, P1 was reacted with with 0.25 equiv. of A7 and then 
0.25 equiv. of ethanol, piperidine or cysteamine were added to monitor the possible 
formation of the ethyl ester, the amide or the thioester (Scheme 1.15). The results 
were overall inconclusive. Even after 10 days, formation of new peaks (broad or 








95% DMSO, 5% buffer












95% DMSO, 5% buffer



















95% DMSO, 5% buffer












95% DMSO, 5% buffer



















95% DMSO, 5% buffer












95% DMSO, 5% buffer















Scheme 1.15: Functionalisation of P1 with benzaldehyde A7 followed by reaction 





This could be because under these conditions water is greatly in excess compared to 
the added nucleophile, or because the mechanism is indeed independent of external 
nucleophiles. Nonetheless, at this stage, there is not enough evidence to confirm 
either of the two hypotheses.  
 To further probe the scope of functionalisation of P1 with aldehydes, the effect 
of excess amounts of aldehyde on the percentage loading was investigated. 
Functionalisations with three aromatic aldehydes, basic 4-imidazolecarboxaldehyde 
(A1), neutral benzaldehyde (A7) and acidic 5-formylsalicylic acid (A12), as well as 
two aliphatic aldehydes: acetaldehyde (A16) and isovaleraldehyde (A17) were 
carried out. In all cases, an increase in percentage loading was observed (Table 1.7). 
In some cases full conversion was almost observed, but no significant changes in the 
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1 74 1 76 1
2 64 1 84 3
3 75 3 87 1
4 89 — 95 —



















Table 1.7: Percentage loading in coupling reactions of P140 with selected 
aldehydes and the amount of impurity formed. Loading and impurity calculated 
from 1H NMR integration. Samples were incubated for 24 h at 60℃ in 5% aqueous 
buffer (5% AcOH in D2O) 95% DMSO-d6. Samples were spiked with equimolar 
amounts of syringic acid (7.19 ppm).
level of impurities formed was observed. The overall increase in percentage loading 
was not surprising considering that the hydrazone formation is an equilibrium and 
given Le Chatelier’s principle on equilibrium repositioning to counteract the increase 
in concentration of one of the reactants. 
 To develop a truly useful tool for investigating structure-activity relationships, 
the effects on percentage loading as a function of polymer size was explored. As 
such, functionalisation experiments with P180 and aldehydes A1, A7, A8, A9, A10, 
A12, A13, A16 and A17 (Table 1.8) were carried out. Overall, the trend shows either 
similar level of coupling like P180A7 and P180A12, slightly lower (P180A13, P180A17) 
or percentage loadings lower than 10% to the initial aldehyde content (P180A1, 
P180A8, P180A9, P180A10, P180A13, P180A16) compared to P140. Similarly to P140, 
improved side-chain functionalisation could be achieved for P180 by reacting the 
polymer scaffold with 2 equiv. of the aldehyde. This suggested that the lower 
percentage loadings observed for reactions between P180 and 1 equiv. of aldehyde 
was probably due to slower kinetics due to increased steric hinderance. To gain a 
better understanding how fast particular aldehydes react with P180 a series of kinetic 
experiments were carried out. 1H NMR spectroscopy was used to monitor the 
reactions between P180, A7, A9, A10, A12, A13 and A17 after different time intervals 
at 60 ℃ (Fig. 1.26). The data showed that while 5-formylsalicylic acid (P180A12) and 
isovaleraldehyde (P180A17) achieved close to their limiting percentage loading for 
P180 within the first 2 hours of incubation at 60 ℃, benzaldehyde (P180A7) and 
2,3-dihydroxybenzaldehyde (P180A10) achieved that point after 4-6 h incubation. In 
the case of the reaction between P180 and 4-hydroxybenzaldehyde (P180A9) and 
indole-3-carboxaldehyde (P180A13) respectively, the data shows a continuous 
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increase in percentage loading over 48 hours incubation and no clear evidence of 
plateauing, suggesting that their limiting percentage loading had not yet been 
achieved. In the case of the previous four aldehydes, no significant increase was 
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Entry Polymer Loading Impurity Entry Polymer Loading Impurity
1 P180A1 60 1 6 P180A12 72 2
2 P180A7 66 1 7 P180A13 46 12
3 P180A8 50 1 8 P180A16 65 —
4 P180A9 59 7 9 P180A17 78 —
5 P180A10 62 1
Table 1.8: Percentage loading and percentage impurity in coupling reactions of 
P180 with different hydrophobic aldehydes. All experiments characterised after 24 h 
incubation at 60 ℃  in 5% aqueous buffer and 95% DMSO-d6. Percentage 
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A1 A7 A8 A9 A10
A12 A13 A16 A17
observed after 48 hours incubation. These experiments have shown that, by 
adjusting reaction time and equivalent amounts of aldehyde used, functional 
polymers with similar levels of percentage loading could be achieved for a variety of 
diverse aldehydes onto poly(acryloyl hydrazide) with varied molecular weights. 
Further experiments could be carried out such as investigating the dynamic aspect of 
the hydrazone bonds or assessing the stability of the polymers post-functionalisation 
under different conditions, but at this stage a working model for rapidly testing a 
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Figure 1.26: Graphs showing percentage loading for six aldehydes with P180 at 
different incubation times. All experiments characterised after incubation at 60 ℃ in 
5% aqueous buffer and 95% DMSO-d6. Percentage functionalisation calculated by 
1H NMR signal integration.













P180 functionalisation with different






















A7 A9 A10 A12 A13 A17
series of functional polymers for different biomedical applications was achieved. In 
parallel, different hydrazone reduction chemistries were explored, with the view that 
once useful functional polymer formulations had been discovered, functionalised 
hydrazone polymers could be reduced. This would potentially allow comparison of 
biological activity between a polymer with dynamic functionality versus a fixed 
counterpart but it would also present the potential for long term storage of viable hits. 
Reduction of hydrazone bonds in functionalised poly(acryloyl hydrazide) P1 
 Reduction of hydrazones27-30 is generally carried out using sodium 
cyanoborohydride (NaBH3CN) as the reducing agent. This is a useful reagent as it is 
a mild reducing agent, and can be used selectively to reduce imines in mildly basic 
solutions (pH 7-10). Under acidic conditions, however, NaBH3CN can release the 
toxic cyanide gas. Since the scope of the research was to develop a ‘tool’ for 
biomedical applications, chemistries that could potentially be applied outside a 
chemistry lab or at least with minimal training (i.e. by a microbiologist) were preferred. 
The functionalisations of P1 were carried out at mild acidic pH, as such there was a 
risk of formation of cyanide gas. The pH of the reaction solution could have been 
adjusted before reduction, however, since hydrazones are unstable under basic 
conditions, this could have potentially affected the equilibrium of the reaction and 
change the percentage loading. To identify potentially useful hydrazone reduction 
chemistries, imine and oxime reduction conditions were explored. Although imine 
reduction is extensively documented and used in industry to produce amines, 
reactions involving mild reducing agents were considered, in order to avoid 
reductions of other functional groups included in the aldehyde molecule.  
 86
 Initially, NaBH4 and NaBH(AcO)3 were tested as safer alternatives to 
NaBH3CN, using benzaldehyde (A7) and tert-butyl carbazate to form a model 
hydrazone on which the reduction conditions were investigated (Scheme 1.16). In a 
typical reaction, the aldehyde was reacted with 1.1 equiv. of tert-butyl carbazate to 
form the hydrazone in quantitative yields within minutes, followed by the addition of 
the reducing agent without further purification. The purpose was to identify suitable 
reduction conditions with minimal required purification steps towards a scaffold that 
could be functionalised and then reduced in-situ.  
 Of the several different conditions tested (Table 1.9) including variations in 
solvent, additives or using in-situ formed NaBH(AcO)3 versus commercially 
purchased NaBH(AcO)3, only the reduction using NaBH4 with acetic acid (Entry 4, 
Table 1.9) (i.e. formation of NaBH(AcO)3 in-situ) gave satisfactory results. In several 
cases, particularly those in which iodine was used as an additive, there was a clear 
decrease in the hydrazone signal, but many unidentified by-products were observed 
(Entries 3, 7, Table 1.9). Although the reduction was successful as it could be 
observed from the disappearance of the hydrazone peak at 8.00 ppm (Fig. 1.27) and 
the appearance of the expected CH2 peak at 3.84 ppm, the presence of a quartet and 
a triplet at 2.72 ppm and 0.99 ppm respectively (i.e. a X-CH2-CH3 group) demanded 
further investigation. It was established that the peaks were not due to any solvent 


























Scheme 1.16: Model experiment used to probe hydrazone reduction.
chemical shifts observed, and the signals’ integration were related to that of the Boc-
group and the newly formed CH2 peak (9:3:2:2). This was attributed to the ethylation 
of the hydrazine at the former hydrazone centre, a process which has been reported 
in the past for imines and enamines and used strategically to reduce and N-alkylate 
in a one-pot reaction. Although, in itself, this would be an interesting concept to use 




Solvent Additives Remaining 
Hydrazone
Byproducts
1 NaBH4 MeOH — 100% No
2 NaBH4 THF — 100% No
3 NaBH4 THF I2 3% Yes
4 NaBH4 THF AcOH 11% No
5 NaBH(AcO)3 THF — 100% No
6 NaBH(AcO)3 THF AcOH 62% Yes
7 NaBH(AcO)3 THF I2 10% Yes
8 NaBH4 DMSO AcOH 58% No










Figure 1.27: 1H NMR spectra of tert-butyl 2-benzylidenehydrazine-1-carboxylate 























alternative reduction methods were explored, especially those used successfully in 
the reduction of oximes. 
 Oxime reduction methods are generally centred around the use of diborane or 
amino-boranes31-33 reducing agents, especially borane-pyridine (BAP) in acidic 
media. Kikugawa et al.34,35 showed that oximes can be reduced to hydroxylamines in 
the presence of a variety of functional groups which were unaffected by the reagent. 
Starting from Kikugawa’s conditions (BH3⋅pyridine, 10% HCl(aq), EtOH), the method 
was adapted in the laboratory to suit the conditions used during the post-
polymerisation modification reaction (Scheme 1.17). 
The disappearance of the hydrazone signal in 1H NMR spectra of P1 functionalised 
with aromatic aldehydes was difficult to prove due to the overlapping broad signals 
(Fig 1.21) around the 8.2-6.0 ppm area (i.e. hydrazone and aromatic protons). As a 
consequence, P1 was reacted with acetaldehyde (A16) and isovaleraldehyde (A17), 
as the hydrazone signals in the 1H NMR spectra of these reactions were clearly 
visible (7.58 and 7.42 ppm respectively) For each aldehyde, two functionalisation 
experiments were set up, in one of which the hydrazone was reduced using the 
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Scheme 1.17: Functionalisation of poly(acryloyl hydrazide) P1 with aldehydes and 
reduction to permanently immobilise the functionality.
Both samples were then purified by dialysis against water and the isolated products 
compared by 1H NMR spectroscopy.  
 For P1A16 (Fig. 1.28) the reduction was evidenced by both the 
disappearance of the hydrazone peak at 7.58 ppm and the appearance of the CH2 
peak at 2.74 ppm, but also in the change in chemical shift of the aldehyde’s CH3 
peak. While as a hydrazone, this peak appears at 1.94 ppm, in the expected region 
for groups directly bound to C=X groups. After reduction, this peak had shifted to 1.02 
ppm denoting a change from hydrazone to hydrazine. From the integration of the 
hydrazone signal against the backbone and methyl peaks, it was estimated, that after 
dialysis, only ~45% of side-chains were still functionalised. This was not unexpected, 
as dialysis against a large volume of water was expected to favour the backwards 
reaction (i.e. regeneration of the aldehyde and P1). For the reduced product of 
P1A16 however, determination of the functionalisation was inaccurate. When the 
polymer backbone signals were integrated for the three corresponding, the -HN-CH2-
CH3 peaks gave integration values of 4H and 7H respectively instead of 2H and 3H 
respectively. This would suggest that due to several factors including shielding and 



















Figure 1.28: 1H NMR spectra in D2O of non-reduced P1A16 (left) and reduced 





scaffold is functionalised. Although, no hydrazone species bound to the polymer were 
observed, that does not completely prove that the reduction goes to completion (i.e. 
unreduced hydrazones could be hydrolysed during dialysis).  
 Similarly for P1A17 the disappearance of the hydrazone peaks at 7.42 and 
7.23 ppm and the presence of a new peak at 2.68 ppm (Fig. 1.29) was observed. 
Furthermore chemical shift changes for the -N=C(H)-CH2-CH-(CH3)2 environments 
from 2.03 and 1.77 ppm in the non-reduced P1A17 were observed, to 1.25 and 1.62 
ppm respectively in the reduced product. Due to the close proximity and overlap of 
the DMSO signal to the new -N-CH2- signal, 1H NMR spectroscopy was carried out in 
CDCl3 to definitely prove that reduction had occurred as evidenced by the peak at 
2.68 ppm. Although it was evident that there were no unreduced hydrazones 
attached to the polymer, quantification of percentage loading post-reduction proved 
again inconclusive. The solubility of the non-reduced P1A17 in DMSO-d6 was good 
compared to the reduced product. This meant that even with an internal standard (i.e. 
syringic acid), accurate percentage loading could not be determined. After dialysis, 
the non-reduced P1A17 seems to display around ~51% functionalisation. 
Conversely, in CDCl3 the reduced P1A17 was soluble while the non-reduced was a 
turbid solution. After spiking the sample with DCM as an internal standard, 82% 
loading for both the reduced and non-reduced products was obtained. The analysis 
was made by integrating either the DCM signal or the syringic acid aromatic signal 
and comparing against isovaleraldehyde’s two methyl groups, knowing both the 
amount of product in the sample and the exact amount of standard used to spike the 
sample. The accuracy of this method was compromised by factors such as poor 
solubility and the presence of water (after freeze drying and vacuum with P2O5) in the 
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sample as these could affect the real mass of product in the sample. Investigation of 
the percentage loading using fluorescence by analysing the percentage free-
hydrazides using the Fluorescamine Assay was considered, by comparing against 
non-functionalised P1, but this method too suffers from many variables. Firstly, 
Fluorescamine is a bulky molecule, and the chances of probing all side-chains are 
minimal. Secondly, it is likely that quenching effects will be observed as more and 
more side-chains are probed. Also, there are no indications as to how the 
fluorescence would be affected by different neighbouring residues. As such, in the 

















Figure 1.29: 1H NMR spectra in DMSO-d6 of non-reduced P1A17 (top-left) and 
reduced P1A17 (top-right) and in CDCl3 of non-reduced P1A17 (bottom-left) and 























were drawn at this stage was that BH3-pyridine seems to be a reducing agent worth 
investigating further. 
Synthesis of fluorescent poly(acryloyl hydrazide) P1 scaffolds 
 Driven by the successful collaboration with Dr Javier Montenegro and his 
laboratory and the encouraging results on the use of functionalised P1 for the 
delivery of siRNA (see chapter 3), the development of a synthetic route towards a 
fluorescent poly(acryloyl hydrazide) was pursued as a scaffold towards fluorescent 
functional polymers. It was envisaged using these polymers to investigate cell 
internalisation mechanisms as well as investigating the mechanism of siRNA delivery.  
 In the initial approach it was decided to target the terminal free thiol on P1 and 
functionalise it with model maleimides (Scheme 1.18) with a view to functionalise 
with fluorescein-maleimide or other fluorescent-maleimide tags. It was quickly 
determined however that even at optimal pH conditions (i.e. 6.5-7.5) selective 
addition at the thiol end in the presence of such a large excess of free hydrazides 
could not be achieved. Furthermore, studies with a model thiol and a hydrazide 
showed that even in a 1:1 ratio selective binding of the maleimide to the thiol could 
not be obtained. 
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The thiol-maleimide coupling on the protected poly(acryloyl hydrazide) Boc-P1 was 
explored. To transform the trithio group into a thiol Boc-P1 was reacted with a large 
excess of tert-butyl carbazate in DMSO at 60 ℃  (Scheme 1.19) and purified by 
dialysis. The product (Boc-P1-SH) was analysed by UV-Vis (Fig. 1.30) to show the 
loss of the peak at ƛ300 nm and prove the presence of the thiol by Ellman’s Assay. 





















































U Boc-P1 + DTNB
Boc-P1-SH +DTNB
Figure 1.30: Normalised SEC/GPC spectra of Boc-P1 and Boc-P1-SH (left). UV-Vis 
spectra of Boc-P1 and Boc-P1-SH (main right) and the UV-Vis of the two samples 
after treatment with DTNB (inset right).
Scheme 1.19: 2 steps reaction towards the functionalisation of poly(acryloyl 









































have been evident by significant changes in the retention time, Mn and Đ as well as 
the presence of a small ‘shoulder’ at lower retention time. Looking at the data 
obtained, an increase of ~1.1kDa in Mn and ~0.017 in Đ was observed (Fig. 1.30). 
This difference was below what would have been expected if thiol oxidation was 
occurring (i.e. 2 x Mn increase), but it was concluded that it may be useful to treat the 
sample with a thiol reducing agent prior to maleimide addition. Reported 
protocols36,37 for the functionalisation of proteins with fluorescent maleimides 
describe using at least a 10-fold excess fluorescent tag per thiol. In order to 
synthesise sufficient fluorescent polymer scaffold for biological studies, the labelling 
reaction had to be carried out with ~200 mg Boc-P1-SH to compensate for the 
material lost during the succeeding purifications by dialyses and deprotection. Due to 
 95
   14.0    15.1    16.2    17.3    18.4    19.6    20.7    21.8    22.9    24.0
minutes
   -2.0
    1.1
    4.3
    7.4
   10.6
   13.7
   16.9
   20.0
µR
IU
   14.0    15.1    16.2    17.3    18.4    19.6    20.7    21.8    22.9    24.0
minutes
    -10
     72
    154
    236
    318


















Retention Time / min
Retention Time / min
Figure 1.31: SEC/GPC chromatograms of P1-Flu1 visualised by RI (top) and UV-
Vis at ƛ300 nm (bottom). 
the prohibitive cost of fluorescein-maleimide the labelling reaction was carried out 
using only a 4-fold excess of maleimide to thiol. Unfortunately, analysis of the 
deprotected polymer P1-Flu1 by SEC/GPC (Fig. 1.31) suggested that most of the 
fluorescent label was not attached to the polymer but rather to some oligomeric 
species as indicated by the more intense sharp signal (according to UV-Vis at 455 
nm) with retention time 18.9 min instead of the broad peak at 17.5 min which is the 
main product according to the RI detector. Separation of the two peaks was 
attempted by purification by chromatography using Sephadex-G10 as the stationary 
phase, but only ~15 mg (out of a maximum possible 92 mg) of a 80% pure 
fluorescent polymer scaffold was isolated and confirmed by 1H NMR spectroscopy 
(Fig. 1.32).  
 Because of the problems encountered during the synthesis of P1-Flu1 and 
high cost of the maleimide dye and even higher costs of other fluorescent tags it was 













Figure 1.32: 1H NMR spectrum of P1-Flu1 in D2O.
As far as it was ascertained during this research, there were no cheap alternatives 
(i.e. amine, hydrazine or hydroxylamine probes) available for labelling carboxylic 
acids. However, one of the cheaper labelling dyes available is fluorescein 
isothiocyanate (FITC), which is used extensively as a label for reactive nucleophiles 
especially amines. As a consequence, it was decided to derivatise the carboxylic acid 
with 1,2-ethylenediamine (Scheme 1.20) to afford Boc-P1 with a nucleophilic 
terminus capable of reacting with FITC in a click-chemistry reaction. The polymer 
was dissolved in a 1:1 mixture of DMSO and 1,2-ethylenediamine and EDC was 
added in portions to activate the carboxylic acid. The product (Boc-P1-NH2) was 
isolated and characterised by 1H NMR and fluorescence spectroscopy after 
purification by dialysis against water. The 1H NMR spectrum (Fig. 1.33) in CDCl3 
showed a new broad peak at 3.25 ppm which were attributed to one of the two CH2 
environments from the attached 1,2-ethylenediamine, however signal integration 
could not be used to calculate the extent of carboxylic acid converted.  
 Instead fluorescence spectroscopy was used to quantify the amounts of amine 
groups using the Fluram Assay from known samples of Boc-P1-NH2. Analysis of 
N-Boc-ethylenediamine as a model substrate with fluorescamine (Fig. 1.34) was 




















Scheme 1.20: Derivatisation of Boc-P1 with 1,2-ethylenediamine to afford Boc-P1-
NH2, a scaffold capable to reacting with FITC.
Boc-P1 Boc-P1-NH2
concentrations for the experiment, and the data obtained was used to calculate the 
ratio of amines to repeating units. An average of 54 monomers was per amine group 
detected was calculated (from the mass of polymer weighed and concentration of 
amines in solution), which is in agreement with DPs calculated for the parent Boc-P1 
polymer.  
 To synthesise the protected fluorescent polymer (Boc-P1-Flu2) 400 mg Boc-
P1-NH2 in DMF was reacted with DIPEA and 4-fold excess FITC (Scheme 1.21) for 
24 hours, and the material was purified by removing the solvent and running the 
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Figure 1.34: Fluorescence spectra showing the results of the Fluram Assay for 
known concentrations of Boc-P1-NH2 (main), and fluorescence intensity at ƛ465 nm 































crude through a Sephadex LH-20 column to obtain Boc-P1-Flu2 with a purity of 
around 97% according to the RI detector and 80% according to the fluorescent 
detector (i.e. two molecules containing a fluorescent label will be detected as having 
similar intensities by the SEC/GPC fluorescence detector but this fails to account that 
in the polymer for every fluorescent tag there are 40-50 repeating units which make 
up most of the mass). 
 P1-Flu2 was synthesised by deprotecting Boc-P1-Flu2 in neat TFA, 
neutralising the acid and purifying by dialysis. The resulting orange powder was 
analysed by 1H NMR spectroscopy (Fig. 1.35), which according to the signal 
integration confirmed that there is one dye per 51 monomers, in accordance with the 
expected DP (i.e. integrating the aromatic area for the 9H in the dye and dividing by 3 
the integration value of the alkyl backbone (154 H), the ratio of dye to repeating units 
1:51) was obtained. 
SEC/GPC using a fluorescence detector showed a broad peak (Fig. 1.36) at the 
expected retention time (i.e. ~16.5 min) but also showed some recurring broad 
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Scheme 1.21: Click-chemistry reaction between the amine on Boc-P1-NH2 and 
































fluorescent peaks past usual void time (~21.5 min). This may suggest some solubility 
issues with P1-Flu2 or the presence of some by-products. Nonetheless, the peak 
associated with P1-Flu2 accounts for 87% of the integrated areas by fluorescence 
and 90% by RI. Using this method more than 50 mg of fluorescent poly(acryloyl 
hydrazide) were isolated, and the coupling with a couple of aldehydes was 
investigated in order to verify that the percentage loading with P1-Flu2 remains 
similar to P1. The coupling reaction of P1-Flu2 in acidic aqueous conditions with 
imidazole A1 was carried out, observed 75% loading was observed by 1H NMR 
spectroscopy (Fig. 1.37) after 4 h, by integrating the signals and comparing the 
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Figure 1.36: SEC/GPC chromatograms of P1-Flu2 detected by fluorescence 
emission at ƛ510 nm (left) and by RI (right). 














Figure 1.35: 1H NMR spectrum of P1-Flu2 in D2O(right) and expanded on the 
















aldehyde signal (9.65 ppm) and the broad aromatic and hydrazone signals (8.8 - 6.4 
ppm). Experiments with isovaleraldehyde A17 in the usual mixture of DMSO and 
acidic buffer showed a coupling of 58% after 2 h incubation at 60 ℃ (Fig. 1.37). SEC/
GPC experiments using the Shodex column system and varied amounts of imidazole 
A1 were also carried out. It was previously determined that poly(acryloyl hydrazide) 
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P1-Flu2 with varying amounts of A1
A1
P1-Flu2 + 0.50 equiv. A1
P1-Flu2 + 0.25 equiv. A1
P1-Flu2 + 1.00 equiv. A1
P1-Flu2
Figure 1.38: SEC/GPC chromatogram showing the functionalisation of P1-Flu2 
with imidazole aldehyde A1 at different equivalence values.
Figure 1.37: 1H NMR spectra the reaction of P1-Flu2 with imidazole A1 in 100mM 
AcOH in D2O after 4 h (left) and the reaction of P1-Flu2 with isovaleraldehyde A17 







P1 does not run through this column, however when it is functionalised with A1 it is 
detected (Fig. 1.14). A similar experiment using the fluorescence detector was 
carried out, to show that similar levels of aldehyde loading could be achieved for 
P1-Flu2 compared to P1 (Fig.1.38). A decrease in retention time with increasing 
equiv. A1 was observed suggesting that and increase in the molecular weight was 
occurring with increased percentage functionalisation. Overall, the studies carried out 




 A reliable route towards the synthesis of relatively large amounts of Boc-
protected acryloyl hydrazide monomer was successfully developed. Using RAFT 
methodology and a simple deprotection step the polymerisation of this monomer to 
afford poly(acryloyl hydrazide) P1 scaffolds, with varying molecular weights was 
achieved. The scaffold was investigated as a tool towards the synthesis of libraries of 
functional polymers through its click-chemistry reaction with aldehydes. Using the 
knowledge gained, P1 was successfully used to develop a platform for quickly 
analysing the siRNA delivery ability of functional polymers derivatised from P1 (see 
Chapter 3).  
 Furthermore, experiments with a series of hydrazone reduction reagents were 
carried out to identify suitable reaction conditions to permanently bind the functional 
groups to the backbone. Borane-pyridine was identified as a mild suitable reducing 
reagent, however, accurate determination of the percentage loading after reduction 
and purification proved challenging. 
 Finally, a route towards the synthesis of poly(acryloyl hydrazide) labelled with 
fluorescein (P1-Flu2) was developed, as a tool towards investigating different 
biological processes using fluorescent functional polymers. Although further 
optimisation of the process is required, and further functionalisation experiments with 
different aldehydes are needed to assess the suitability of P1-Flu2 as a scaffold, the 
explored chemistry could be suitable towards the synthesis of libraries of P1 
scaffolds, which could incorporate a variety of fluorescent dyes for diverse 
applications.  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1.5 Future work 
 From a synthetic point of view, the RAFT polymerisation to synthesise Boc-P1 
could be optimised further to produce poly(acryloyl hydrazide) with narrower 
dispersities such that the structure-activity relationship of functional polymers could 
be evaluated with increased confidence (i.e. prove that any observed 
physicochemical benefits of a sample of functionalised P1 is not due solely to a 
subset of a particular molecular weight).  
 With regards to the functionalisation of P1, it is believed there are three key 
aspects worth investigating. The first feature is related to functionalisation with 
multiple aldehydes at the same time. This was investigated briefly as part of the work 
on siRNA delivery (see Chapter 3) but more thorough experiments could be carried 
out to determine if loading of different types of aldehyde affects the structure of final 
polymer (i.e. randomisation of side-chains, block-functionalisation, facial segregation 
etc.). The second feature worth determining is related to the dynamic aspect of the 
hydrazone bonds and re-equilibration between functional polymers with different 
hydrazone side-chains. Also re-equilibration in the presence of a template is 
important to understand processes involved in the formation of polyionic complexes 
such as those with siRNA or plasmids. Finally, a thorough investigation of the 
products obtained after the reduction of hydrazone bonds in functionalised P1 could 
be a valuable addition to this scaffold’s toolbox, but this is conditioned by the 
availability of better analytical methods. 
 Finally, the synthesis of P1-Flu2 has opened the way towards the synthesis of 
similar fluorescent P1 scaffolds. Both the reaction with 1,2-ethylenediamine and the 
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subsequent reaction with the dye need optimising to minimise wastage especially of 
expensive fluorescent dyes.  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1.6 Experimental 
Cyanomethyl methyl(4-pyridyl)carbamodithioate (CTA2) was purchased from Sigma-
Aldrich® and used without further purification. All other chemicals were purchased 
from Sigma-Aldrich®, Fisher Scientific®, VWR® or Acros® and used without further 
purification. All solvents were Reagent grade or above, purchased from Sigma-
Aldrich®, Fisher Scientific® or VWR® and used without further purification. 
Nuclear Magnetic Resonance (NMR) spectra were recorded on either a Bruker 
Avance III 300 MHz or a Bruker Avance III 400 MHz spectrometer. Chemical shifts 
are reported in ppm (ẟ units) referenced40 to the following solvent signals: residual 
DMSO in DMSO-d6 at ẟH 2.50, H2O in D2O at ẟH 4.79, CHCl3 in CDCl3 at ẟH 7.26. 
Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum Two FT-IR 
spectrometer. Peaks are reported as strong (s), medium (m) or weak (w), sharp (sh) 
or broad (br). Ultraviolet-visible (UV-vis) spectra were recorded on a Cary 50 
Spectrophotometer. Fluorescence spectra were recorded on a Shimadzu RF-5301PC 
Spectrofluorophotometer. Mass spectra were recorded on a Waters Xevo G2-XS ToF 
using electrospray ionisation (ESI) and time-of-flight (ToF) in positive or negative ion 
mode. Thin-layer chromatography was carried out on sheets coated with silica gel. 
Size Exclusion Chromatography/Gel Permeation Chromatography (SEC/GPC) were 
recorded on a Shimadzu Prominence LC-20A fitted with a Thermo Fisher 
Refractomax 521 Detector and a Shimadzu SPD20A UV-vis Detector or fitted with a 
Shimadzu SPD-M20-A Photodiode Array Detector and a Shimadzu RF-10A 
Fluorescence Detector. Boc-P1X was analysed using 0.05 M LiBr in DMF at 60 ℃ as 
the eluent and a flow rate of 1 mL·min-1. The instrument was fitted with a Polymer 
 106
Labs PolarGel guard column (50 × 7.5 mm, 5 µm) followed by two PLGel 
PL1110-6540 columns (300 × 7.5 mm, 5 µm). Molecular weights were calculated 
based on a standard calibration method using polymethylmethacrylate. P1 was 
analysed using Lonza® DPBS at 35 ℃ as the eluent and a flow rate of 1 mL·min-1. 
The instrument was fitted with a Polymer Labs PL-aquagel-OH guard column (50 x 
7.5 mm, 8 µm) followed by a PL-aquagel-OH 30 column (300 x 7.5 mm, 8 µm) and a 
PL-aquagel-OH 40 column (300 x 7.5 mm, 8 µm). Molecular weights were calculated 
based on a standard calibration method using PEG. Activation of P1X was analyzed 
using 100 mM acetic acid at pH 2.9 at 40 ℃  as the eluent and a flow rate of 0.6 
mL·min-1. The instrument was fitted with a Shodex Asaphipak GF-510 HQ column 
and a Shodex Asaphipak GF-310 HQ column (300 × 7.5 mm, 5 µm). All dialyses 
were carried out using Spectrum Labs SpectraPor® Dialysis Tubing MWCO 1000 in 
water unless specified otherwise for a minimum of 24 hours and at least 3 changes of 
solvent. 
tert-Butyl 2-acryloylhydrazine-1-carboxylate (1.3) 
 Acrylic acid (3.81 mL, 54.95 mmol) and tert-butyl carbazate (8.89 g, 65.95 
mmol) were dissolved in a H2O/THF mixture (2:1, 180 mL) at RT. 
N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) (11.75 g, 
61.29 mmol) was added in portions to the solution over 15 minutes and left stirring for 
3 h. The crude reaction was extracted with EtOAc (3 x 75 mL) and the organic layer 








organic phase was dried with anhydrous Na2SO4 and the solvent was removed under 
reduced pressure to afford the crude product as a white solid. The crude product was 
purified by recrystallization from EtOAc (70 ℃ to RT, followed by cooling in freezer) to 
afford (5.05 g, 50% yield) of a white crystalline powder identified as 1.3. Rf = 0.87 
(100% EtOAc); νmax (neat)/cm-1 3311m sh (N-H), 3221m sh (N-H), 2981w sh (C-H), 
1715s sh (C=O), 1668s sh (C=O); δH(300 MHz, DMSO-d6) [calibrated using (CHD2)
(CD3)SO resonance at 2.50 ppm] 1.40 (s, 9H, C(CH3)3), 5.69 (dd, 1H, CH2CH), 
6.17-6.20 (m, 2H, CHCH2), 8.84 (s, 1H, OC(O)NH), 9.79 (s, 1H, CHC(O)NH); δC(100 
MHz, DMSO-d6) [calibrated using (CD3)2SO resonance at 39.52 ppm] 28.1 
(C(CH3)3), 79.2 (C(CH3)3), 126.2 (CH2CH), 129.4 (CH2CH), 155.3 (OC(O)NH), 164.3 
(CHC(O)NH). The characterisation data is in accordance to literature.41 
Acryloylhydrazide hydrochloride (1.4) 
 Hydrazide 1.3 (2.00 g, 10.73 mmol) in 1 M HCl(aq) (80 mL) was stirred at 0 ℃ 
for 24 h and stirred a further 48 h at RT. Excess HCl was removed under reduced 
pressure while keeping the solution cold. Water was removed by lyophilisation to 
afford (0.9 g, 68% yield) of a white crystalline powder identified as 1.4. νmax (neat)/
cm-1 3345s br (N-H), 3170s br, 2911w sh (C-H), 1684s sh (C=O); δH(300 MHz, 
DMSO-d6) [calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 4.35 (br, 3H, 
+NH3), 5.85 (dd, 1H, CH2CH), 6.26-6.39 (m, 2H, CHCH2), 11.44 (s, 1H, CHC(O)NH); 
δC(100 MHz, DMSO-d6) [calibrated using (CD3)2SO resonance at 39.52 ppm] 127.7 







2-(((Ethylthio)carbonothioyl)thio)-2-methylpropanoic acid (CTA1) 
 Ethane thiol (3.6 ml, 47.64 mmol) was added to a suspension of tripotassium 
phosphate (15.4 g, 71.46 mmol) in acetone (150 mL) and stirred for 10 min. Carbon 
disulfide (7.2 ml, 119.10 mmol) and 2-bromoisobutyric acid (7.3 g, 42.88 mmol) were 
added to the above suspension in quick succession and left stirring overnight. The 
solution was concentrated by purging with argon and filtered. The cream coloured 
solid residue was dissolved in 1 M HCl (150 mL) and extracted with DCM (3 x 100 
mL). The organic layer was collected and washed further with 0.1M HCl (2 x 100 mL), 
water (2 x 100 mL) and brine (2 x 100 mL) and dried with anhydrous Na2SO4. The 
solution was concentrated under reduced pressure to afford an orange oil. The crude 
product was purified by recrystallisation from hexane (55 ℃  to 0 ℃  followed by 
overnight cooling in freezer) to afford a bright yellow powder (3.5 g, 36% yield). UV 
(DMSO) λmax 310 nm; δH(300 MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO 
resonance at 2.50 ppm] 1.25 (t, 3JH,H = 7.36 Hz, 3H, CH2CH3), 1.62 (s, 6H, C(CH3)2), 
3.29 (q, 3JH,H = 7.36, 2H, CH2CH3), 12.95 (s, 1H, COOH); δC(100 MHz, DMSO-d6) 
[calibrated using (CD3)2SO resonance at 39.52 ppm] 12.9 (CH2CH3), 25.1 (C(CH3)2), 
30.7 (CH2CH3), 56.1 (C(CH3)2), 173.2 (COOH), 221.6 (SC(S)S). The characterisation 







Poly(tert-butyl 2-acryloylhydrazine-1-carboxylate) (Boc-P1x) 
 In a typical experiment, a solution of 4,4’-azobis(4-cyanovaleric acid) (ACVA) 
(18.4 mg, 0.064 mmol) in DMSO (1.5 ml) and a solution of CTA (72.3 mg, 0.322 
mmol) in DMSO (1.5 mL) were added sequentially to a solution of tert-butyl 2-
acryloylhydrazine-1-carboxylate (3.00 g, 16.095 mmol) in DMSO (14.88 mL). A 50 µL 
aliquot of this solution was taken at this stage to aid in the calculation of conversion. 
The reaction mixture was then sealed and degassed with argon for 30 min. The 
degassed solution was left to react at 70 ℃  for 7 h. The reaction was stopped by 
allowing it to cool down to room temperature and by exposing it to air. A 50 µL aliquot 
of this solution was taken at this stage to aid in the calculation of conversion. The 
polymer was purified by dialysis against water. The water was removed by 
lyophilisation and by drying in a desiccator with P2O5 to afford Boc-P140 as an off-
white powder (2.2 g, 73% yield). UV (DMSO) λmax 300 nm; νmax (neat)/cm-1 3244m br 
(N-H), 2916w sh (C-H), 1642s br (C=O), 1523m sh (C=O); δH(300 MHz, DMSO-d6) 
[calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 1.41 (br, 11H, 9H in 
C(CH3)3, 2H in CHCH2), 2.03 (br, 1H, CHCH2), 8.60 (br, 1H, OC(O)NH), 9.22 (br, 1H, 













Poly(acryloyl hydrazide) (P1x) 
 In a typical experiment, trifluoroacetic acid (TFA) (15 mL) was added dropwise 
to poly(tert-butyl-2-acryloylhydrazine-1-carboxylate) (Boc-P140) (1.5 g) and the yellow 
solution was stirred at RT for 2 h. Excess of TFA was removed by blowing a steady 
stream of argon and the resulting oil was diluted in water (15 mL). The P140·TFA salt 
formed was neutralised by adding NaHCO3 until no foaming was observed. The 
colourless solution was allowed to stir overnight. The crude polymer was purified by 
dialysis against water. The water was removed by lyophilisation and by drying in a 
desiccator with P2O5 to afford P140 as a white powder (650 mg, 92% yield). νmax 
(neat)/cm-1 3254w br (N-H), 1609m br (C=O), 1428s sh (C-C); δH(300 MHz, D2O) 
[calibrated using HDO resonance at 4.79 ppm] 0.95 (s, 3H, C(CH3)), 1.01 (s, 3H, 
C(CH3)), 1.59-2.08 (br m, 3H x DP, CHCH2); δC(100 MHz, D2O) 34.3 (CHCH2), 40.5 









Functionalisation of poly(acryloyl hydrazide) (P1x) with aldehydes (RCHO) 
 In a typical experiment, poly(acryloyl hydrazide) P1x (5 mg, 0.058 mmol) was 
dissolved in D2O (35.63 µL) with 5% AcOH (1.87 µL). DMSO-d6 (337.5 µL) was 
added to the above solution while vortexing. In a separate vial fitted with a magnetic 
stirrer, DMSO-d6 (375 µL) was added to the aldehyde (0.058 mmol, 1.0 equiv.). The 
polymer solution was added to the aldehyde solution and the reaction was incubated 
at 60 ℃ for 24 h and analysed by 1H NMR spectroscopy. 
Hydrazone reduction in functionalised poly(acryloyl hydrazide) 
 In a typical experiment, to an incubated solution (4.5 mL) of polymer (30 mg, 
0.348 mmol) and aldehyde (0.348 mmol, 1.0 equiv.), 8 M borane-pyridine was added 
(1.16 mmol, 145 µL, 3.33 equiv.) at RT. 10% (3 M) HCl(aq) (387 µL, 3.33 equiv.) was 
added dropwise over 5 min. and the solution was stirred for 2 h. The crude polymer 
was purified by dialysis against water. The water was removed by lyophilisation and 



















Modification of poly(tert-butyl 2-acryloylhydrazine-1-carboxylate) with 
1,2-ethylenediamine (Boc-P1-NH2) 
 In a typical experiment, DMSO (5 mL) and 1,2-ethylenediamine (5 mL) were 
added successively to Boc-P1 (0.5 g, 2.69 mmol). To this solution, EDC (1.0 g, 5.22 
mmol) was added in three portions over 2 h. and stirred for a further 2 h. The polymer 
was purified by dialysis against water. The water was removed by lyophilisation and 
by drying in a desiccator with P2O5 to afford Boc-P1-NH2 as a white powder (0.35 g, 
70% yield). δH(300 MHz, CDCl3) [calibrated using CHCl3 resonance at 7.26 ppm] 
1.46 (br, 11H x DP, 9H in C(CH3)3, 2H in CHCH2), 2.22 (br, 1H, CHCH2), 3.25 (br, 4H, 
NH2CH2CH2), 7.17 (br, 1H x DP, OC(O)NH), 9.35 (br, 1H x DP, CHC(O)NH); DP 
(Fluorescence, Fluram Assay) 51. 
Fluorescent poly(acryloyl hydrazide) (P1-Flu2) 
 In a typical experiment, DMF (5 mL) and DIPEA (100 µL) were a added to 
Boc-P1-NH2 (200 mg, 1.07 mmol). To this, FITC (100 mg) in DMF (5 mL) was added, 
and the solution was stirred overnight protected from light. A 100 µL aliquot was used 

























fluorescence detector. The solution was concentrated under reduced pressure to 
afford a thick oil. The crude oil was diluted in DMF and purified by chromatography 
(Sephadex LH-20, EtOH) to afford Boc-P1-Flu2 as an orange oil. To this oil, TFA (5 
mL) was added and stirred for 3 h. Excess of TFA was removed by blowing a steady 
stream of argon and the resulting oil was diluted in water (10 mL). The P1-Flu2·TFA 
salt formed was neutralised by adding NaHCO3 until no foaming was observed. The 
crude polymer was purified by dialysis against water. The water was removed by 
lyophilisation and by drying in a desiccator with P2O5 to afford P1-Flu2 as an orange 
powder (70 mg, 76% yield). δH(300 MHz, D2O) [calibrated using HDO resonance at 
4.79 ppm] 1.00 (s, 3H, C(CH3)), 1.05 (s, 3H, C(CH3)), 1.62-2.10 (br m, 3H x DP, 
CHCH2) 6.27-7.94 (br m, 9H, FITC Ar-H); DP (1H NMR) 50. 
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Chapter 2 




 In comparison with alkene substrates, attempts of using radical addition 
methods in alkyne polymerisation have been mostly unsuccessful.1 Instead, most 
focus has gone into polymerisation of alkyne substrates using transition metal 
catalysts, in which Mo, W and Rh catalysts have proven most efficient. The metal 
catalysed polymerisation of alkynes can be described through either of two 
mechanisms: metathesis (metal carbene) or insertion (metal alkyl) (Scheme 2.1).2 
The main issues associated with these types of polymerisation reactions are the high 
substrate specificity. Group 6 metal-halides such MoCl5 and WCl6, have been 
shown1 to be suitable catalysts for the polymerisation of various bulky 
monosubstituted alkyne substrates but their tolerance for polar substituents is 
relatively poor. As a consequence it is unlikely that this chemistry would prove useful 
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C C C C M
Metal alkyl (insertion) polymerisation
Scheme 2.1: The propagating mechanisms and propagating species of metal 
catalysed alkyne polymerisation. (M=metal)
for the polymerisation of hydrazide containing alkynes. Rh based catalysts however, 
have been shown to tolerate polar substituents remarkably well, as evidenced by the 
results obtained in the polymerisations of propiolic acid esters, N-propargylamides 
and other polar substituents.3,4 The bicyclo[2.2.1]hepta-2,5-diene-rhodium(I) chloride 
dimer [Rh(nbd)Cl]2 has proven particularly efficient in acetylene polymerisations with 
a high yield in cis-transoid conformation (Fig. 2.1). This conformation is a direct 
consequence of the insertion-type mechanism5,6 through which Rh catalysed 
polymerisations proceed. Mechanistically, all polymers synthesised through this 
mechanism should have a 100% cis-content, however, due to molecular rotation in 
solution, the cis-content can be lost.7-10 The geometry of such conformations 
resemble the helicity of naturally occurring moieties (i.e. antimicrobial peptides), 















Figure 2.1: Four possible helical stereoisomers of acetylene polymers.
 This rhodium catalyst and variants have generally shown particularly high 
potential in the polymerisation of phenyl-bearing acetylene monomers that 
incorporate polar groups such as carboxylic acids.1 However, to the best of the 
author’s knowledge, no current research exists into the polymerisation of acetylene 
moieties bearing hydrazide, hydrazine or O-hydroxylamine substituents. The closest 
similarity to such substrates are a series of N-substituted and N-unsubstituted 
2-propynamides.11,12 Polymerisation of these substrates has proved difficult with 
commonly used metal catalysts based on Mo or W and even with the [Rh(nbd)Cl]2 
catalyst. Two palladium based catalysts, [Pd(CH3CN)4](BF4)2 and PdCl2(PhCN)2, 
have shown promising results with the polymerisation of N-butyl-2-propynamide. As a 
consequence, these are likely to be potential candidates for obtaining a scaffold with 
a simple acetylenenic backbone (i.e. an analogue of poly(acryloyl hydrazide)) that 
incorporates our target hydrazide side-chains. 
Due to their versatility in polymerising phenyl-bearing acetylenes1,13-19 with polar 
substituents it is worth considering Rh catalysts as viable candidates for polymerising 
phenylacetylene substrates that incorporate hydrazides in the para-position. Rh-
catalysed polymerisations can be carried out in most common organic solvents, polar 
and non-polar, but water has also been explored as possible solvent. 
 Several examples16,20 exist in which organorhodium catalysts were used in 
aqueous media to afford rapid, high yielding and highly stereoregular 
polyphenylacetylenes. Patented research by Tang et al.21 showed that the 
polymerisation of phenylacetylene and p-(methylphenyl)acetylene can be carried out 
in water both in the presence and absence of additives, with a variety of rhodium 
catalysts (e.g.) [Rh(nbd)Cl]2, [Rh(cod)Cl]2, Rh(nbd)(tos)(H2O) or Rh(cod)(tos)(H2O). 
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It was observed, that generally, rhodium catalysed polymerisations of 
phenylacetylenes are strongly affected by the presence of polar molecules in 
solution. Polymerisation yields in non-polar solvents such as toluene were 
significantly lower compared to those in polar solvents (i.e. MeOH, THF, H2O) or in 
non-polar solvents with polar additives (i.e. Toluene with H2O, MeOH, Et3N). Addition 
of Et3N as a co-catalyst is common practice throughout many examples of 
polymerisation using [Rh(nbd)Cl]2 and it is suggested that the amine coordinates to 
the metal, breaking the dimer into the active catalytic rhodium species. 
 Compared to vinyl or acrylate based polymers, acetylene based polymers, 
although possessing important useful properties (e.g. high conductivity), have found 
very little use in commercial applications. The polymer backbone is highly susceptible 
to oxidation when exposed to air,22 and formation of carbonyls, epoxides and 
peroxides has been reported. Furthermore thermal cis-trans isomerization of cis-
transoidal polyacetylenes in solution, has been shown to accompanied by cyclisation 
and chain scission reactions,9,10,23 leading to the degradation of the backbone (Fig. 
2.2). This is driven by the formation of aromatic rings, which are energetically more 
stable. The isomerization process occurs more rapidly at higher temperatures (> 120 
℃) and as a consequence, it is believe that, for biological applications this property 
could be advantageous (e.g. degradation of antimicrobial polymers to minimise 






















Figure 2.2: Mechanism of cis-trans isomerization of polyacetylenes, which can 
alternatively lead to cyclisation and aromatisation. This causes chain scission 
resulting in aromatic small molecules and shorter chain fragments.
2.2 Objectives 
 The first objective was to synthesise Boc-protected- (2.1) and unprotected 
propiolohydrazide monomers (2.2) and to attempt their polymerisation using Pd and 
Rh catalysts to achieve poly(propiolohydrazide) P2 (Scheme 2.2) as a direct 
comparison with poly(acryloyl hydrazide) P1 (see Chapter I). 
Given the proven record in the polymerisation of monosubstituted phenylacetylene, 
as a second objective, it was aimed to synthesise Boc-protected- (2.3) and 
unprotected 4-ethynylbenzohydrazide (2.4), and polymerise these monomers to 
achieve poly(4-ethynylbenzohydrazide) (P3) (Scheme 2.3). Following the synthesis 
and characterisation of these polymers the it was aimed to explore the 
functionalisation of these acetylene hydrazide scaffolds with aldehydes and 
























































Scheme 2.2: First objective. The synthesis of poly(propiolohydrazide) P2 via direct 





























































Scheme 2.3: Second objective. The synthesis of poly(4-ethynylbenzohydrazide) P3 






2.3 Results and Discussion 
 The Boc-protected propiolohydrazide precursor 2.1 was synthesised in a 
similar fashion as the Boc-protected acryloyl precursor 1.3. In this situation however 
(Scheme 2.4) there was no requirement for THF as a co-solvent, as both the 
reagents and the product were water-soluble. 
Depending on the excess reagent, purification was performed either via an acidic (i.e. 
excess tert-butyl carbazate) or a basic (i.e. excess propiolic acid) work-up. In 
comparison to the synthesis of the Boc-protected acryloyl hydrazide 1.3 the 
purification of compound 2.1 required no recrystallization step. The reaction was very 
efficient in the sense that on a small scale (up to 0.5 g propiolic acid), reaction 
completion occurs within 15 minutes. Additionally, the reaction was successfully 
scaled up to afford a quick route to large quantities of this intermediate.  
 Characterisation of the product revealed a series of unexpected results. Although 
thin layer chromatography indicates a single product present, 1H and PENDANT 13C 
NMR (Fig. 2.3) showed a “duplication” of the expected peaks ((i.e. four N-H peaks, 
two alkyne H and two Boc (CH3)3 peaks in the 1H NMR spectrum) , with the 
duplicates accounting for ~20% of the integration total. Possible explanations include 
the presence of rotamers, but high temperatures 1H NMR spectroscopy analysis was 


















Scheme 2.4: Reaction scheme showing the synthesis of the target precursor 
tert-butyl-2-propiolohydrazine-1-carboxylate compound (2.1).
2.1
alkyne peaks (4.34 and 4.26 ppm) showed a decrease in the chemical shift value 
with increasing temperature (from 30 ℃ to 110 ℃) while the (CH3)3 peak showed an 
increase in chemical shift and a coalescence between the two peaks. Furthermore, 
all peaks showed broadening with increasing temperature, but the evidence is not 
sufficient to conclude the presence of rotamers. Alternatively, the “duplication” could 
in fact be a seemingly identical unidentified derivative of the target hydrazide.  
 Deprotection of tert-butyl-2-propiolohydrazine-1-carboxylate proved 
challenging and was largely unsuccessful. Despite attempting several well-known 
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Figure 2.3: (left) 1H NMR and (right) PENDANT 13C NMR spectra of tert-butyl-2-
propiolohydrazine-1-carboxylate (left) 2.1. The expected peaks at 10.29, 8.92, 4.26 












Boc-group removal strategies (Scheme 2.5), the target monomer 2.2 could not be 
isolated. 
Attempts with TFA, as a reagent and solvent, could be seen by 1H NMR 
spectroscopy (Fig. 2.5) to have been the only conditions to afford the desired target 
molecule. In the purification process however, the impure oil obtained could not be 















3) 2M HCl, Et2O, THF
2.1 2.2
Scheme 2.5: Conditions attempted for substrate 2.1 deprotection.












Figure 2.5: 1H NMR spectrum of impure 2.2 isolated after precipitating the crude 







Furthermore, consecutive attempts at precipitation seemed to introduce even more 
impurities. Deprotection using 2 M HCl in Et2O was also unsuccessful. The expected 
Boc-group removal was observed, but this was accompanied most likely by Michael 
addition reactions (Fig. 2.6). No alkyne signals were observed in the 4.3 ppm region, 
instead, several pairs of doublets in the alkene region (i.e. 6.4 - 7.6 ppm) were 
observed. Curiously, this pattern of reactivity seems to be also observed during the 
polymerisation reactions as likely side-products. Due to the repeated failures in 
isolating the deprotected monomer it was decided to attempt the synthesis of Boc-P2 






Reaction with 2M HCl, Et2O in THF
Figure 2.6: 1H NMR spectrum of the precipitate isolated from the deprotection of 
2.1 using 2M HCl in Et2O and THF. Several pairs of doublets with different 
intensities can be observed between 6.3-10.0 ppm. These are believed to be 









 The polymerisation of 2.1 was explored under three different metal catalysts 
and different reaction conditions (Table 2.1). The first attempts using the [Rh(nbd)Cl]2 
catalyst proved generally ineffective (Table 2.1, Entry 1,2). Although full monomer 
consumption was observed (Fig. 2.7), conversion to polymer seems to be small. 
Initially it was thought that likely by-products were small size oligomers or possibly 
[2+2+2] cyclisation products. To rule out the [2+2+2] cyclisation product the possible 
[2+2+2] product 2.5 (Fig. 2.7) was synthesised, using the same EDC, H2O/THF 
protocol from trimesic acid and tert-butyl carbazate. The 1H NMR spectrum of this 
product (Fig. 2.7) was inconsistent with any features of the 1H NMR spectra that 
were obtained for the polymerisation reactions. The quartet at 3.93 ppm (2H) and the 
triplet at 1.15 ppm (3H), may be evidence of Et3N undergoing Michael addition to the 
monomer.24 The alkene signals at 5.85 and 5.55 ppm showed an integration with 
respect to the former quarter and triplet of (1:1:6:9) suggesting three ethyl groups per 








Figure 2.7: 1H NMR spectrum of polymerisation crude of 2.1 with [Rh(nbd)Cl]2 in 
TEA/THF (crosses) showing the consumption of monomer and the suspected 
presence of the Michael addition product of 2.1 with TEA (left). Expanded region 
9.8 - 4.6 ppm (inset). 1H NMR spectrum of tri-tert-butyl 2,2’,2’'-(benzene-1,3,5-
tricarbonyl) tris(hydrazine-1-carboxylate) 2.5 (i.e. the expected product of the 



























the Rh catalyst were similarly futile. As a consequence, it was decided to explore 
palladium based catalysts. Due to its moderate success in polymerising N-butyl-2-
propynamide,11 [Pd(CH3CN)4](BF4)2 was considered as an appropriate catalyst for 
these type of substrates. Monomer conversion to polymer rather than by-products 
seemed to occur in prevalence at higher temperatures (Table 2.1, Entry 3,4 vs 5), 
but full monomer consumption was not obtained even after reacting for a couple of 
weeks (Table 2.1, Entry 5). The polymerisation of 2.1, using PdCl2(PhCN)2 as a 
catalyst in toluene, lead to full monomer consumption with polymeric compounds as 
the predominant product within 48 hours, but only at elevated temperatures (Table 
2.1, Entry 6,7). Characterisation of the products obtained proved challenging. Proton 
NMR spectra of reaction crudes containing toluene were particularly difficult to 
analyse due to the aromatic protons blocking an area where most new signals are 














Figure 2.8: 1H NMR spectra of a Boc-P2 polymer sample before (left) and after 
(right) purification by precipitation. The peak at 6.67 ppm was identified as an N-H 
peak as it was shown to be an exchangeable proton in the presence of MeOD. The 
small broad peak at 7.24 ppm integrates to ~10% of the integration value of the 
peak at 6.87 ppm, and only 2% of the integration value of the CH3 in the Boc-group. 
This suggested that there could be small quantities of a polymeric species (i.e. Boc-














































   
   
   
   
   
   













Figure 2.9: (Top) FT-IR spectra of polymer products isolated after reactions of 2.1 
with [Pd(CH3CN)4](BF4)2 (left) and PdCl2(PhCN)2 (right) respectively. The absence 
of alkyne vibrational stretch, and broadening of the hydrazide and Boc-group 
carbonyl peaks suggests presence of polymeric or oligomeric products. (Bottom) 
SEC/GPC chromatograms of products of the polymerisation of 2.1 showing 
polymeric (10.8 min) and oligomeric (20.7 min) specific peaks in the isolated 
product. Molecular weight are calculated based on PMMA calibration standards.
Mw ~ 1.5x106 Da
Mw ~ 1600 Da
identified were a pair of singlets at ~6.87 and ~6.67 ppm assigned as C-H and N-H 
environments (Fig. 2.8). These peaks did not show the characteristic broadening 
expected of polymer species. FT-IR spectra showed (Fig. 2.9) the disappearance of 
the alkyne vibrational stretch and a coalescence of the two carbonyl stretches into a 
single broader peak. SEC/GPC (Fig. 2.9) suggested the presence of small amounts 
of a relatively large polymeric species, but the main peak is characteristic of several 
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Table 2.1: Summary of key polymerisation reaction attempts with monomer 2.1. 
aAccording to 1H NMR; bVolume ratio: 2:1; cVolume ratio: 1:1; dVolume ratio: 2.5:1; 
eVolume ratio: 6:1; fIsolated after dialysis; gIsolated after precipitation from THF to 
H2O at 80 ℃.













100 0.201 30 24 100 17f
2 MeOH/
Et3Nc




83 0.163 30 432 84 14f
4 THF 91 0.443 30 192 25 9g
5 Toluene
/THFe
95 0.159 70 72 75 20g
Catalyst: PdCl2(PhCN)2
6 Toluene 107 0.486 70 48 100 34g
7 Toluene 187 0.868 70 48 100 58g
8 DMSO 49 0.904 70 24 100 25f
discrete oligomeric moieties. After these failed attempts to synthesise larger 
molecular weight Boc-P2, in which different catalysts, temperatures and solvent 
conditions were considered, the work these types of polymers was halted and 
research was diverted towards phenylacetylene type monomers as the literature 
suggested that they were more likely to have a higher chance of success. 
 The phenylacetylene hydrazide monomer 2.4 was synthesised in three steps. 
In the first step 4-iodobenzoic acid was reacted with tert-butyl carbazate under the 
previously reported conditions (i.e. EDC, water, THF) (Scheme 2.6) in high yields to 
afford the Boc-protected iodobenzylhydrazide 2.6. 
The alkyne functionality was inserted via the Sonogashira coupling between the 
aforementioned iodobenzoyl (2.6) and trimethylsilylacetylene (Scheme 2.7). The 
expected product was isolated in good yields after purification via column 












































Scheme 2.7: tert-butyl-2-((4-trimethylsilyl)ethynyl)benzoyl)hydrazine-1- 
carboxylate 2.7 synthesised via the Sonogashira coupling of compound 2.6 and 
trimethylsilylacetylene.
spectroscopy and mass spectremetry confirmed the expected structure 2.7 (Fig. 
2.10). 
The new alkyne bond was evidenced by both the stretch at ~2170 cm-1 in the FT-IR 
spectrum and two new quaternary carbon centres in the 13C NMR spectrum, while 












































    
   C=O
N-H
Figure 2.10: (Top) FT-IR spectra of compounds 2.6 (left) and 2.7 (right) showing the 
newly introduced alkyne functionality characterised by the C≡C stretch at 2159 
cm-1. (Bottom) 1H (left) and PENDANT 13C (right) NMR spectra of alkyne 2.7 
confirming the structure of the molecule. The trimethylsilyl (TMS) group is 
evidenced by the peak at 0.24 ppm in the 1H NMR and -0.19 ppm in the 13C NMR 
spectra, and the alkyne peak is evidence by the peaks at 104.30 and 96.83 ppm in 















 At this stage two distinct deprotection strategies (Scheme 2.8) were explored. 
Selective deprotection of the alkyne was achieved using K2CO3 in a 1:1 THF/MeOH 
mixtures, to afford tert-butyl 2-(4-ethynylbenzoyl)hydrazine-1-carboxylate 2.3. 
Alternatively, a dual deprotection to remove both the TMS and the Boc group was 
carried out to afford the TFA salt 2.8 of our target molecule 2.4. Both products were 
purified either by work-ups, precipitation or trituration. In both cases 1H NMR 
spectroscopy (Fig. 2.11) confirmed the loss of the TMS group at 0.24 ppm and the 











































Scheme 2.8: Selective removal of the TMS group (top) or dual removal of the TMS 
and Boc groups to afford phenylacetylenes 2.3 and 2.8 respectively (bottom).
Figure 2.11: 1H NMR spectra of Boc-protected 4-ethynylbenzohydrazide 2.3 (left) 

























 Initially the polymerisation of the TFA hydrazide salt 2.8 was explored using 
the [Rh(nbd)Cl]2 catalyst with Et3N in H2O, DMSO or H2O/DMSO mixtures (Scheme 
2.9). Regardless of whether the concentration of monomer in solution was high (1.0 
M) or low (0.2 M), polymerisation occurred rapidly as suggested by the immediate 
increase in viscosity upon the addition of the catalyst.  
Unfortunately, the polymers isolated were insoluble despite attempts at using varied 
combinations of aqueous, organic or acidic media as well as H-bonding-disrupting 
additives such as urea. It is believed that the polymer molecules H-bond to each 
other via the hydrazide side-chains to create unbreakable networks. As a 
consequence of its insolubility, the only characterisation information obtained was 
from IR-spectroscopy (Fig. 2.12). The data suggested that a structure high in cis-
transoid content is present according to Simionescu et al.8,25 According to the 
literature, cis-transoid specific peaks are at 740, 895 and 1380 cm-1 for 
poly(phenylacetylene). In the FT-IR spectra of P3 peaks at 755, 896 and 1373 cm-1 
were observed, which could be considered within a margin of error due to poor 
resolution and the fact that the reported values are for unsubstituted 




















Scheme 2.9: Attempted polymerisation conditions for phenylacetylene 2.8, the TFA 
salt of monomer 2.4.
 As a consequence of the insolubility issues encountered, it was decided to 
attempt the polymerisation of the Boc-protected monomer 2.3 (Scheme 2.10), with a 




















896 cm-1 755 cm-1
Figure 2.12: FT-IR spectra of monomer 2.8 and the insoluble polymer P3. The 
highlighted peaks could be consistent with the reported values for 
poly(phenylacetylene) and the small deviations could be attributed to poor 


















Scheme 2.10: Polymerisation conditions for Boc-protected phenylacetylene 
hydrazide 2.3 to afford Boc-P3.
Polymerisation of this substrate proved efficient and the obtained Boc-P3 polymers 
showed solubility in organic polar solvents such as THF, MeOH and DMSO. The 
effects of monomer concentration on the reaction kinetics and polymer size were 
investigated by analysing by SEC/GPC in MeOH three reaction crudes at [0.5], [1.0] 
and [1.5] monomer concentration after 2 hours. As expected, monomer conversion 
was higher with increased concentration, but larger molecular weight polymers were 
also observed while less oligomers were present (Fig. 2.13).
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19.22 27.8 28.6 29.9 30.70 32.4
[M]=0.5 - - 28.01 4.17 0.35 2.18 2.83 62.46
[M]=1.0 0.54 72.09 - 3.10 - 0.75 1.43 22.09
[M]=1.5 7.6 55.37 - - 0.45 23.88 4.20 8.52
Retention time (min)
Figure 2.13: (Top) SEC/GPC chromatogram showing the difference in reaction 
profiles of polymerisations of 2.3 at different monomer concentrations after 2h. 
(Bottom) Table summarising the area under the curve for each peak observed.
In the figure above, the retention time at 32.4 min. is due to the monomer, peaks 
between 27.8-30.70 are suspected to be oligomers while peaks between 14.3-19.22 
are target polymers. It could be seen that for [M]=1.5 a rapid consumption of 
monomer is observed. Because the area under the curve is dependent on the 
absorption profile at 275 nm, a 8.52% AUC for the monomer does not necessarily 
mean that a conversion of 91% has occurred, as the polymer could be a better UV-
Vis absorber. However, these values can be used to compare the reactions at 
different concentrations. 
With these findings in mind, the monomer was polymerised at [M]=1.5 on a 250 mg 
scale to successfully obtain 230 mg of a polymer/oligomer mixture as evidenced by 
the SEC/GPC chromatogram (Fig. 2.14). The chemical shifts and shape of the peaks 
in the 1H NMR spectrum (Fig. 2.15) of this sample were consistent with the literature 
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Figure 2.14: SEC/GPC chromatogram of polymer Boc-P3. According to the area 
under curve, the area peaking at 17.4 min represents 60% of the total, while the 
oligomers account for the rest of the sample.













Polymer 36l r Boc-P3
prediction9,10,26 for poly(phenylacetylene): alkene proton around 5.82 and broad 
aromatic protons between 6.70 and 7.50 ppm. The sharper features hidden 
underneath the broad peaks could be due to the oligomers present as evidenced by 
the SEC/GPC. 
 To obtain the target polymer scaffold P3, the deprotection of polymer Boc-P3 
with TFA in DMSO was attempted. In all experiments where the content of TFA was 
lower than that of DMSO, no deprotection was observed. This could be attributed to 
the protonation of DMSO in solution. When the deprotection was carried out in 3:1 
TFA/DMSO, successful removal of the Boc group was observed. Isolation of the 
compound proved difficult however. Removal of DMSO using solvent removal 
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Figure 2.15: 1H NMR spectrum of polymer Boc-P3 showing the expected broad 
peaks. The peaks at 10.08 and 8.89 ppm are consistent with the N-H peaks, 7.58, 
6.76 and 5.82 ppm with the aromatic peaks and vinyl peak respectively, while the 













techniques was unsuccessful and dialysis under basic conditions, to deprotonate the 
TFA hydrazide, lead to the insoluble polymer P3. The deprotection was successfully 
repeated in 3:1 TFA/THF (Scheme 2.11). The solvent was removed by a series of 
dissolutions in Et2O and evaporation through blowing a stream of argon. An orange 
precipitate (TFA-P3) was isolated and dried further under vacuum to afford the TFA 
salt of polymer P3. 
 Polymer TFA-P3 was analysed by 1H NMR spectroscopy in DMSO-d6 (Fig. 
2.16), but the solubility of the polymer was poor. Heating was required to achieve 
dissolution and a viscous solution was obtained. The spectrum showed the expected 
broad aromatic and the alkene peak at 7.49, 6.70 and 5.75 ppm respectively. No 
peak was observed in the expected region of for the Boc-group, while the NH3+ is 
believed to be masked by the excess TFA solvent at 4.34 ppm. To determine if the 
scaffold is reactive towards aldehydes, 0.45 equiv. benzaldehyde (A7) were added to 
the NMR sample. Immediate and complete coupling was observed as evidenced by 
the absence of both the aldehyde signal and sharp aromatic signals. However, 





















Scheme 2.11: Reaction scheme showing the deprotection of polymer Boc-P3 to 
afford the target hydrazide scaffold P3 as a TFA salt.
chains and aromatic signals of the aldehyde, it was difficult to assign and integrate 
peaks in that region. As such, analysis of the conjugation with aromatic aldehydes to 
poly(4-ethynylbenzohydrazide) was significantly more challenging compared to 
poly(acryloyl hydrazide) P1. Further functionalisation with 1.35 equiv. benzaldehyde 
resulted in ~70% loading immediately after addition, which increased to ~75% after 
22 hours. Further monitoring over 4 days, showed a slight decrease in the 
percentage conjugation (Fig. 2.17). This could potentially be attributed to increased 
amounts of water in the sample over time (due to the hygroscopic nature of DMSO), 
which could alter the equilibrium of hydrazone formation. It could also be observed 
that in these experiments compared to poly(acryloyl hydrazide) no mono- and 
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Figure 2.16: 1H NMR spectrum of polymer TFA-P3 showing similar broad peaks as 
polymer Boc-P3 but no Boc-group peak. The peak at 4.34 ppm could be accounted 















dihydrazone impurities were formed. One possible reason behind this lies in the 
highly arranged helical structure of this scaffold. If the hypothesis (see Chapter 1) 
behind the impurity forming mechanism is true, neighbouring hydrazide chains are 
required in close proximity to catalyse the system. This should be easier achieved in 
a random coil polymer than a highly structured helical polymer in which the hydrazide 
side chains are further apart and with limited flexibility. 
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Polymer TFA-P3
TFA-P3 + 0.45 equiv. A7 t=0
TFA-P3 + 1.35 equiv. A7 t=0
TFA-P3 + 1.35 equiv. A7 t=2h
TFA-P3 + 1.35 equiv. A7 t=22h
TFA-P3 + 1.35 equiv. A7 t=4 days
Figure 2.17: 1H NMR spectra of polymer TFA-P3 and its conjugation to 
benzaldehyde (A7). Immediate coupling is occurring upon addition of A7. Maximum 




Further coupling experiments with ~0.8 equiv. isovaleraldehyde (A17) showed a 




TFA-P3 + 0.8 equiv. A17 t=2h
TFA-P3 + 0.8 equiv. A17 t=18h
TFA-P3 + 0.8 equiv. A17 t=4 days
TFA-P3 + 0.8 equiv. A17 t=7 days
Figure 2.18: 1H NMR spectra of polymer TFA-P3 and its conjugation to 
isovaleraldehyde (A17). Almost all of the 0.8 equiv. A17 has coupled within 2h. 
Over the next 7 days ~11% of the bound A17 decouples from the scaffold. This is 
seen by the increasing size of the sharp peaks at 0.91 and 0.89 ppm, the doublet of 






aldehyde to the scaffold was observed within 2 hours. Analysis of the sample over 7 
days shows that some of the aldehyde is being slowly regenerated. The broad alkyl 
signals at 2.14, 1.80 and 0.90 ppm (Fig. 2.18) became sharper over time and 
recovered the original splitting pattern observed for isovaleraldehyde. There are no 
further changes between 4 and 7 days, suggesting equilibrium had been reached by 
that time. Overall, only about 11% of the aldehyde was in the unconjugated form. 
These two experiments showed that functionalisation of P3 was less predictable 
compared to P1, despite achieving similar percentage functionalisation with A7 and 
A17. 
 As mentioned before, poly(phenyl acetylene)s synthesised via rhodium 
catalysed polymerisation mechanistically produce 100% cis-containing conformers. 
Loses in cis-content is due to molecular rotation in the backbone and it can be highly 
dependent on solvent, temperature and pendant side-chains. The stability of the 
protected polymer Boc-P3 was investigated via SEC/GPC, UV-Vis and fluorescence 
spectroscopy 
Stability studies via SEC/GPC (Fig. 2.19) were carried out by re-injecting at 45 min 
intervals a sample of polymer Boc-P3 dissolved in the MeOH. At t0 the spectra 
showed a sharp intense peak at retention time ~11.1 min flanked by much smaller 
peaks at 8.7 and 9.7 min. In the first 18h significant changes were observed at every 
interval. The main peak at ~11.1 min decreased in intensity and broadened towards 
longer retention times, while the peaks at 8.7 and 9.7 min increased in intensity until 
they plateaued. The shorter retention time suggested polymeric species with larger 
hydrodynamic radius. Since the length of a helical polymer can be thought of as the 
radius of a particle, the transition to a larger “hydrodynamic radius” suggested a 
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transition to a polymer conformation with a longer length. This could be explained by 
a change in conformation from cis-transoid to trans-transoid, which is expected to 
have the longest helical length (Fig. 2.20). 
UV-Vis analysis of a sample of polymer Boc-P3 over 72 hours was overall 
inconclusive. There seemed to be a small decrease in absorbance over time, mostly 
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Figure 2.19: (Top) SEC/GPC chromatograms at 24h intervals showing the stability 
of polymer Boc-P3 in MeOH over time. (Bottom) Analysis showing the changes in 
intensity at particular retention times with each 45 min injection interval.
evident around 420 nm, but the changes are below 0.05 AU (Fig. 2.21). Analysis by 
fluorescence spectroscopy showed interesting trends. The sample was analysed 
over 9 days by measuring the emission profile at two excitation wavelengths "ex440 
and "ex484 with emission maxima at "em526 and "em554 respectively. Over 9 days, the 
intensity of the emission profiles at "ex440 and "ex484 increased 200-fold and 3-fold 
respectively, and a small blueshift in the emission maxima was observed. However, 
when the excitation profile at "em526 and "em554 over the same period was analysed, 
a 4-fold increase in the intensity was observed, but with a substantial blueshift in the 
maximum excitation wavelength. "ex maxima changed from ~484 nm to ~440 nm, 
which is consistent with the 200 fold increase in the emission profile when "ex440 was 
used. This reinforced the hypothesis that a different polymer conformation was 
present which had different photophysical properties. This would not be surprising, as 
the conjugation through the backbone in the cis-transoidal model versus the trans-
transoidal model is different.
 Stability studies were also carried out for polymer TFA-P3 conjugated with 
isovaleraldehyde. The sample was analysed by SEC/GPC in a similar fashion to 
polymer Boc-P3. The spectra at t0 showed a broad peak at ~9.5 min retention time, 
and a smaller peak at ~16 min (Fig. 2.22). The peak at ~9.5 min, increased 3-fold in 
intensity and showed further broadening towards lower retention times during the first 
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Figure 2.20: Model representations of a 22 carbon cis-transoid chain (left) and 
trans-transoid chain (right).
24 hours. Past this time point however, a reverse trend is observed with a loss of 
intensity, broadness and shift of the local maxima towards the initial retention time. 
The peak ~16 min increased slowly in intensity, but showed no reversal in trends. In 
fact, it showed a continuous shift towards lower retention time, with a final peak value 
at ~14.5 min. The trends in the stability of this system are much harder to explain in 
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Absorbance at 290 nm
Absorbance at 350 nm
Absorbance at 410 nm
Absorbance at 425 nm
Figure 2.21: (Top) (left) UV-Vis spectra of a 0.01 mg/ml sample of polymer Boc-P3 
at various time intervals in MeOH. (right) Graph showing the changes at various 
wavelengths in the UV-Vis over time. (Bottom) Spectra showing the changes in the 
emission and excitation profiles of a sample of polymer Boc-P3 over time. As can 
be seen in the bottom two panels, a blue-shift in the excitation profile was observed 
suggesting conformational changes in the polymer’s structure.
comparison to polymer Boc-P3, and there was not sufficient evidence to say whether 
conformational changes were occurring or if the changes observed were due to the 
equilibration of the polymer – isovaleraldehyde conjugate. 
 Overall, considering the stability issues associated with the Boc-P3 scaffold, 
the poor solubility of polymer TFA-P3 in aqueous conditions, and the unpredictable 
conjugation behaviour, this polymeric scaffold was not taken forward as a scaffold for 
functional polymers with biological applications at that time. 
 A third alkyne-based polymer scaffold was synthesised in the group by Andy 
Wilkinson and Arka Chakraborty under the supervision of the author of this thesis. 
The aim was to synthesise a helical polymer (Scheme 2.12) scaffold akin to the initial 
poly(acetylene hydrazide) P2, which wouldn’t suffer from the solubility issues of the 
P3 scaffold. A propargyl type monomer 2.9 was chosen, as there was sufficient 
literature evidence that a hydrazide derivative would be polymerised.3,4,6,27
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Figure 2.22: SEC/GPC chromatograms at 12h intervals showing the stability in 
MeOH over time of polymer TFA-P3 conjugated with isovaleraldehyde (A17).
The monomer was synthesised in two steps (Scheme 2.13) by first reacting 
propargyl choloroformate with tert-butyl carbazate to obtain the protected monomer 
2.10, followed by deprotection using 2M HCl/Et2O, which yielded the chloride salt of 
monomer 2.9. Polymerisation of both the protected and deprotected monomers was 
evaluated. Initially, [Rh(nbd)Cl]2 was used as the catalyst with monomer 2.10 but 
large polydispersities and a large ratio of oligomers were observed. Rh(nbd)BPh4 has 
been reported to successfully polymerise propargyl-type monomers and it was 
decided to use it to attempt the polymerisation of monomers 2.10 and 2.11. 
Polymerisation of the protected monomer 2.10 (Scheme 2.14) was successful and 
samples with different molecular weights were synthesised (Table 2.2) by adjusting 
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Scheme 2.13: Reaction scheme showing the synthesis of monomer 2.11, the 
chloride salt of monomer 2.9 via the synthesis of the Boc-protected intermediate 
2.10 and its subsequent deprotection.
the catalyst to monomer ratio. The experiments showed that below a [M[/[cat.] ratio 
below 100:1 (Entry 1,2) the increase in molecular weight is proportional to the ratio , 
while the dispersity is sufficiently low. Above this ratio, (Entry 3) the number average 
molar mass continues to be proportional to the ratio, but the weight average deviates 
significantly and large molecular weight polymers are produced, suggesting that a 
loss in controlled polymerisation is occurring. 
 It is that the polymerisation of the chloride salt 2.11 was successful, however 
the isolated polymer P4 showed similar solubility issues as those reported for during 
the synthesis of P3 by polymerisation of the phenylacetylene hydrazide TFA salt 2.8. 
The reaction appeared very fast due to the increased viscosity observed but the 
product was insoluble and characterisation was not achieved. It is believed that Et3N 




















Scheme 2.14: Reaction scheme showing the synthesis of the Boc-protected 
poly(propargyl hydrazide) Boc-P4 from monomer 2.10.
2.10 Boc-P4
Table 2.2: Characterisation data of samples of polymer Boc-P4 synthesised. aData 
obtained from SEC/GPC against PMMA calibration standards.
Entry Polymer [M]/[cat.] Mna Mwa Đ
1 Boc-P450 50 6404 10350 1.62
2 Boc-P4100 100 9244 18372 1.99
3 Boc-P4200 200 17467 109535 6.27
the formation of polymeric networks bound intermolecularly by strong, extensive 
H-bonding networks. Deprotection of polymer Boc-P4 was achieved by reacting in 
neat TFA followed by purification by dialysis against 100 mM AcOH to exchange the 
TFA counterions for acetate counterions (Scheme 2.15). Dialysis against water 
resulted to the loss of TFA counterions and deprotonation of the hydrazonium ion and 
formation of the extensive H-bonded network of the insoluble P4.  
 Coupling experiments with a selection of aldehydes showed mixed results in a 
solvent dependent manner (Table 2.3). Isovaleraldhyde, 5-formylsalicylic acid and 
imidazole-4-carboxaldehyde (Entry 1,6 and 8) showed excellent conjugation to the 
scaffold in DMSO, but other aldehydes, both aromatic (Entry 2, 3, 4, 5, 7) and 
aliphatic (Entry 9, 10), showed poor coupling. Longer chain aliphatic aldehydes like 
octanal (Entry 10) showed excellent coupling in a mixture of 1:1 DMSO-d6, CDCl3, 
but in this solvent system, no improvement in the coupling of aromatic aldehydes and 
longer branched aliphatic aldehydes like 2-ethylhexanal was observed. Overall, it 
appeared that the coupling conditions had to be fine-tuned for each aldehyde, which 






















Scheme 2.15: Reaction scheme showing the deprotection of the Boc-protected 
poly(propargyl hydrazide) Boc-P4 to form the acetate salt (AcO-P4) of the target 
polymer scaffold P4.
Boc-P4 AcO-P4
be potentially useful to compare a functionalised poly(acryloyl hydrazide) to an 
equivalent poly(propargyl hydrazide) in order to evaluate differences arising due to 
random coil versus helical geometry. 
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Table 2.3: Coupling experiments between poly(propargyl hydrazide) AcO-P450 and 
different aldehydes. aconjugation in DMSO-d6; bconjugation in CDCl3/DMSO-d6 
(1:1). 
Entry Polymer %conjugationa Entry Polymer %conjugationa
1 P450A1 88 6 P450A12 99
2 P450A7 12 (9)b 7 P450A13 23
3 P450A8 — (24)b 8 P450A17 79
4 P450A9 14 9 P450A18 — (—)b



























A1 A7 A8 A9 A10























 Stability studies of the protected polymer were carried out by SEC/GPC in a 
similar experiment as before. The data showed small changes in the main peak at 
~13 min (Fig. 2.23), but there was a shift towards shorter retention times in the 
shouldering peak at ~16.4 min that could be indicative of changes in conformation. 
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Figure 2.23: SEC/GPC chromatograms at 12h intervals showing the stability of 
polymer Boc-P4 in MeOH over time.
Injection at t=0 
Injection at t=12h 












 Synthesis of the propiolohydrazide monomer 2.2 was not accomplished due to 
difficulties in the deprotecting stage. The target polymer P2 was not obtained via the 
polymerisation the Boc-protected substrate 2.1 as it seems that short oligomers and 
Michael addition by-products were being produced instead of Boc-P2. Research was 
focused towards the phenylacetylene hydrazide monomer 2.4, which was 
successfully synthesised. Polymerisation of the deprotected hydrazide led to the 
formation of an insoluble product P3 that according to characterisation data showed 
features a of cis-transoid polymer. Polymers from Boc-protected phenylacetylene 
hydrazide monomers 2.3 were synthesised and characterised. The stability of these 
polymers in solution was analysed to show that probable isomerisation of Boc-P3 
from cis-transoid to trans-transoid conformations are observed. The polymers were 
successfully deprotected and the P3 scaffold was isolated as a TFA salt. 
Deprotonation of the scaffold to form the original target polymer P3 resulted in an 
insoluble product. The TFA-P3 scaffold was slightly soluble in DMSO after heating 
and its functionalisation with aldehydes was investigated. The coupling reaction was 
found occur generally very fast, but the polymer undergoes a slow equilibration 
process over several days. A third scaffold based on poly(propargyl hydrazide) P4 
was successfully synthesised as an alternative to poly(4-ethynylbenzohydrazide). 
Direct polymerisation of the unprotected hydrazide 2.9 resulted again in an insoluble 
product. Polymerisation of the Boc-protected monomer 2.10 was successful and 
samples with different molecular weights were synthesised. Stability studies indicated 
that this polymer may be more stable than Boc-P3. The polymer was deprotected in 
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TFA and isolated as an acetate salt AcO-P4 after dialysis. This scaffold showed 
better solubility compared to scaffold TFA-P3, and functionalisation with aldehydes 
was investigated in a mixture of solvent systems. The conjugations observed were 
either very efficient or very poor and each aldehyde had to be investigated 
independently to optimise the coupling conditions. Overall, it is believed that the 
major limitation of helical hydrazide polymers stems from their extensive H-bonded 
networks, which rendered them insoluble if the hydrazide is not protonated.  
2.5 Future work 
 There is some scope to use scaffolds TFA-P3 and AcO-P4 in order to compare 
the biological activity of functionalised polymers starting from hits isolated by fast-
screening of poly(acryloyl hydrazide) P1. This could be potentially useful to study 
how helical polymers, which have a rigid structure differ in activity compared to a 
flexible random coil polymer. It may also be worth investigating similar polymers 
bearing hydrazine or O-hydroxylamine instead of hydrazide functionalities to 
investigate if the solubility of the scaffolds improves. These should form fewer 
H-bonds between the polymer chains, and could lead to a helical scaffold useful for 
fast screening of functional polymers in aqueous media. Aside from the 
functionalisation with aldehydes, there is further scope to use the hydrazide chains 
as chemoselective handles for reactions with a variety of electrophiles (e.g. epoxides, 
activated esters, isothiocyantes, etc.), which may be more efficient than the 
functionalisations of TFA-P3 or AcO-P4 with aldehydes.  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2.6 Experimental 
 All chemicals were purchased from Sigma-Aldrich®, Fisher Scientific®, VWR® 
or Acros® and used without further purification. All solvents were Reagent grade or 
above, purchased from Sigma-Aldrich®, Fisher Scientific® or VWR® and used 
without further purification. 
Nuclear Magnetic Resonance (NMR) spectra were recorded on either a Bruker 
Avance III 300 MHz or a Bruker Avance III 400 MHz spectrometer. Chemical shifts 
are reported in ppm (ẟ units) referenced28 to the following solvent signals: residual 
DMSO in DMSO-d6 at ẟH 2.50, H2O in D2O at ẟH 4.79, CHCl3 in CDCl3 at ẟH 7.26. 
Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum Two FT-IR 
spectrometer. Peaks are reported as strong (s), medium (m) or weak (w), sharp (sh) 
or broad (br). Ultraviolet-visible (UV-Vis) spectra were recorded on a Cary 50 
Spectrophotometer. Fluorescence spectra were recorded on a Shimadzu RF-5301PC 
Spectrofluorophotometer. Mass spectra were recorded on a Waters Xevo G2-XS ToF 
using electrospray ionisation (ESI) and time-of-flight (ToF) in positive or negative ion 
mode. Melting points were measured on a Stuart SMP10 digital melting point 
apparatus. Thin-layer chromatography was carried out on sheets coated with silica 
gel. Size Exclusion Chromatography/Gel Permeation Chromatography (SEC/GPC) 
were recorded on a Shimadzu Prominence LC-20A fitted with a Thermo Fisher 
Refractomax 521 Detector and a Shimadzu SPD20A UV-Vis Detector or fitted with a 
Shimadzu SPD-M20-A Photodiode Array Detector and a Shimadzu RF-10A 
Fluorescence Detector. All samples were analysed at 40  ℃  in MeOH as the eluent 
and a flow rate of 0.6 mL·min-1. The instrument was fitted with a Shodex Asaphipak 
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GF-310 HQ column (300 × 7.5 mm, 5 µm). Molecular weights were calculated based 
on a standard calibration method using polymethylmethacrylate. All dialyses were 
carried out using Spectrum Labs SpectraPor® Dialysis Tubing MWCO 1000 in water 
unless specified otherwise for a minimum of 24 hours and at least 3 changes of 
solvent. 
tert-Butyl 2-propioloylhydrazinecarboxylate (2.1) 
 Propiolic acid (0.88 mL, 13.99 mmol) and tert-butyl carbazate (1.69 g, 12.59 
mmol) were dissolved in H2O (45 mL) at r.t. N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (2.95 g, 15.39 mmol) was added in portions to the 
solution over 1 min. and stirred for 15 min. The aqueous phase was extracted with 
EtOAc (3 x 50 mL). The organic layer was washed with sat. NaHCO3 soln (3 x 50 
mL), H2O (50 mL), and brine (50 mL). The organic phase was dried with Na2SO4 and 
the solvent removed under reduced pressure to afford a colourless oil. Et2O (5 x 2 
mL) was added to the oil and removed under high vacuum to afford, after drying, 2.1 
as a white solid (1.88 g, 81% yield): Rf = 0.85 (100% EtOAc); νmax(neat)/cm-1 3253m 
sh (N-H), 2948w (C-H), 2116w sh (C≡C), 1725s sh (C=O), 1665s sh (C=O); δH(300 
MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 1.39 (s, 
9H, C(CH3)3), 4.33 (s, 1H, CCH), 8.95 (s, 1H, OC(O)NH), 10.31 (s, 1H, CC(O)NH); 
δC(100 MHz, DMSO-d6) [calibrated using (CH3)2SO resonance at 39.52 ppm] 19.0 









(CC(O)NH); MS (TOF ES-) m/z 183 ([M-H]-, 100%). The characterisation data is in 
accordance to literature.29 
tert-Butyl 2-(4-iodobenzoyl)hydrazine-1-carboxylate (2.6) 
 A solution of tert-butyl carbazate (2.45 g, 18.18 mmol) in H2O (80 mL) was 
added slowly over 1 min. to a stirring solution of 4-iodobenzoic acid (4.00 g, 15.81 
mmol) dissolved in THF (40 mL) at room temperature. N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (3.49 g, 18.18 mmol) was added to the emulsion in 
portions over 1 min. and allowed to react for 2 hrs. The aqueous phase was extracted 
with EtOAc (3 x 100 mL). The organic layer was washed with 0.1 M HCl(aq) (3 x 100 
mL), H2O (100 mL), and brine (100 mL). The organic phase was dried with Na2SO4 
and the solvent removed under reduced pressure to afford 2.6 as a white solid (4.7 g, 
82% yield): Rf = 0.15 (20% EtOAc/Hexane); νmax(neat)/cm-1 3332s sh (N-H), 3225s sh 
N-H), 2968m sh (C-H), 1720s sh (C=O), 1654s sh (C=O), 1568s sh (C=C); δH(300 
MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 1.42 (s, 
9H, C(CH3)3), 7.63 (d, J 8.4, 2H, C3H), 7.88 (d, J 8.7, 2H, C2H), 8.95 (s, 1H, 
C5(O)NH), 10.28 (s, 1H, C6(O)NH); δC(100 MHz, DMSO-d6) [calibrated using 
(CH3)2SO resonance at 39.52 ppm] 28.2 (C8), 79.4 (C7), 99.5 (C1), 129.4 (C3), 132.0 
(C4), 137.4 (C2), 155.5 (C6), 165.5 (C5); MS (TOF ES+) 385.0 ([M-Na]+ 100%; Melting 














tert-Butyl 2-(4-((trimethylsilyl)ethynyl)benzoyl)hydrazine-1-carboxylate (2.7) 
 PdCl2(PPh3)2 (293 mg, 0.41 mmol) and Copper(I) iodide (132 mg, 0.69 mmol) 
were added sequentially to a stirring solution of aryl iodide 2.6 (1.00 g, 2.76 mmol) in 
piperidine (26.5 mL). The solution was degassed by bubbling argon gas for ~10 min 
after which ethynyltrimethylsilane (1.2 mL, 8.28 mmol) was added dropwise over 2 
min. and stirred for 5 hours. The solution was diluted in toluene (100 mL) and washed 
with sat. NH4Cl soln. (2 x 100 mL) and brine (3 x 100 mL), dried with Na2SO4 and 
concentrated under reduced pressure to afford a dark brown oil. The product was 
purified by flash chromatography (20% EtOAc/hexane, dry loading) to afford 2.7 as a 
cream product (710mg, 77% yield): Rf = 0.45 (25% EtOAc/Hexane); νmax(neat)/cm-1 
3250w br N-H), 2965m sh (C-H), 2150w sh (C≡C),1673m sh (C=O), 1647s sh (C=O), 
1587m sh (C=C); δH(300 MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO 
resonance at 2.50 ppm] 0.24 (s, 9H, (CH3)3Si), 1.42 (s, 9H, (CH3)3C), 7.57 (d, J = 
8.4Hz, 2H, C6H), 7.84 (d, J = 8.4Hz , 2H, C5H), 8.96 (s, 1H, C8(O)NH), 10.29 (s, 1H, 
C9(O)NH); δC(100 MHz, DMSO-d6) [calibrated using (CH3)2SO resonance at 39.52 
ppm] -0.19 (C1), 28.1 (C11), 79.3 (C10), 96.8 (C2), 104.3 (C3), 125.3 (C7), 127.7 (C6), 


















tert-Butyl 2-(4-ethynylbenzoyl)hydrazine-1-carboxylate (2.3) 
 K2CO3 (1.17 g, 8.41 mmol) was added to a solution of phenylacetylene 2.7 
(0.7 g, 2.10 mmol) in 1:1 MeOH/THF (42 mL). The suspension was left to react for 4 
hours and then it was extracted with a 1:2 Et2O/H2O (48 mL). The organic phase was 
washed with water (2 x 30 mL) and brine (3 x 30 mL) and then it was dried with 
Na2SO4. The solvent was removed under reduced pressure to afford crude 
phenylacetylene, which was purified by trituration with ice-cold Et2O to afford 2.3 as a 
light brown powder (347 mg, 64%): δH(300 MHz, DMSO-d6) [calibrated using (CHD2)
(CD3)SO resonance at 2.50 ppm] 1.43 (s, 9H, C(CH3)3), 4.41 (s, 1H, CCH), 7.60 (d, 
2H, C5H), 7.86 (s, 2H, C4H), 8.96 (s, 1H, C7(O)NH), 10.29 (s, 1H, C8(O)NH); δC(100 
MHz, DMSO-d6) [calibrated using (CH3)2SO resonance at 39.52 ppm] 28.1 (C10), 
79.4 (C9), 82.8 (C2), 83.2 (C1), 125.0 (C6), 127.7 (C5), 131.8 (C4), 132.6 (C3), 155.5 
(C8), 165.3 (C7); MS (TOF ES-) m/z 259.29 ([M-H]-, 100%); Melting point range 
165-173 ℃ (sample decomposition).  
4-Ethynylbenzohydrazide 2,2,2-trifluoroacetate salt (2.8) 
 Trifluoroacetic acid (2.0 mL, 26.0 mmol) was added to phenylacetylene 2.7 
































stream of argon gas and then precipitated in Et2O. The suspension was centrifuged 
in Et2O (3 x 10 mL) and the pellet was purified by trituration with ice-cold EtOAc to 
afford a brown powder (311 mg, 62%) δH(300 MHz, DMSO-d6) [calibrated using 
(CHD2)(CD3)SO resonance at 2.50 ppm] 4.46 (s, 1H, CCH), 7.64 (d, 2H, C5H), 7.87 
(d, 2H, C4H), 11.23 (s, 1H, C7(O)NH); δC(100 MHz, DMSO-d6) [calibrated using 
(CH3)2SO resonance at 39.52 ppm] 82.8 (C1), 82.9 (C2), 124.3 (C6), 127.3 (C5), 131.7 
(C4), 133.3 (C3), 165.0 (C7); MS (TOF ES+) 161.1 ([M-H]+ 100%); Melting point range 
130-135 ℃ (sample decomposition). 
Poly(tert-butyl 2-(4-ethynylbenzoyl)hydrazine-1-carboxylate) (Boc-P3) 
 A solution of [Rh(nbd)Cl]2 (8.85 mg, 0.019 mmol) in 1:1 DMSO/Et3N (0.160 
mL) was added under an atmosphere of argon to a solution of phenylacetylene 2.3 
(250 mg, 0.960 mmol) in DMSO (0.480 mL) and left to react for 4 hours at 60 ℃. The 
product was precipitated by addition of H2O to the reaction vial and the polymer was 
purified by centrifugation against H2O (3 x 10 mL). The pellet was re-suspended in 
H2O and dried via lyophilisation to afford polymer Boc-P3 as a brown powder (230 
mg, 92% yield): νmax(neat)/cm-1 3269w br N-H), 2968w sh (C-H), 1703m sh (C=O),









[calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 1.40 (s, 9H, C(CH3)3), 5.82 
(br, 1H, CCH), 6.5-8.25 (br, 4H, C6H4), 8.88 (br, 1H, NH), 10.09 (br, 1H, NH); δC(100 
MHz, DMSO-d6) [calibrated using (CH3)2SO resonance at 39.52 ppm] 28.1, 79.2, 
127.3, 155.5, 165.4. 
Poly(4-ethynylbenzohydrazide) trifluoroacetate (TFA-P3) 
 Trifluoroacetic (9 mL) was added to a solution of polymer Boc-P3 (100 mg) in 
THF (9 mL) and stirred for 1 hour. The solvent was removed by blowing argon. The 
resulting oil was diluted with Et2O and the solvent was removed by blowing Argon 
until a precipitate was formed. The process was repeated to isolate polymer TFA-P3 
as a brown-red precipitate and dried under high vacuum. (60 mg, 100% yield): 
δH(300 MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 











1-(tert-Butyl) 2-(prop-2-yn-1-yl) hydrazine-1,2-dicarboxylate (2.10) 
 A solution of tert-butyl carbazate (1638.5 mg, 12.15 mmol) was stirred until 
complete dissolution in ethyl acetate (40 mL). The solution was cooled in an ice/
acetone bath for 5 minutes. To this a solution of propargyl chloroformate (0.410 mL, 
4.05 mmol) in ethyl acetate (10 mL) was added dropwise over 10 minutes. The 
resulting mixture was left to stir for 1.5 hours at room temperature and monitored by 
TLC (ethylacetate, permanganate dip, Rf = 0.9). Once the time had elapsed the 
solution was neutralised with K2CO3 (565.4 mg, 4.05 mmol) and subsequently was 
washed with 0.1 M HCl (3 x 30 mL), sat. Na2CO3 (3x 3 0 mL), water (3 x 30 mL), 
Brine (3 x 30 mL). The organic phase was dried with excess Na2SO4 and filtered. 
Finally the solution was dried under reduced pressure to remove all solvent. The 
resulting 2.10 was collected as a white solid (2.336 g, 11.06 mmol, 81%); νmax(neat)/
cm-1 3277m sh (N-H), 2860w, sh (C-H), 2137m sh (C≡C), 1730s sh (C=O),1690s sh 
(C=O); δH(300 MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO resonance at 2.50 
ppm] 9.14 (s, 1H, NH), 8.82 (s, 1H, NH), 4.66 (d, J = 2.5Hz, 2H, CH2), 3.50 (br, t, J = 
2.4Hz, 1H, C≡C-H), 1.39 (s, 9H, C(CH3)3); δC(100 MHz, DMSO-d6) [calibrated using 
(CH3)2SO resonance at 39.52 ppm] 156.2 (CH2OC(O)NH), 155.9 (OC(O)NH), 79.7 
(C(CH3)3), 79.3 (HC≡C), 78.0 (H-C≡C), 52.5 (OCH2), 28.5 (C(CH3)3); MS (TOF ES+) 







Poly(1-(tert-butyl) 2-(prop-2-yn-1-yl) hydrazine-1,2-dicarboxylate) (Boc-P4) 
 A solution of 2.10 (100 mg, 0.47 mmol) in THF (0.351 mL) was made, argon 
gas was bubbled over this for 5 minutes. To this a solution of Rh(nbd)BPh4 (4.49 mg, 
0.0093 mmol), in Et3N (0.058 mL) and THF (0.058 mL) was added. This was left 
stirring in an oil bath at 50 ℃  for 24 hours. The resulting mixture was pipetted over 
hexane and polymer Boc-P4 was collected as a cream precipitate (61 mg, 0.28 
mmol, 61%); νmax (neat)/cm-1 3310m br, N-H), 2980w br (C-H), 1708s br (C=O), 
1156s br (C-O); δH(300MHz, DMSO-d6) [calibrated using (CHD2)(CD3)SO resonance 
at 2.50 ppm] 9.5-9.0 (br, 2H, (NH)2), 5.15 (br, 1H, H-C=C), 4.57 (br, 2H, CH2), 1.40 
(br, s, 9H, C(CH3)3).  
Prop-2-yn-1-yl hydrazine carboxylate hydrochloride (2.11) 
 A sample of 2.10 (200 mg, 0.93 mmol) was taken and dissolved in HCl/ether 
solution 2.0 M (9.35 mL, 18.7 mmol). This solution was left to react for 6 hours, once 
the time had elapsed the mixture was dried under reduced pressure and 2.11 was 














s, C-H / N-H), 2122 (s, C≡C), 1747 (s, C=O), 1175 (d, C-O); δH(300 MHz, DMSO-d6) 
[calibrated using (CHD2)(CD3)SO resonance at 2.50 ppm] 10.56 (s, 1H, NH), 4.79 (d, 
J = 2.4 Hz, 2H, CH2), 4.5-2.5 (br, s, 3H, +NH3), 3.64 (t, J = 2.4 Hz, 1H, H-C≡C); 
δC(100 MHz, DMSO-d6) [calibrated using (CH3)2SO resonance at 39.52 ppm] 53.4 
(CH2), 78.3 (C≡CH), 78.4 (HC≡C), 155.1 (C=O); MS (TOF ES+) m/z 115.0 ([M+H]+, 
100%). 
 Poly(prop-2-yn-1-yl hydrazine carboxylate) acetate (AcO-P4) 
 A sample of Boc-P4 (900 mg, 7 mmol) was dissolved in pure TFA (42 mmol, 
3.24 ml). This solution was left to stir for 4 hrs and monitored by NMR spectroscopy. 
Once complete, the reaction was placed in a dialysis membrane (cellulose, 1 kDa 
pore size) and diluted with water (5 mL). The sample was dialysed twice against 100 
mM AcOH and three times against water. After dialysis, the solution was collected 
from the membrane and the product was obtained via lyophilisation to afford AcO-P4 
as a cream powder (225 mg, 0.99 mmol, 14%); νmax (neat)/cm-1 3251s br (N-H), 
1707s br (C=O), 1500s sh (C=C), 1270s (C-O); δH (300 MHz, D2O) [calibrated using 
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In Situ Functionalized Polymers for 
 siRNA Delivery 
This chapter is based upon the following article: 
J. M. Priegue, D. N. Crisan, J. Martínez-Costas, J. R. Granja, F. Fernández-
Trillo and J. Montenegro, Angew. Chem. Int. Ed., 2016, 55, 7492–7495 
The article is reproduced with permission from John Wiley and Sons, licensed to 
Daniel Crisan in print and electronic format, license number 4251870642397, license 
date 18th December 2017, full article for the use in this thesis.  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Foreword 
This chapter is concerned with the exploitation of poly(acryloyl hydrazide) P1 (see 
Chapter 1) towards the discovery of functionalised polymers for siRNA delivery as 
documented in the collaborative article “In Situ Functionalized Polymers for siRNA 
Delivery” - Angew. Chem. Int. Ed. 2016, 55, 7492-7495 with Dr Javier Montenegro 
and his laboratory at the University of Santiago de Compostela. In this 
communication (in which the author of the thesis was 2nd author) it was showed that 
P1 could be functionalised with combinations of a cationic aldehyde and a variety 
hydrophobic aldehydes in a 50:50 mixture of DMSO and H2O. In the first instance, 
the percentages of cationic and hydrophobic aldehydes were adjusted to quickly rule 
out those functional polymers which were insoluble in this mixture and not useful for 
further evaluation. Those formulations which passed the solubility test (i.e. >50% 
cationic aldehyde) were evaluated for their membrane activity against a model 
system. This served to distinguish the polymers which expressed detergent-like 
properties (i.e. potentially cytotoxic with real cell lines) and the polymers which 
showed no membrane activity until complexed with dsDNA (as a model siRNA 
strand). The candidates that showed good dsDNA transport activity with the model 
egg yolk phosphatidylcholine (EYPC) membrane were tested in the final stage to 
determine their ability to transport siRNA in modified HeLa cells that expressed GFP 
(green fluorescent protein) and the knockdown of the gene responsible for GFP was 
evaluated. The experiments were designed in such a way that no purification steps 
were required between functionalisation of poly(acryloyl hydrazide) P1, complexing to 
siRNA and testing against the cells, hence the “in situ” aspect of the study.  
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 The author of the thesis’ contribution to this research, is represented by the 
synthesis of P1 and subsequent functionalisation studies (see Chapter I). 
Furthermore, he evaluated the range of percentage cationic and percentage 
hydrophobic side-chains in which the functionalised polymers were soluble in 
aqueous conditions. This was carried out by visual inspection to observe the 
polymers that precipitated out of solution, both during the functionalisation of P1 in a 
50:50 mixture of DMSO and H2O, and the subsequent dilution in aqueous media. I 
also carried out the initial evaluation of membrane activity of functionalised polymers 
with the EYPC model membrane to determine detergent-like activity and the 
complexation of dsDNA. Further activity studies with the EYPC model membrane 
were carried out by the Montenegro Laboratory to confirm the methodology and the 
results obtained in our Lab. All the knockdown studies with siRNA in HeLa-GFP cells 
were carried out in Spain by Juan Priegue under the supervision of Dr Montenegro.  
 Below, an attempt has been made to contextualise this research by 
exemplifying the current techniques explored for therapeutic siRNA delivery, the 
structural and chemical features of nanovectors, and by arguing about the usefulness 
of polymeric scaffolds to quickly determine formulations which can be applied to 
different siRNA strands and different cell lines on a case by case basis. As 
summarised in the article’s abstract, the reported method constitutes a blueprint for 
the high-throughput screening and future discovery of new polymeric functional 
materials with important biological applications.  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3.1 Background 
 RNA interference (RNAi)1-3 is a gene expression inhibition process in which 
RNA molecules cause the destruction of specific messenger RNA (mRNA) 
molecules4. Naturally, this post-transcriptional gene silencing process5 occurs as a 
defensive mechanism against invasion by mobile genetic elements such as viruses. 
RNAi can however be exogenously induced in order to trigger gene suppression in 
cell cultures and living organisms, and as such is considered a valuable research tool 
and a practical tool in therapeutics6,7 and biotechnology.  
 Mechanistically,8,9 RNAi is initiated when an endoribonuclease enzyme10 (i.e. 
Dicer) cleaves long double-stranded RNA (dsRNA) into short (~21-25 nucleotides) 
double-stranded fragments known as small interfering RNA (siRNA). One of the 
siRNA strands is incorporated into a multiprotein RNA-induced silencing complex 
(RISC). The siRNA strand acts as a recognition template for complementary mRNA, 
which leads to the activation of proteins which cleave the mRNA. The net result of 
this cascade process is gene silencing (Fig. 3.1).  
Although naturally RNAi functions in the presence of dsRNA, the cleaving of the latter 
by Dicer usually results in a random array of siRNA molecules that have different 
efficiencies in gene silencing. More efficient gene silencing can be obtained by 
presenting RISC with the most efficient siRNA strand for a particular mRNA 
sequence. This can be achieved for research and practical applications through gene 
delivery.11,12  
 For efficient therapeutic siRNA delivery, multiple obstacles have to be taken 
into consideration and appropriate measures should be integrated into a delivery 
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system. Firstly, ‘naked’ siRNA fragments are highly susceptible to degradation in 
bodily fluids due to the presence of nucleases that cleave the phosphodiester 
bonds13. Furthermore, due to its small size (< 5 nm), siRNA has a short circulation 
time in the body and it is rapidly cleared by the renal system. As a consequence, 
there is often a higher concentration (up to 40 times) of siRNA in the kidneys 
compared to other tissues.14 Thirdly, due to the negatively charged phosphate 
backbone, siRNA folds into overall negatively charged particles. Since the 
applications of siRNA therapeutics involves the delivery of siRNA across slightly 
negatively charged cell membranes, the siRNA particles’ negative charge must be 
shielded to prevent ionic repulsions with the cell membrane.15 Lastly, the delivery 





















Figure 3.1: Schematic representation of the mechanism of RNA interference.
before the siRNA encounters the RISC complex in the cytoplasm.16 As such, the 
siRNA must be able to efficiently disrupt the endosome and escape in the cytoplasm 
in order to elicit a therapeutic response. 
 To improve the overall uptake of siRNA, different strategies11,12,15,17-20 
particularly the chemical modification of the siRNA, or using diverse gene carriers, 
have been designed to deal with one or more of the obstacles above. 
 Chemically modified ‘naked’ siRNA has been directly delivered with moderate 
success through end-group modification, which enhanced the resistance to 
nucleases.21,22 RNA is distinguished from DNA by the 2’-OH position, which is also 
the catalytic target of RNases. Modification at this site, such as substituting non-
bridging oxygen atoms with sulfur atoms increases the stability of the siRNA in 
serum. Despite increased stability, cellular uptake remains comparatively low due to 
the siRNA - cell membrane anionic repulsions. Further modifications, such as 
conjugating cholesterol directly to the siRNA, resulted in enhanced cellular uptake 
and increased biocompatibility.23 This system was successfully used to target herpes 
simplex virus24 after intravaginal administration without triggering an immune 
response, but the high dose of cholesterol-siRNA required limited its further 
therapeutic use. Other chemical modifications of siRNA also include conjugation of 
glycoprotein receptor ligands, which is being investigated in the treatment of 
amyloidosis.25 Despite encouraging progress with modified ‘naked’ siRNA, including 
phase III clinical trials, no approved drug exists at this stage. Complementary to the 
chemical modification of siRNA is the use of gene delivery vectors, which aim to 
increase the total circulation time and the overall uptake by forming vector-siRNA 
nanoparticles that release the nucleic acid inside the cells. 
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 Common nanovectors explored for the delivery of siRNA for therapeutical 
purposes include lipid-based, non-lipid organic-based and inorganic particle 
nanovectors. Regardless of its type, every nanovector should aim for the following 
three properties: i) protect the siRNA from degradation by ribonucleases. ii) enrich 
siRNA content at the target site. and iii) facilitate the cellular uptake of siRNA.11  
Although there have been considerable amounts of research and early stage clinical 
trials for treatment of age-related macular degeneration,26 metastasised cancers27 
and even post-exposure prophylaxis against lethal dose of Zaire Ebolavirus,28 there 
are still features of the delivery nanovectors that require optimisation before 
mainstream therapeutic use can be achieved. Several nanovectors and their features 
with their respective advantages and disadvantages are summarised below.  
 Lipid-based nanovectors such as cationic lipidic liposomes19 are able to 
ionically bind the negatively charged siRNA molecules. As such, they can entrap and 
carry a higher percentage load compared to neutral lipidic liposomes.29 The slightly 
cationic surface also supports enhanced interaction between the delivery vector and 
negatively charged cell membranes, which facilitates the cellular uptake. 
Furthermore, the siRNA is shielded from RNases by being localised at the core of the 
nanoparticles and the circulation time is also increased due to the larger size of the 
liposome nanoparticle compared to the ‘naked’ siRNA particle. Among these, some of 
the most widely used transfection agents used are Lipofectamine™,30 
Oligofectamine™, DOTAP and DOTMA (Fig. 3.2). These reagents have been 
successfully tested for siRNA delivery against influenza in animal models, as well as 
several in vitro uses. However, it has been shown that therapeutically, cationic lipidic 
systems can lead to an inflammatory immune response,20 which limits their use in 
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vivo. Neutral lipidic liposomes are generally more biocompatible, but they suffer from 
low entrapment efficiencies due to the absence of the ionic interactions that lead to 
the formation of vector-siRNA polyionic complexes.11 Furthermore, there are also 
fewer favourable interactions between the vector and the negatively charged 
membranes, which diminishes the cellular uptake. As a consequence, when using 
neutral lipidic liposomes, larger doses are required to achieve the same therapeutic 
effect compared to cationic lipid liposomes.  
 Similarly to binding cholesterol to ‘naked’ siRNA for increased biocompatibility, 
the effectiveness of cationic lipids has been combined with the biocompatibility of 
cholesterol in the form of directly conjugated cholesterol-based polyamine lipids31,32 
(Fig. 3.3). These nanocarriers were found adept at siRNA-mediated gene silencing in 
cell culture experiments, but at this stage, it remains to be seen if these nanovectors 
satisfy the requirements for therapeutic applications. 
 To harness the advantages of liposomes derived from both cationic and 
neutral lipids, a series of pH-sensitive ionisable aminolipids33 have been synthesised. 






























Lipofectamine (DOSPA:DOPE 3:1) 
DOSPA DOPE
DOTAP DOTMA
Figure 3.2: Structure of several representative cationic lipidic systems.
acidic pH, the lipids are cationic and form liposomes with high siRNA percentage load 
due to favourable ionic interactions. When the liposomes are delivered at neutral pH, 
the aminolipids are deprotonated resulting in a neutral, biocompatible liposome, with 
a siRNA percentage load comparable to that of cationic lipids but the biocompatibility 
of neutral liposomes.  
 Extended circulation lifetimes, stability and pharmacokinetic properties has 
also been achieved by synthesising nanovectors that contain poly(ethylene glycol) 
(PEG).34 PEG is a non-toxic, FDA approved polymer already in use as a laxative but 
also as an excipient in pharmaceutical products.35 PEG-ylation36 is used to mask 
active agents from the host immune system, increase solubility in aqueous conditions 
and increase the size of the nanoparticles, which reduces renal clearance18. This 
process can also be applied in siRNA delivery by providing additional protection 
against RNases and increase circulation time.34,37,38 Cationic liposomes with a PEG-
ylated surface,39 have been evaluated in an in vivo mouse model against hepatitis B 
virus and displayed increased pharmacological efficiency. The PEG shell provided 
the liposomes with a neutral, hydrophilic exterior, that shielded the cationic content 
and decreased the rate of systemic clearance.  
 A distinct class of lipid-like nanovectors that have been explored for siRNA 
delivery are termed lipidoids for which extensive combinatorial libraries of these 














Figure 3.3: Structure of several cholesterol-based polyamine lipids as synthesised 
by Islam et al.32
like, molecules combine several features including amide linkages, multiple long and 
short alkyl tails and multiple amine groups (Fig. 3.4) to bind siRNA, protect it from 
nucleases and enhance its availability at the delivery site. The best performing 
molecules achieved gene silencing effects similar to Lipofectamine 2000. 
Formulations of lipidoids with cholesterol and PEG-ylated lipids have been made in 
order to tune the chemical and physical properties of the siRNA delivery vehicle to 
achieve promising results in vivo.42 Dynamic amphiphilic lipidoid libraries (Fig. 3.5) 
have been synthesised using a combination of hydrazone or oxime bonds to afford 
around 900 distinct structures, which were evaluated for siRNA in vitro delivery in 
HeLa cells.43,44 This screening assay was used to rapidly compare the influence of 
the cationic species (ammonium or guanidinium groups) and the different 


























Figure 3.4: Structure of libraries of lipidoids as synthesised by Akinc et al.40 (left) 
and Love et al.41 (right).















































showing siRNA related enzyme knockdown two-fold higher compared to 
Lipofectamine RNAiMax.43  
 Non-lipid organic nanovectors are generally composed of linear or branched 
polymeric networks and usually with a high content of polycations or amphiphilic 
character15,19 (Fig. 3.6). Macromolecular structures such as dendrimers and 
cyclodextrins11 have been successfully combined with siRNA, targeting factors and 
PEG for stability in biological fluids to form targeted nanoparticle-delivery systems. 
Such a system was the focus of a phase I clinical trial but it was also used to probe 
the RNAi mechanism in humans.27 Cationic polymers such as polyethylenimines 
(PEI) have been successfully used, alone or conjugated with other blocks19 (i.e. 
PEG), to form nanoparticles with siRNA and they have been shown to reprogram 
dendritic cells from an immunosuppression state to an anti-tumour state.45 Their high 
cationic charge density allows the condensation of the nucleic acid into polyionic 
complexed particles. Furthermore, polycationic polymers such as PEI also show a 
good buffering capacity in particular cellular compartments (i.e. endosome).19 These 
properties allow these type of polymers to efficiently protect the nucleic acid against 
nucleases. Amphiphilic polymers46 are generally composed of segments of 
polycations and neutral, often hydrophobic components.47 Like lipidoids, the cationic 
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components allow efficient siRNA loading but also good buffering capacity, while the 
hydrophobic component influences the interactions with the cellular membrane. 
 Gold nanoparticles have also been employed successfully in gene silencing as 
an example of an inorganic nanovector. Controlled siRNA delivery was achieved 
using siRNA-Au nanoparticles of discrete sizes, with a tat-lipid coating for enhanced 
cellular uptake.48 The controlled release was obtained by pulsed near-infrared laser 
exposure in a power and time dependent manner. Such techniques are viewed as a 
means to achieve therapeutic effects especially with non-targetted delivery vectors, 
by activating only the nanoparticles accumulated in the tumour sites.  
 Although this is only a brief overview of different siRNA delivery strategies, 
several repeated structural motifs can be observed. It is favourable to include a 
source of cations to increase the percentage load of siRNA11,17,19 such as including a 
source of polyamines, guanidinium groups or the gold shell of the Au nanoparticles. 
The positive charge also aids in cellular uptake due to favourable ionic interactions 
with the negatively charged membrane. Hydrophobic/lipid residues also aid in cellular 
uptake due to their interaction with the phospholipid membrane of the cells.43 PEG-
ylation of nanovectors has been shown to enhance the delivery of siRNA by 
increasing the circulation time, protecting the cargo from nucleases, decreasing 
cytotoxicity by masking the cationic shell from the host immune system and aiding in 
aqueous solubility.34,39 
 Despite the encouraging progress and the relatively large number of clinical 
trials, there are many technical hurdles yet to overcome. In siRNA therapeutics of 
cancers or targets prone to mutations, sudden changes in the composition of the 
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target tumour tissue or cell-lines11 for example could decrease the efficacy of a 
nanovector system, which took precious time and resources to design. 
 Direct treatment by overloading the system with unmodified siRNA oligos has 
been shown to trigger an innate immune response.49,50 While chemically modifying 
the strand may solve some of these problems,51 it is improbable that this is a viable 
solution to wide-spread siRNA therapeutics unless direct injection at the target site is 
carried out.  
 Another important technical hurdle is the difficulty in tissue-specific delivery of 
the nanovectors. There are multiple biological barriers preventing efficient circulation 
of siRNA-nanovectors to the target site. Firstly, nanoparticle sizes smaller than 
300-400 nm can passively cross the endothelial cells of the blood vessels in tumours, 
which permit therapeutic accumulation at that site.52 However, before they reach the 
target site, the nanovector must prolong the circulation time of the siRNA carried by 
protecting against nucleases.15 Furthermore, apart from siRNA degradation, there are 
also lipases that can degrade the carrier exposing the cargo to the aforementioned 
nucleases. Most examples in successful clinical trials as summarised above, are 
based to some degree on PEG-ylation of the nanovector to protect the cargo.17,34 
Many currently designed nanovectors generally “target” the liver,11,20 but not 
necessarily out of choice, but rather as a limitation to the system. The liver acts a 
natural filter and is responsible for the uptake and sequestrating of foreign objects 
such as pathogens and macromolecules, where inevitably the siRNA would be 
degraded. Again, PEG-ylation increases the biocompatibility and reduces reticulo-
endothelial uptake but only with moderate success.11 As mentioned previously, siRNA 
oligos can trigger an immune response, as such, the nanovector must be designed to 
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evade cells of the immune system. Finally, targets of siRNA therapy are generally 
characterised by poor heterogeneity.53 That is to say, even at the same target site, 
complete access by one nanovector alone may be impossible, and multiple carriers 
may be required for efficient delivery. 
 Using polymer scaffolds such as poly(acryloyl hydrazide) P1 may offer an 
attractive screening solution to the technical hurdles summarised above, similar to 
the work on dynamic amphiphilic lipidoids above43 (Fig. 3.5). Firstly, functionalisation 
with different sources and ratios of cations can influence the siRNA percentage load 
and overall charge of the resulting nanoparticle. Furthermore, hydrophobic residues 
can be used to tune the membrane permeability with respect to different cell-lines 
and facilitate uptake preferentially to therapeutic target sites (Fig. 3.7, 1-3). 
 Secondly, polymer scaffolds can be synthesised with different molecular 
weights and functionalised such that, to produce nanovectors with similar chemical 
properties but different physical properties and nanoparticle sizes. This could lead to 
populations of delivery vectors that could selectively access targets in heterogenous 
sites in a size dependent manner (Fig. 3.7, 4).  
 Rapidly expanding libraries of functionalised polymers can thus be 
synthesised based on three parameters: nature and percentage content of cationic 
component, nature and percentage content of hydrophobic component and size of 
the starting scaffold. Such libraries can be synthesised and screened rapidly and 
cheaply, as evidenced in our article.  
 Structurally, further protection of the cargo, enhanced biocompatibility and 
better pharmacokinetic properties could be incorporated on the carrier by conjugating 
additional components (i.e. PEG, cholesterol, targeting vectors) (Fig. 3.7, 5) either 
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via the side-chains or at the end-groups. These components could be introduced 
prior to the post-polymerisation functionalisation to afford complex scaffolds that can 
be used to synthesise more libraries of potential delivery vectors. 
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Figure 3.7: Applications of poly(acryloyl hydrazide) P1 as a scaffold for the 
synthesis of nanovectors for siRNA delivery. 1 synthesis of functionalised polymers 
by varying the percentage cationic and hydrophobic aldehyde content. 2 
conjugation of siRNA to libraries of nanovectors by ionic interactions. 3 polyplex 
delivery and gene knockdown. 4 synthesis of polyplexes of varied dimensions by 
starting from P1 with varying molecular weights. 5 functionalisation of P1 with 
molecules that increase biocompatibility i.e. PEG, cholesterol, or with targeting 
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siRNA
responsive drug delivery.[16,23, 24] Alternative elegant strategies
for multi-hydrazone formation have also been developed in
the context of DNA or protein-templated dynamic combina-
torial libraries.[25–28]
The proposed poly(acryloyl hydrazide) scaffold (P1) was
prepared using controlled free radical polymerization (see the
Supporting Information). P1 was highly water soluble and
aqueous hydrazone formation was readily confirmed by
employing the UV-active 4-imidazolecarboxaldehyde.
1H NMR spectroscopic analysis of P1 incubated (for less
than 1 h) with 4-imidazolecarboxaldehyde (0.3–0.9 equiv in
100 mm AcOH in D2O) showed a broadening of the aromatic
proton resonance signals of the aldehyde (see Figure S3 in the
Supporting Information). Comparison of the residual alde-
hyde signal against the overall amount of protons revealed
that the loading of 4-imidazolecarboxaldehyde on P1 was
about 70% (Figure S3).[23] No increase in loading was
detected with a higher number of equivalents of aldehyde,
longer times (up to 4 h), different solvents, or even with
heating. Further characterization was obtained from gel
permeation chromatography (GPC; Figure 1). A clear peak
for the polymer P1(Imidazole) (retention time Rt = 18 min)
was already detected with only 0.25 equiv of 4-imidazolecar-
boxaldehyde added to P1, confirming attachment of the
chromophore to P1 (Figure 1). Increasing amounts of 4-
imidaz lecarboxaldehyde resulted in an increase in the
intensity of the peak at 18 min, with the signal reaching
a maximum at around 0.75 equiv. Further equivalents simply
increased the amount of free 4-imidazolecarboxaldehyde
(Rt = 31 min), validating the NMR estimation of a maximum
polymer loading of about 70% (Fi ure S3).
Having established the feasibility of modifying P1 with
a model aldehyde, we explored the use of P1 for the in situ
screening of membrane-active polymers. A close inspection of
some of the structural motifs commonly found in membrane-
active polymers (for example antimicrobial or cell-penetrat-
ing polymers) highlights a high prevalence of amphiphilic
structures with the presence of both cationic (such as
guanidinium) and hydrophobic moieties (such as isopr pyl
or benzyl).[19, 29,30] The potential of establishing bidentate
hydrogen bonding and stable protonation under physiological
conditions makes the guanidinium group (pKa⇡ 12.5) the
optimal cationic moiety for membrane penetration. Thus, we
decided to investigate a small library of aldehydes where the
cationic aldehyde (1, Scheme 1) was kept constant and
independently combined with different hydrophobic alde-
hydes (Figure 2; see also the Supporting Information).
Activated polymers for membrane transport were thus
prepared by combining an aqueous stock solution of P1 with
a DMSO solution containing the cationic and the correspond-
ing hydrophobic aldehydes in different molar ratios (see the
Supporting Information for details). Hydrazone formation of
P1 with long hydrophobic aldehydes (  8 carbon atoms) lead
to the rapid precipitation of the resulting polymers, making
these combinations inappropriate for further evaluation.
However, the combination of a series of short hydrophobic
aldehydes (for example isovaleraldehyde (2)) with 1 afforded
water-soluble and stable polyhydrazone nanoparticles (Fig-
ure S4). Dynamic light scattering (DLS) analysis revealed
suitable sizes for membrane transport (about 200 nm) at
a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15
(Figures S4 and S17).[21] Neighboring effects (i.e. cation
repulsion) could impact the final composition of the final
hydrazone-modified polymer. Therefore, to further character-
ize the post-polymerization reaction, we measured the DLS
properties and the zeta potential of P1 combined with
different ratios of guanidinium aldehyde (1) and isovaler-
aldehyde (2). These measurements showed that increasing the
molar fraction of hydrophobic aldehyde increased the size
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated
polymers with cargo (siRNA) and polyplex delivery. c = molar fraction.
Figure 1. GPC (lAbs =275 nm) analysis of P1 incubated with
1 (black &), 0.75 (red ~), 0.5 (blue ^), 0.25 (purple &), or 0 (gray *)
equiv of 4-imidazolecarboxaldehyde. The spectrum for pure 4-imidazo-
lecarboxaldehyde (orange *) is also shown. Conditions: 100 mm acetic
acid, pH 2.9, 2 h. Inset: Increase in absorbance of the high molecular






























































































































































































































































































































































































































































































































































































































































































































































































































































































andte.orgdelivery and gene knockdown
responsive drug delivery.[16,23, 24] Alternative elegant strategies
for multi-hydrazone formation have also been developed in
the context of DNA or protein-templated dynamic combina-
torial libraries.[25–28]
The proposed poly(acryloyl hydrazide) scaffold (P1) was
prepared using controlled free radical polymerization (see the
Supporting Information). P1 was highly water soluble and
aqueous hydrazone formation was readily confirmed by
employing the UV-active 4-imidazolecarboxaldehyde.
1H NMR spectroscopic analysis of P1 incubated (for less
than 1 h) with 4-imidazolecarboxaldehyde (0.3–0.9 equiv in
100 mm AcOH in D2O) showed a broadening of the aromatic
proton resonance signals of the aldehyde (see Figure S3 in the
Supporting Information). Comparison of the residual alde-
hyde signal against the overall amount of protons revealed
that the loading of 4-imidazolecarboxaldehyde on P1 was
about 70% (Figure S3).[23] No increase in loading was
detected with a higher number of equivalents of aldehyde,
longer times (up to 4 h), different solvents, or even with
heating. Further characterization was obtained from gel
permeation chromatography (GPC; Figure 1). A clear peak
for the polym r P1(Imidazole) (retention time Rt = 18 min)
was already detected with only 0.25 equiv of 4-imidazolecar-
boxaldehyde added to P1, confirming attachment of the
chromophore to P1 (Figure 1). Increasing amounts of 4-
imidazolecarboxaldehyde resulted in an increase in the
intensity of the peak at 18 min, with the signal reaching
a maximum t around 0.75 equiv. Further equivalents simply
increased the amount of free 4-imidazolecarboxaldehyde
(Rt = 31 min), validating the NMR estimation of a maximum
polymer loading of about 70% (Figure S3).
Having established the feasibility of modifying P1 with
a model aldehyde, we explored the use of P1 for the in situ
screening of membrane-active polymers. A close inspection of
some of the structural motifs commonly found in membrane-
active polymers (for example antimicrobial or cell-penetrat-
ing polymers) highlights a high prevalence of amphiphilic
structures with the presence of both c tionic (such as
guanidinium) and hydrophobic moieties (such as isopropyl
or benzyl).[19, 29,30] The potential of establishing bidentate
hydrogen bonding and stable protonation under physiological
conditions makes the guanidinium group (pKa⇡ 12.5) the
optimal cationic moiety for membrane penetration. Thus, we
decided to investigate a small library of aldehydes where the
cationic aldehyde (1, Scheme 1) was kept constant and
independently combined with different hydrophobic alde-
hydes (Figure 2; see also the Supporting Information).
Activated polymers for membrane transport were thus
prepared by combining an aqueous stock solution of P1 with
a DMSO solution containing the cationic and the correspond-
ing hydrophobic aldehydes in different molar ratios (see the
Supporting Information for details). Hydrazone formation of
P1 with long hydrophobic aldehydes (  8 carbon atoms) lead
to the rapid precipitation of the resulting polymers, making
these combinations inappropriate for further evaluation.
However, the combination of a series of short hydrophobic
aldehydes (for example isovaleraldehyde (2)) with 1 afforded
water-soluble and stable polyhydrazone nanoparticles (Fig-
ure S4). Dynamic light scattering (DLS) analysis revealed
suitable sizes for membrane transport (about 200 nm) at
a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15
(Figures S4 and S17).[21] Neighboring effects (i.e. cation
repulsion) could impact the final composition of the final
hydrazone-modified polymer. Therefore, to further character-
ize the post-polymerization reaction, we measured the DLS
properties and the zeta potential of P1 combined with
different ratios of guanidinium aldehyde (1) and isovaler-
aldehyde (2). These measurements showed that increasing the
molar fraction of hydrophobic aldehyde increased the size
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated
polymers with cargo (siRNA) and polyplex delivery. c = molar fraction.
Figure 1. GPC (lAbs =275 nm) analysis of P1 incubated with
1 (black &), 0.75 (red ~), 0.5 (blue ^), 0.25 (purple &), or 0 (gray *)
equiv of 4-imidazolecarboxaldehyde. The spectrum for pure 4-imidazo-
lecarboxaldehyde (orange *) is also sh wn. Conditions: 100 mm acetic
acid, pH 2.9, 2 h. Inset: Increase in absorbance of the high molecular
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responsive drug deliv ry.[16,23, 24] Alternative el gant strategies
for multi-hydrazone formation have also been developed in
the context of DNA or protei -te plated dynamic co bina-
torial libraries.[25–28]
The proposed poly(acryloyl hydrazide) scaffold (P1) was
prepared using controlled free radical polymerization (see the
Supporting Information). P1 was highly water soluble and
aqueous hydrazone formation was readily confirmed by
employing the UV-active 4-imidazolecarboxaldehyde.
1H NMR spectroscopic analysis of P1 incubated (for less
than 1 h) with 4-imidazolecarboxaldehyde (0.3–0.9 quiv in
100 mm AcOH in D2O) showed a broadening of the aro atic
proton resonance signals of the aldehyde (see Figure S3 in the
Supporting Information). Comparison of the residual alde-
hyde signal against the overall amount of protons revealed
that the loading of 4-imidazolecarboxaldehyde on P1 was
about 70% (Figure S3).[23] No increase in loading was
detected with a higher number of equivalents of aldehyde,
longer times (up to 4 h), different solvents, or even with
heating. Further characterization was obtained from gel
permeation chromatography (GPC; Figure 1). A clear peak
for the polymer P1(Imidazole) (retention time Rt = 18 min)
was already detected with only 0.25 quiv of 4-imidazolecar-
boxaldehyde added to P1, confirming attachment of the
chro ophore to P1 (Figure 1). Increasing amounts of 4-
imidazolecarboxaldehyde result d in an increase in the
intensity of the peak at 18 min, with the signal reaching
a maxi u t round 0.75 equiv. Further equivalents simply
increased the amount of free 4-imidazolecarboxaldehyde
(Rt = 31 min), v lidating the NMR estimation of a maximum
polymer loading of about 70% (Figure S3).
H ving established the feasibility of modifying P1 with
a model aldehyde, we explored t e use of P1 for the in situ
screening of membrane-active polymers. A close inspection of
some of the structural motifs commonly found in membrane-
active polymers (for exampl antimicrobial or cell-penetrat-
ing polymers) highlights a high prevalence of amphiphilic
structures with the presence of bot cationic (such as
guanidinium) and hydrophobic moieties (such as isopropyl
or b nzyl).[19, 29,30] The poten ial of establishing bidentate
hydrogen bonding and stable prot n n under physiological
conditions makes the guanidinium group (pKa⇡ 12.5) the
optimal cationic moiety for membrane penetration. Thus, we
decided t investigate a small library of aldehydes where the
cationic aldeh de (1, Scheme 1) was kept constant and
indepe dently combined with differ nt hydrophobic alde-
hydes (Figure 2; see also the Supporting Information).
Activat d p lymers for membrane transport were thus
repared by combin g an aqueous stock solution of P1 with
a DMSO solution containing the cationic and the correspond-
ing hydrop obic ald hydes in differ nt molar ratios (see the
Supporting Information for details). Hydrazone formation of
P1 with long hydrophobic aldehydes (  8 carbon atoms) lead
to the rapid precipitation of the resulting polymers, making
these combinations inappropriate for further evaluation.
However, the combination of a series of short hydrophobic
aldehydes (for example isovaleraldehyde (2)) with 1 afforded
water-soluble and stable polyhydrazone nanoparticles (Fig-
ure S4). Dynamic light scattering (DLS) analysis revealed
suitable sizes for membrane transport (about 200 nm) at
a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15
(Figures S4 and S17).[21] Neighboring effects (i.e. cation
repulsion) could impact the final composition of the final
hydrazone-modified polymer. Therefore, to further character-
ize the post-polymerization reaction, we measured the DLS
properties and the zeta potential of P1 combined with
different ratios of guanidinium aldehyde (1) and isovaler-
aldehyde (2). These measurements showed that increasing the
molar fraction of hydrophobic aldehyde increased the size
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated
polymers with cargo (siRNA) and polyplex delivery. c = molar fractio .
Figure 1. GPC (lAbs = 275 nm) analysis of P1 incubated with
1 (black &), 0.75 (red ~), 0.5 (blue ^), 0.25 (purple &), or 0 (gray *)
equiv of 4-imidazolecarboxaldehyde. The spectrum for pure 4-imidaz -
lecarboxaldehyde (orange *) is also shown. Conditions: 100 mm acetic
acid, pH 2.9, 2 h. Inset: Increase in absorbance of the high molecular
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responsive drug delivery.[16,23, 24] Alternative elegant strategies
for multi-hydrazone formation have also been developed in
the context of DNA or p otei -templated dyn mic combina-
torial libraries.[25–28]
The proposed poly(acryloyl hydrazide) scaffold (P1) was
repared using controlled fr e radical polymerization (see the
Supportin Information). P1 was hi hl water soluble nd
aqueous hydrazone formation was readily confirmed by
employing th UV- ctive 4-imidazoleca b xald hy e.
1H NMR spectroscopic anal sis of P1 incubated (for less
than 1 h) with 4-imidazolecarboxaldehyde (0.3–0.9 equiv in
100 mm AcOH in D2O) showe a broadening of the aromatic
proton r sonanc ignals f the al ehyde (see Figure S3 in the
Supporting Information). Co parison of the residual alde-
hyde signal against the overall amount of rotons revealed
that th loading of 4-imidazol carboxaldehyde on P1 was
about 70% (Figure S3).[23] No increase in loading was
detected with a higher number of equivalents of aldehyde,
lo g r times (up t 4 h), fferent solv nts, or eve with
heating. Further characterization was obtained from gel
permeation chromatography (GPC; Figure 1). A clear peak
for the polym r P1(Imidazole) (retention ti Rt = 18 min)
wa alr ady detecte with nly 0.25 equiv of 4-imidazolecar-
boxaldehyde added to P1, confirming attachment of the
chromophore t P1 (Figure 1). Increasing amounts of 4-
i idazolecarboxald hyde resulted in an increase in the
inte sity of the peak at 18 min, with the signal reaching
a m ximum a ro nd 0.75 equiv. F rther equivalents simply
increas d the amount of free 4-imidazolecarboxaldehyde
(Rt = 31 min), validating the NMR estimation of a maximum
lymer loading of about 70% (Figure S3).
Having established the feasibility of modifying P1 with
a del aldehyde, we ex lored the use of P1 for the in situ
screening of membrane-active polymers. A close inspection of
som of the st u tural motifs commonly found in membrane-
active polymers (for example antimicrobial or cell-penetrat-
i g polym rs) highlights a high prevale ce of amphiphilic
st uctures with the presence of both cationic (such as
guanidiniu ) and hydrophobic moieties (such as isopropyl
o benzyl).[19, 29,30] The p tential o establishing bidentate
hydrogen b nding and stable protonation u der physiological
conditio s kes the gu nidinium group (pKa⇡ 12.5) the
optimal cationic moiety for membrane p netration. Thus, we
decided to investigate a small library of aldehydes where the
cationic aldehyde (1, Scheme 1) was kept constant and
in pendently c mbined with different hydrophobic alde-
hydes (Figure 2; see also the Supporting Information).
Activated polymers for membrane transport were thus
prep red by combining an queous stock solution of P1 with
a DMSO solution containing the cationic and the correspond-
ing hydrophobic aldehydes in different molar ratios (see the
Su porting Information for det ils). Hydrazone formation of
P1 with long hydrophobic aldehydes (  8 carbon atoms) lead
to the rapid precipitation of the resulting polymers, making
these combinations inappropriate for further evaluation.
However, the combination of a series of short hydrophobic
aldehydes (for example isovaleraldehyde (2)) with 1 afforded
water-soluble and stable polyhydrazone nanoparticles (Fig-
ure S4). Dynamic light scattering (DLS) analysis revealed
suitable sizes for membrane transport (about 200 nm) at
a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15
(Figures S4 and S17).[21] Neighboring effects (i.e. cation
repulsion) could impact the final composition of the final
hydrazone-modified polymer. Therefore, to further character-
ize the post-polymerization reaction, we measured the DLS
properties and the zeta potential of P1 combined with
different ratios of guanidinium aldehyde (1) and isovaler-
aldehyde (2). These measurements showed that increasing the
molar fraction of hydrophobic aldehyde increased the size
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated
polymers with cargo (siRNA) and polyplex delivery. c = molar fraction.
Figure 1. GPC (lAbs =275 nm) analysis of P1 incubated with
1 (black &), 0.75 (red ~), 0.5 (blue ^), 0.25 (purple &), or 0 (gray *)
equiv of 4-imidazolecarboxaldehyde. The spectrum for pure 4-imidazo-
lecarboxaldehyde (orange *) is also shown. Conditions: 100 mm acetic
acid, pH 2.9, 2 h. Inset: Increase in absorbance of the high molecular
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responsive drug delivery.[16,23, 24] Alternative elegant strategies
for multi-hydrazone formation have also been developed in
the context of DNA or protein-templated dynamic combina-
torial libraries.[25–28]
The proposed poly(acryloyl hydrazide) scaffold (P1) was
prepared using controlled free radical polymerization (see the
Supporting Information). P1 was highly water soluble and
aqueous hydrazone formation was readily confirmed by
employing the UV-active 4-imidazolecarboxaldehyde.
1H NMR spectroscopic analysis of P1 incubated (for less
than 1 h) with 4-imidazolecarboxaldehyde (0.3–0.9 equiv in
100 mm AcOH in D2O) showed a broadening of the aromatic
proton resonance signals of the aldehyde (see Figure S3 in the
Supporting Information). Comparison of the residual alde-
hyde signal against the overall amount of protons revealed
that the loading of 4-imidazolecarboxaldehyde on P1 was
about 70% (Figure S3).[23] No increase in loading was
detected with a higher number of equivalents of aldehyde,
longer times (up to 4 h), different solvents, or even with
heating. Further characterization was obtained from gel
permeation chromatography (GPC; Figure 1). A clear peak
for the polymer P1(Imidazole) (retention time Rt = 18 min)
was already detected with only 0.25 equiv of 4-imidazolec r-
boxaldehyde added to P1, confirmi g attachment of the
chromophore to P1 (Figure 1). Increasing amounts of 4-
imidazolecarboxaldehyde resulted in an increase in the
intensity of the peak at 18 min, with the signa reaching
a maximum at around 0.75 equiv. Further equivalents sim ly
increased the am unt f free 4-imidazolecarbox ld hyde
(Rt = 31 min), validating the NMR estimation of a maximum
polymer loading of about 70% (Figure S3).
Having established the feasibility f modifying P1 with
a model ld hyde, we expl red e use of P1 fo the in situ
screening of membrane-active polymers. A close inspecti n of
some of the structural m tifs c mmonly found in membran -
active polymers (for example antimicrobial or cell-penetrat-
ing polymers) highlig ts a high prevalence of a phiphilic
structures with the presence of b th cat onic (such as
guanidinium) and hydrophobic mo eties (such as isopropyl
or benzyl).[19, 29,30] The potent al of establishing bidenta e
hydrogen bonding and stable protonation under physiological
conditions makes t guanidinium group (pKa⇡ 12.5) the
optimal cationic moiety for memb ane penetration. Thus, we
decided to investigate a small ibra y of aldehydes wh r the
cationic aldehyde (1, Scheme 1) was kept constan and
independently combined with different hydrophobic alde-
hydes (Figure 2; see also the Supporting Information).
Activated polymers for membrane transport were thus
prepared by combining an aqueous stock solution of P1 with
a DMSO solution containing the cationic and the correspond-
ing hydrophobic aldehydes in different molar ratios (see the
Supporting Information for details). Hydrazone formatio of
P1 with long hydrophobic aldehydes (  8 carbon atoms) lead
to the rapid precipitation of the resulting polymers, making
these combinations inappropriate for further evaluation.
However, the combination of a series of short hydrophobic
aldehydes (for example isovaleraldehyde (2)) with 1 afforded
water-soluble and stable polyhydrazone nanoparticles (Fig-
ure S4). Dynamic light scattering (DLS) analysis revealed
suitable sizes for membrane transport (about 200 nm) at
a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15
(Figures S4 and S17).[21] Neighboring effects (i.e. cation
repulsion) could impact the final composition of the final
hydrazone-modified polymer. Therefore, to further character-
ize the post-polymerization reaction, we measured the DLS
properties and the zeta potential of P1 combined with
different ratios of guanidinium aldehyde (1) and isovaler-
aldehyde (2). These measurements showed that increasing the
molar fraction of hydrophobic aldehyde increased the size
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated
polymers with cargo (siRNA) and polyplex delivery. c = molar fraction.
Figure 1. GPC (lAbs = 275 nm) analysis of P1 incubated with
1 (black &), 0.75 (red ~), 0.5 (blue ^), 0.25 (purple &), or 0 (gray *)
equiv of 4-imidazolecarboxaldehyde. The spectrum for pure 4-imidazo-
lecarboxaldehyde (orange *) is also shown. Conditions: 100 mm acetic
acid, pH 2.9, 2 h. Inset: Increase in absorbance of the high molecular
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nanoparticle size as a function





with molecules that 
increase biocompatibility 













the same starting 
polymer scaffold
 As explained in the chapter’s foreword, the progress in collaboration with 
Javier Montenegro’s Laboratory has explored the first few levels of complexity of this 
system (Fig. 3.7, 1-3), namely the synthesis of a library of nanovectors by 
functionalisation of P1 with a guanidinium aldehyde as the cationic source and a 
variety of commercially available hydrophobic aldehydes (manuscript and supporting 
information below). The results have been encouraging, with the best candidate 
showing similar levels of gene silencing potential as Lipofectamine™ RNAiMAX 
(currently the standard in the field for in vitro studies) but with 30 times less 
nanovector required. Furthermore, studies are already underway to better 
understand the structure/topography/activity relationships of these systems, but this 
is only the beginning, as it is hoped that the demonstrated blueprint can promote 
further interest into the next levels of complexity. 
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Abstract: A new method is reported herein for screening the
biological activity of functional polymers across a consistent
degree of polymerization and in situ, that is, under aqueous
conditions and without purification/isolation of candidate
polymers. In brief, the chemical functionality of a poly(acryloyl
hydrazide) scaffold was activated under aqueous conditions
using readily available aldehydes to obtain amphiphilic
polymers. The transport activity of the resulting polymers can
be evaluated in situ using model membranes and living cells
without the need for tedious isolation and purification steps.
This technology allowed the rapid identification of a supra-
molecular polymeric vector with excellent efficiency and
reproducibility for the delivery of siRNA into human cells
(HeLa-EGFP). The reported method constitutes a blueprint
for the high-throughput screening and future discovery of new
polymeric functional materials with important biological
applications.
Polymers are emerging as one of the most promising
scaffolds for the multivalent presentation of relevant biolog-
ical information.[1,2] Polymeric displays of chemical motifs
trigger new opportunities for cargo conjugation and delivery
of the resulting covalent and/or supramolecular nanocompo-
sites.[3] Polymers have been suggested as one of the best
nanomaterials for drug delivery.[3, 4] Along these lines, the
delivery of exogenous small interfering RNA (siRNA)[5,6] is
one potential therapy where polymers have attracted great
attention.[7] RNA interference (RNAi) can regulate gene
expression in a catalytic manner, and as such, offers several
advantages over other gene therapies.[8] However, the poten-
tial biosafety problems associated with viral vectors and the
intrinsic limitations of siRNA (for example, nuclease diges-
tion) strongly hinder the development of suitable therapies.[6]
It is therefore crucial to innovate and to identify new synthetic
vectors for the delivery of functional polynucleotides.
Current progress in polymer synthesis allows the prepa-
ration of materials with multiple functionalities capable of
mimicking some of the desired characteristics of viral vectors
for gene delivery.[7,9] To speed up this discovery process,
screening strategies have been developed.[10–14] However, in
most of these cases the monomer composition strongly affects
the outcome of the polymerization results.[15] Furthermore,
these platforms are often compromised by the lack of
strategies that allow evaluation of a range of chemical
compositions across a consistent molecular weight and/or
polymer length. Moreover, there are even fewer procedures
that allow the in situ evaluation of the generated polynucleo-
tide vectors.[12] Therefore, purification/isolation steps have to
be implemented, even for inactive candidates, increasing the
time required and the cost of the discovery process. Unfortu-
nately, as the sophistication in polymer design increases, so
does the synthetic effort required to prepare polymer vectors.
In this Communication we report the synthesis of poly-
(acryloyl hydrazide)s for their straightforward functionaliza-
tion with aldehydes to afford amphiphilic polymers that can
be screened in situ (that is, under aqueous conditions and
without further purification) for the activated transport of
nucleotides across lipid membranes (Scheme 1). Optimiza-
tion of these hydrazone-activated polymers can be performed
under aqueous conditions and without purification, minimiz-
ing the synthetic effort and the time required to identify novel
candidates for polynucleotide delivery. This versatile tech-
nology allowed the rapid identification of a single component
formulation for the delivery of siRNA with better perfor-
mance than one of the best commercial reagents (lipofect-
amine RNAiMAX).
Post-polymerization functionalization is an ideal strategy
to develop and to evaluate polymer compositions across
a consistent degree of polymerization.[16] Post-polymerization
often relies on highly efficient reactions (such as cycloaddi-
tions, reversible carbonyl chemistry, thiol-ene) to modify
polymer properties.[16] Of these, we anticipated that using
a poly(acryloyl hydrazide) scaffold (P1, Scheme 1) would give
the required solubility in water to be able to screen for siRNA
delivery without the need to purify the candidate amphiphiles.
Poly(hydrazides) are weakly protonated at neutral pH[10] and
can readily react with aldehydes to form acyl hydrazones that
are sufficiently stable under physiological conditions.[17]
Accordingly, hydrazone formation has been widely used in
biological settings including drug delivery,[18] sensing,[19, 20] or
even in the synthesis of polynucleotide delivery vectors.[21,22]
However, the use of poly(hydrazide) as a “clickable” and
versatile scaffold has been limited and only a few examples
report its use to synthesize glycopolymers or for pH-
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responsive drug delivery.[16,23, 24] Alternative elegant strategies
for multi-hydrazone formation have also been developed in
the context of DNA or protein-templated dynamic combina-
torial libraries.[25–28]
The proposed poly(acryloyl hydrazide) scaffold (P1) was
prepared using controlled free radical polymerization (see the
Supporting Information). P1 was highly water soluble and
aqueous hydrazone formation was readily confirmed by
employing the UV-active 4-imidazolecarboxaldehyde.
1H NMR spectroscopic analysis of P1 incubated (for less
than 1 h) with 4-imidazolecarboxaldehyde (0.3–0.9 equiv in
100 mm AcOH in D2O) showed a broadening of the aromatic
proton resonance signals of the aldehyde (see Figure S3 in the
Supporting Information). Comparison of the residual alde-
hyde signal against the overall amount of protons revealed
that the loading of 4-imidazolecarboxaldehyde on P1 was
about 70% (Figure S3).[23] No increase in loading was
detected with a higher number of equivalents of aldehyde,
longer times (up to 4 h), different solvents, or even with
heating. Further characterization was obtained from gel
permeation chromatography (GPC; Figure 1). A clear peak
for the polymer P1(Imidazole) (retention time Rt = 18 min)
was already detected with only 0.25 equiv of 4-imidazolecar-
boxaldehyde added to P1, confirming attachment of the
chromophore to P1 (Figure 1). Increasing amounts of 4-
imidazolecarboxaldehyde resulted in an increase in the
intensity of the peak at 18 min, with the signal reaching
a maximum at around 0.75 equiv. Further equivalents simply
increased the amount of free 4-imidazolecarboxaldehyde
(Rt = 31 min), validating the NMR estimation of a maximum
polymer loading of about 70% (Figure S3).
Having established the feasibility of modifying P1 with
a model aldehyde, we explored the use of P1 for the in situ
screening of membrane-active polymers. A close inspection of
some of the structural motifs commonly found in membrane-
active polymers (for example antimicrobial or cell-penetrat-
ing polymers) highlights a high prevalence of amphiphilic
structures with the presence of both cationic (such as
guanidinium) and hydrophobic moieties (such as isopropyl
or benzyl).[19, 29,30] The potential of establishing bidentate
hydrogen bonding and stable protonation under physiological
conditions makes the guanidinium group (pKa⇡ 12.5) the
optimal cationic moiety for membrane penetration. Thus, we
decided to investigate a small library of aldehydes where the
cationic aldehyde (1, Scheme 1) was kept constant and
independently combined with different hydrophobic alde-
hydes (Figure 2; see also the Supporting Information).
Activated polymers for membrane transport were thus
prepared by combining an aqueous stock solution of P1 with
a DMSO solution containing the cationic and the correspond-
ing hydrophobic aldehydes in different molar ratios (see the
Supporting Information for details). Hydrazone formation of
P1 with long hydrophobic aldehydes (  8 carbon atoms) lead
to the rapid precipitation of the resulting polymers, making
these combinations inappropriate for further evaluation.
However, the combination of a series of short hydrophobic
aldehydes (for example isovaleraldehyde (2)) with 1 afforded
water-soluble and stable polyhydrazone nanoparticles (Fig-
ure S4). Dynamic light scattering (DLS) analysis revealed
suitable sizes for membrane transport (about 200 nm) at
a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15
(Figures S4 and S17).[21] Neighboring effects (i.e. cation
repulsion) could impact the final composition of the final
hydrazone-modified polymer. Therefore, to further character-
ize the post-polymerization reaction, we measured the DLS
properties and the zeta potential of P1 combined with
different ratios of guanidinium aldehyde (1) and isovaler-
aldehyde (2). These measurements showed that increasing the
molar fraction of hydrophobic aldehyde increased the size
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated
polymers with cargo (siRNA) and polyplex delivery. c = molar fraction.
Figure 1. GPC (lAbs =275 nm) analysis of P1 incubated with
1 (black &), 0.75 (red ~), 0.5 (blue ^), 0.25 (purple &), or 0 (gray *)
equiv of 4-imidazolecarboxaldehyde. The spectrum for pure 4-imidazo-
lecarboxaldehyde (orange *) is also shown. Conditions: 100 mm acetic
acid, pH 2.9, 2 h. Inset: Increase in absorbance of the high molecular
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and thus the cationic character of the resulting polymeric
nanoparticles (Figure S4 b). The maximum increase was
detected at a molar fraction of 2 of c2 = 0.3–0.4, with further
increases causing an important decrease in both the size and
the zeta potential (Figure S4 B). These results confirmed that
changes in the aldehyde molar ratios are directly translated
into the composition of the hydrazone-modified polymer.
Lead hydrazone-activated polymers from DLS analysis
were then evaluated in supramolecular DNA transport
experiments using large unilamellar vesicles (egg yolk l-a-
phosphatidylcholine (EYPC LUVs)) loaded with 8-hydrox-
ypyrene-1,3,6-trisulfonic acid trisodium salt and p-xylene-bis-
pyridinium bromide (EYPC LUVs HPTS/DPX).[19, 20] This
routine assay reports the release of internal dye molecules as
an increase in the fluorescence of HPTS (Figure S5). This
model allows the quick identification of inactive formulations
as well as compositions that lead to significant membrane
damage. In these experiments, a heterogeneous mixture of
short double-stranded DNA molecules (dsDNAs; herring
DNA) was selected to model siRNA. Transport experiments
in these fluorogenic vesicles revealed isovaleraldehyde (2)
and hexanal (3), and 2-naphthaldehyde (4) and benzaldehyde
(5), as the leading hits for the aliphatic and the aromatic
series, respectively (Figure 2; Figure S8, Table S2). Increasing
the molar fraction of hydrophobic aldehydes over 0.15
(c(Hydrophobic)> 0.15) afforded amphiphilic polymers
with membrane-disrupting behaviors (Figure S6). Control
experiments confirmed a lack of activity for the parent
hydrazide P1 either pure or independently combined with
hydrophilic (1) or hydrophobic aldehydes (Figure S7).
Following the synthesis and in situ screening of polyhy-
drazones for membrane activity and DNA transport, the
aldehyde lead candidates from fluorogenic assays, 2, 3, 4, and
5, were taken forward for their evaluation in siRNA delivery
(EGFP (enhanced green fluorescent protein) gene knock-
down) in HeLa-EGFP cells (Figure 3; see the Supporting
Information for details).[31] Again, isolation and purification
of the synthesized activated polymers was not required and
transfection experiments were performed by simply diluting
freshly prepared polyhydrazones (buffer/DMSO; see the
Supporting Information for details) in culture media. In
these experiments, activated polymers with aldehydes 3, 4,
and 5 showed no activity for siRNA delivery in cells
(Figure S11). Aliphatic isovaleraldehyde (2), however,
showed efficient EGFP knockdown with an accurate repro-
ducibility in all the transfection replicates measured (Figur-
es S9–S14).
The biocompatible experimental conditions for the prep-
aration of hydrazone-activated polymers allowed the straight-
forward optimization of this polymeric vector. We evaluated
P1 with different molar ratios of isovaleraldehyde (c2 = 0–
0.4) and different polymer concentrations to maximize trans-
fection efficiency and cell viability (Figure 3; Figure S15).
Interestingly, the optimum molar ratio of the hydrophobic
aldehyde (c2 = 0.15; Figure 3A) correlated well with the
molar ratio identified in vesicle transport experiments
(Figure 2; Figures S6, S8). Maximum transfection efficiency
for P1(1)85(2)15 (where the subindices indicate the percentage
of the corresponding aldehyde) could be achieved at a con-
centration of 4 mm (Figure S12). Under these conditions, we
could confirm the formation of supramolecular polyplexes
(150 nm) with a positive z-potential of + 7 mV (Figure S17).
Additionally, gel electrophoresis showed complete complex-
ation of RNA into the polymeric polyplexes with as little as
0.12 mm of P1(1)85(2)15 (Figure S18).
Cell viability was optimal for the parent polymer P1 and
for the entire range of molar fractions and concentrations of
the active P1(1)85(2)15 (Figure 3A; Figures S15,S16). How-
ever, increasing the molar ratio of the hydrophobic aldehyde
(c2 = 0.4) caused a slight decrease in cell viability together
Figure 2. YMAX values versus polymer concentration (left) or versus
EC50 (half maximal effective concentrations; right) for the DNA trans-
port experiments in EYPC-LUVs HPTS/DPX for hydrazone-activated
polymers at c(Hydrophobic)= 0.15 and c1= 0.85. In the left plot, 5
(squares) and 2 (circles) are employed as the hydrophobic aldehydes.
Figure 3. A) Transfection efficiency (bars) and cell viability (circles) in
HeLa-EGFP cells at constant siRNA (14 nm) and P1(1)85(2)15 (4 mm)
concentrations and prepared with different molar fractions of 2.
B) Dose–response curves of lead candidate P1(1)85(2)15 (empty circles;
EC50 =0.09 ngmL
ˇ1) and Lipofectamine RNAiMAX (empty squares;
EC50 =2.5 ngmL
ˇ1), as well as the percentage cell viability for P1(1)85-
(2)15 (gray filled circles, top).
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with an increase in the standard deviation of the assay
(Figure 3A, circles). This observation could be related with
the membrane detergent behavior detected for highly hydro-
phobic polyhydrazones in vesicle experiments (Figure 3A;
Figure S15, Figure S6). Remarkably, a comparison of the
dose–response curves of transfection efficiency revealed that
the polymeric vector performed with almost equal efficiency
using a concentration more than ten times less than that of the
commercial reagent lipofectamine RNAiMAX (Figure 3B).
Furthermore, the stability of all the components involved in
the preparation of this polymeric cytofectin allowed the
storage of the stock solutions for months while keeping intact
their transfection efficiency.
In conclusion, we have developed a novel strategy for the
in situ evaluation (that is, under aqueous conditions and
without purification) of polymers with biological activity.
Poly(hydrazide) functionality has been “activated”, under
aqueous conditions, to yield amphiphilic functional polymers
that did not require any further purification for their
evaluation in relevant biological assays. This procedure
allowed the rapid identification of a single-component
supramolecular polymeric formulation for siRNA transfec-
tion with better performance than the current gold standard
for siRNA delivery. We believe that the reported method is
not limited to the screening of polynucleotide delivery and
that it can be easily adapted (through an informed choice of
aldehydes) for the high-throughput screening of polymers
with complex chemical functionalities and different biological
relevance. The control over the distribution and sequential
arrangement of the aldehyde groups onto the polymer
scaffold will be a great future challenge that will allow the
investigation of intriguing topology/activity relationships. Our
efforts in these directions will be reported in due course.
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 Materials and Methods 
2-(((ethylthio)carbonothioyl)thio)-2-methylpropanoic acid (CTA)S1 was synthesised according to protocols 
described in the literature. 8-Hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS) was purchased from 
Sigma-Aldrich® and p-xylene-bis-pyridinium bromide (DPX) was purchased from InvitrogenTM. Egg yolk L-α-
 S2 
phosphatidylcholine (EYPC) was purchased from Avanti Polar Lipids, Inc. All other chemicals were purchased 
from Sigma-Aldrich®, Scharlau, Panreac Química SLU, Fisher Scientific® or Acros® and used without further 
purification. All solvents were HPLC grade, purchased from Sigma-Aldrich® or Fisher Scientific®, and used 
without further purification. 
Nuclear Magnetic Resonance (NMR) spectra were recorded on either a Bruker Avance III 300 MHz, a 
Bruker Avance III 400 MHz spectrometer, a Varian Mercury 300 MHz or a Varian Inova 500 MHz spectrometer. 
Chemical shifts are reported in ppm (δ units) referenced to the following solvent signals: DMSO-d6 δH 2.50, D2O 
δH 4.79 and CDCl3, δH 7.26. Electrospray ionization mass spectrometry (ESI-MS) for the characterization of new 
compounds was performed on a Finnigan MAT SSQ 7000 instrument or an ESI API 150EX and are reported as 
mass-per-charge ratio m/z (intensity in %, [assignment]). Accurate mass determinations (HR-MS) using ESI-MS 
were performed on a Sciex QSTAR Pulsar mass spectrometer. Infrared (IR) spectra were recorded on a Perkin 
Elmer Spectrum Two FT-IR spectrometer. Ultraviolet-visible (UV-vis) spectra were recorded on a Campsec 
M550 Double Beam Scanning UV-vis Spectrophotometer. Fluorescence measurements were performed with a 
FluoroMax-2 spectrofluorometer (Jobin-Yvon Spex) equipped with a stirrer and a temperature controller. Size 
Exclusion Chromatography (SEC) spectra were recorded on a Shimadzu Prominence LC-20A fitted with a 
Thermo Fisher Refractomax 521 Detector (Boc-P1) or a SPD20A UV-vis Detector (P1). Boc-P1 was analyzed 
using 0.05 M LiBr in DMF at 60 °C as the eluent and a flow rate of 1 mL·min-1. The instrument was fitted with a 
Polymer Labs PolarGel guard column (50 × 7.5 mm, 5 µm) followed by two PLGel PL1110-6540 columns (300 × 
7.5 mm, 5 µm). Molecular weights were calculated based on a standard calibration method using 
polymethylmethacrylate. Activation of P1 was analyzed using 100 mM acetic acid at pH 2.9 as the eluent and a 
flow rate of 1 mL·min-1. The instrument was fitted with a Shodex Asaphipak GF-510 HQ column and a Shodex 
Asaphipak GF-310 HQ column (300 × 7.5 mm, 5 µm). Vesicles were homogenized using a Mini-Extruder from 
Avanti Polar Lipids Inc. Activated polymer and Polyplex hydrodynamic diameter and ζ-potential were 
determined using a Malvern Zetasizer Nano ZS90. For cell experiments, the absorbance at 560 nm (cytotoxicity 
assays) and fluorescence (λex 489nm; λem 509nm, transfection experiments) were measured using a microplate 
reader (Infinite F2000pro Tecan). Gels were resolved on an electrophoresis cell (Fisher Scientific UK), while an 
UV image station (Chem-genius, Syngene) was used to record and analyze gel images. 
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Synthesis of Guanidinium Aldehyde (1)  
  
Scheme S1: Synthesis of aldehyde 1. a) N,N!-di-Boc-1H-pyrazole-1-carboxamidine, DIPEA, CH3CN/H2O, 55 ºC, 73%.  b) 2-
(1,3-dioxolan-2-yl)ethanamine, DCM, HBTU, DIPEA, rt, 80%. c) HCl 3M, 60 ºC, 70%.  
Compound 7. !-alanine (6) (750 mg, 8.42 mmoles) was dissolved in CH3CN/H2O (6:1, 35 mL) and treated 
with N,N!-di-Boc-1H-pyrazole-1-carboxamidine (627.3 mg, 2.03 mmoles) and N,N-diisopropylethylamine 
(DIPEA) (868 "l, 5.07 mmoles). The resulting solution was stirred for 2 h at 55 ºC. The product was extracted 
with DCM (3x 10 mL) and the solution was washed with aqueous HCl (5%, 3 x 20 mL). The organic layers were 
combined, dried over Na2SO4 and concentrated under vacuum. The residue was purified by flash chromatography 
(gradient DCM/MeOH 98:2#90:10, Rf (90:10) = 0.70) to give 675 mg of compound 7 (73%). Spectroscopic data 
matched those reported in the literature.S2 
Compound 8. A solution of 7 (520 mg, 1.57 mmoles) in DCM (30 mL) was treated with TBTU (519.67 
mg, 1.57 mmoles), 2-(1,3-dioxolan-2-yl)ethanamine (316 "l, 2.83 mmoles) and DIPEA (1 mL, 6.28 mmoles, 
added dropwise). The reaction mixture was stirred at rt under Argon atmosphere for 1 hour. The reaction crude 
was washed with aqueous HCl (5%, 3 x 20 mL) and aqueous saturated NaHCO3 (2 x 20 mL). The organic layer 
was dried with anhydrous Na2SO4, filtered and concentrated under vacuum. The residue was purified by flash 
chromatography (gradient DCM/MeOH 99:1#90:10, Rf (90:10) = 0.76) to give 542.6 mg of compound 8 (80%) 
(Figure S19). 1H-NMR (300 MHz, CDCl3) $ (ppm) 11.4 (s, 1H), 8.7 (t, 3JH,H = 4.9 Hz, 1H), 6.66-6.57 (m, 1H), 
4.8 (td, 3JH,H = 4.3, 0.7 Hz, 1H), 3.95-3.91 (2H, m), 3.85-3.81 (2H, m), 3.70-3.59 (2H, m), 3.4-3.3 (2H, m), 2.41 
(t, 3JH,H = 6.2 Hz, 2H, m), 1.86-1.84 (2H, m), 1.49 (9H, s), 1.48 (9H, s). 13C-NMR (500 MHz, CDCl3) $ (ppm) 
170.79 (s), 163.40 (s), 156.25 (s), 152.84 (s), 103.89 (d), 83.09 (s), 79.28 (s), 64.89 (t), 36.05 (t), 35.40 (t), 34.71 
(t), 32.80 (t), 28.30 (q), 28.05 (q). ESI-MS (H2O/CH3CN) m/z 431 (100, [M+H]+), 453 (20, [M+Na]+). IR (neat) % 
max 3314 (m sh, N-H), 3124 (w, N-H), 2975 (m sh, C-O), 1721 (m sh, C=O), 1611 (s, N-H), 1409 (s, C-H), 1364 
(s, C-H), 105 (s, C-O) cm-1. 
Compound 1. A solution of compound 8 (0.69 mmoles, 300 mg) in water was treated with an aqueous 
solution of HCl (3M, 10 ml  mL). The reaction mixture was stirred at 60 ºC for 1 hour. Then the solvent was 









































fractions (Rt = 4.0  min, ) were lyophilized and stored at -20 °C to give 90 mg of compound 1 (70%) (Figure S20 
and S21). RP-HPLC [Nucleosil 100-7 C18 H2O (0.1% TFA)/CH3CN (0.1% TFA) 100:0 (0→10 min), 
100:0→75:35 (10→35 min), 0:100 (>35 min)]. Purity and characterization were confirmed by analytical RP-
HPLC, 1H-NMR and ESI-MS. 1H-NMR (300 MHz, D2O) δ (ppm) 9.53 (s, 1H), 5.00-4.77 (m, 1H), 3.40-3.25 (m, 
2H), 3.24-3.04 (m, 2H), 2.65-2.60 (m, 2H), 2.52-2.29 (m, 2H), 1.94-1.73 (m, 1H), 1.70-1.60 (m, 2H). ESI-MS 
(H2O/CH3CN) m/z 187 (100, [M+H]+, 205 (30, [M+H2O]+). HR-MS (MS): Calcd for C7H15N4O2: 187.1185; 
found: 187.1190. IR (neat) ν max 3312 (m b, N-H), 3121 (m b, N-H), 2976 (w sh, C-O), 1722 (m, C=O), 1614 (s, 
N-H), 1363 (s, C-H) 1057 (s, C-O) cm-1. NMR analysis of 1 revealed a discrete mixture of isomers due to 
potential intramolecular cyclization and/or aldehyde oligomerization.S3 Treatment of 1 with benzylhydroxylamine 
afforded the corresponding oxime 9 as a pure single product. 
 
Scheme S2. To determine the purity of the isomer mixture present in 1, this mixture was reacted with benzyl hydroxylamine 
to afford oxime 9 as a pure single product. This result suggested that all isomers of compound 4 reacted, under the coupling 
conditions, to afford the desired oxime 5. 
Compound 9. A solution of compound 1 (100 mM) in aqueous acetic acid (AcOHaq) (100 mM, pH = 4.5) 
was mixed with 1.2 equivalents of O-benzylhydroxylamine (100 mM) in DMSO. The mixture was stirred at 60 ºC 
for 2 h. The crude was purified by RP-HPLC (The collected fractions (Rt = 18.8 min) were lyophilized and stored 
at -20 °C to give 9.0 mg of compound 9 (80%) (Figures S22, S23 and S24). RP-HPLC [Nucleosil 100-7 C18 H2O 
(0.1% TFA)/CH3CN (0.1% TFA) 100:0 (0→5 min), 100:0→35:75 (5→35 min), 0:100 (>35 min)]. The presence 
and purity of the O-akyloxime 9 was checked by analytical RP-HPLC, NMR and ESI-MS. 1H-NMR (500 MHz, 
D2O) δ (ppm) 7.5 (t, 3JH,H = 6.4 Hz, 1H, Isomer E), 7.43-7.35 (5H, m), 6.85 (t, 3JH,H = 5.7 Hz; 1H, Isomer Z), 5.10 
(s, 2H, Isomer Z), 5.05 (s, 2H, Isomer E), 3.40-3.30 (m, 4H), 2.59 (dd, 3JH,H = 12.3, 6.4 Hz, 1H), 2.40-2.30 (m, 
3H). 13C-NMR (500 MHz, D2O) δ (ppm) 173.5 (s), 152.2 (d) Isomer E, 152.0 (d) Isomer Z, 137.2 (s), 137.0 (s), 
128.6 (d), 128.3 (d), 128.2 (d), 128.1 (d), 128.0 (d), 75.39 (t) Isomer Z, 75.0 (t) Isomer E, 37.4 (t), 36.0 (t) Isomer 
Z, 35.9 (t) Isomer E, 34.7 (t) Isomer E, 34.6 (t) Isomer Z, 29.2 (t), 25.7 (t). ESI-MS (H2O/CH3CN) m/z 292 (100, 
[M+H]+). HR-MS (ESI): Calcd for C14H22N5O2: 292.1771; found: 283.1768. IR (neat) ν max 3369 (m b, N-H), 





















 DMSO, 60 ºC.
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Synthesis of Activated Polymers 
• Synthesis of Poly(acryloyl hydrazide) P1  
 
Scheme S3: a) tert-butyl carbazate, EDC, H2O/THF (2:1), 25 oC, 50%. b) CTA, ACVA, DMSO, 70 oC, 73%. c) i. TFA, 25 
oC; ii. H2O, NaHCO3, 25 oC, 92%. 
Compound 11. Acrylic acid (10) (3.81 mL, 54.95 mmol) and tert-butyl carbazate (8.89 g, 65.95 mmol) 
were dissolved in a H2O/THF mixture (2:1, 180 mL) at rt. N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC) (11.75 g, 61.29 mmol) was added in portions to the solution over 15 minutes and left 
stirring for 3 h. The crude reaction was extracted with EtOAc (3 x 75 mL) and the organic layer was washed with 
0.1 M HCl (3 x 75 mL), H2O (50 mL) and brine (2 x 50 mL). The organic phase was dried with anhydrous 
Na2SO4 and the solvent was removed under reduced pressure to afford the crude product as a white solid. The 
crude product was purified by recrystallization from EtOAc (70 oC to rt) to afford a 5.05 g of a white crystalline 
powder identified as 11 (50%) (Figure S25). Rf = 0.87 (100% EtOAc). 1H-NMR (300 MHz, DMSO-d6) δ (ppm) 
9.79 (s, 1H), 8.84 (s, 1H), 6.17-6.20 (m, 2H), 5.69 (dd, 3JH,H = 7.8, 4.5 Hz, 1H), 1.40 (s, 9H). 13C-NMR (100 
MHz, DMSO-d6) δ (ppm) 164.3 (s), 155.3 (s), 129.4 (d), 126.2 (t), 79.2 (s), 28.1 (q). IR (neat) ν max 3311 (m sh, 
N-H), 3221 (m sh, N-H), 2981 (w sh, C-H), 1715 (s sh, C=O), 1668 (s sh, C=O) cm-1. 
Boc-P1. A solution of 4,4’-azobis(4-cyanovaleric acid)  (ACVA) (18.4 mg, 0.064 mmol) in DMSO (1.5 
mL) and a solution of CTA (72.3 mg, 0.322 mmol) in DMSO (1.5 mL) were added sequentially to a solution of 
tert-butyl-2-acryloylhydrazine-1-carboxylate (11) (3.00 g, 16.095 mmol) in DMSO (14.88 mL). A 50 µL aliquot 
of this solution was taken at this stage to aid in the calculation of conversion. The reaction mixture was then 
sealed and degassed with Argon for 30 min. The degassed solution was left to react at 70 oC for 7 h. The reaction 
was stopped by allowing it to cool down to room temperature and by exposing it to air. A 50 µL aliquot of this 
solution was taken at this stage to aid in the calculation of conversion. The polymer was purified by dialysis 
against water. The water was removed by lyophilisation and by drying in a desiccator with P2O5 to afford 2.2 g of 
Boc-P1 (Figure S26) as an off-white powder (73% yield). UV (DMSO) λmax 300 nm. 1H-NMR (300 MHz, 
DMSO-d6) δ (ppm) 9.22 (1H, br), 8.60 (1H, br), 2.03 (1H, br), 1.41 (11H, br). Conversion 80%. Mn (DMF GPC) 
10270, ĐM (DMF GPC) 1.39. DP (UV-Vis) 45. 
− Calculation of Conversion 
50 µL aliquots of the reaction mixture were taken before and after the polymerization. These aliquots were 



























a) b) c) -
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Monomer conversion was calculated by 1H-NMR spectra by comparing the integration of the vinyl proton signals 
from the monomers (5.69 and 6.19 ppm) to the integration from the aromatic groups in syringic acid (7.20 ppm). 
− Calculation of Degree of Polymerization (DP) Using UV 
DP in Boc-P1 was calculated by measuring the absorbance at 300 nm (λmax for Boc-P1), 305 nm and 310 
nm (λmax for CTA) and comparing against calibration curves using CTA (Figure S1 and Table S1). This way, the 
amount (mg·mL-1) of trithiocarbamate in Boc-P1 was estimated,† and the ratio between monomer units and end-
groups calculated. 
 
Figure S1: A) UV-vis of Boc-P1 (1.3 mg·mL-1) and CTA (0.03 mg·mL-1) solutions in DMSO. B) Calibration curves 
showing the linear relationship between absorbance and [CTA]. 
Poly(acryloyl hydrazide) P1. Trifluoroacetic acid (TFA) (15 mL) was added dropwise to poly(tert-butyl-
2-acryloylhydrazine-1-carboxylate) (Boc-P1) (1.5 g) and the yellow solution was stirred at rt for 2 h. Excess of 
TFA was removed by blowing a steady stream of Argon and the resulting oil was diluted in water (15 mL). The 
P1·TFA salt formed was neutralised by adding NaHCO3 until no foaming was observed. The colourless solution 
was allowed to stir overnight. The crude polymer was purified by dialysis against water. The water was removed 
by lyophilisation and by drying in a desiccator with P2O5 to afford 650 mg of P1 (Figure S27) as a white powder 
(92%). 1H-NMR (300 MHz, D2O) δ (ppm) 1.59-2.08 (br m, (3·DP)H), 1.01 (s, 3H), 0.95 (s, 3H). 13C-NMR (100 
MHz, D2O) δ (ppm) 174.9 (s), 40.2-40.5 (d), 34.4-35.7 (d). DP (1H-NMR) 40. IR (neat) νmax 3254 (w br, N-H), 
1609 (m br, C=O), 1428 (s sh) cm-1. 
− Calculation of DP using 1H-NMR 
DP in P1 was calculated from the 1H-NMR spectra by comparing the integration of the methyl substituents 
in the end-group (0.95 and 1.01 ppm, 6 H) to the integration from the aliphatic region in the polymer backbone 
(1.59-2.08 ppm) (Figure S2 and Table S1). 
                                                
† DP of polymerization calculated this way is approximate. Absorption (i.e. molar extinction coefficient, λmax) properties for 
CTA and P1 are not necessarily the same. Similarly, not all polymer chains will incorporate a trithiocarbamate as an end-group. 
However, the calculated value is within error of those calculated by 1H-NMR (Table S1). 




































Figure S2: 1H-NMR spectra of P1 showing the relevant region where the methyl substituents (a) and the aliphatic hydrogens 
(b) can be identified. 
Table S1
 [M] / [CTA]a DP (conversion)b DP (UV-vis)c DP (1H-NMR)d 
Boc-P1 50:1 40 45 - 
P1 - - - 40 
a Calculated from the initial monomer and CTA concentrations used for the polymerization. 
b Calculated from the initial monomer and CTA ratio and the conversion of monomer from 1H-NMR. 
c Calculated by UV-vis against a CTA standard as the ratio of monomer to trithiocarbamate in Boc-P1 (Figure S1).  
d Calculated by 1H-NMR, using the methyl groups as an internal standard, as the ratio between monomer and end-group 
(Figure S2). 
• Conjugation of Poly(acryloyl hydrazide) with Aldehydes  
Poly(acryloyl hydrazide) (P1) in aqueous acetic acid (AcOHaq, 100 mM, pH 3.0) was reacted with 6 
equivalents of a solution of different molar fractions of 1 and hydrophobic aldehyde in DMSO. For instance, in a 
model experiment with pure guanidinium aldehyde (!1 = 1), P1 (25 !l, 35 mM in AcOHaq) was reacted with 1 (25 
!l, 200 mM in DMSO) to afford a final concentration of activated polymer of 50 mM. In a typical experiment with a 
mixture of aldehydes (!1 = 0.85, !2 = 0.15), 25 !l of a solution of P1 (35 mM in AcOHaq pH 3.0) was mixed with a 
solution of 25 !l composed by 3.8 !l of a solution of hydrophobic aldehyde (200 mM in DMSO) and 21.2 !l of a 
solution of 1 (200 mM in DMSO) to give a final concentration of polymer of 50 mM (Table S2). This mixture was 
shaken at 60 ºC for 2 h. Activated polymers were used without further purification in the transport vesicle 
experiments. 
" Calculation of loading using 1H-NMR 
Loading in P1-4-imidazolecarboxaldehyde was calculated from the 1H-NMR spectra by comparing the 
integration of the residual aldehyde (9.7 ppm, XH) against the overall number of protons in that region (3H, 1H 
from aldehyde or hydrazone, 2H from 4-imidazolecarboxaldehyde ring). Signal at 6.0 ppm corresponds to the 
cyclic acetal and has been included in the overall integration. 
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Figure S3: A) 1H NMR spectra of P1 (1.3 mg/mL) incubated (< 1h) with increasing amounts of 4-imidazolecarboxaldehyde. 
From bottom: 0.3, 0.6 and 0.9 eq. of 4-imidazolecarboxaldehyde. B) Integration of residual aldehyde (9.7 ppm) against the 
overall number of protons (3H) in this region. 
− Dynamic light scattering of P1(1)85(2)15 
P1(1)85(2)15 was prepared accordingly to the general procedure for the conjugation of poly(acryloyl hydrazide) 
with aldehyde aldehydes. The final concentration in the reaction vessel was 17 mM. From this stock solution 20 µl 
were diluted with 1980 µl of MilliQ water to afford a final concentration of 17 µM of activated polymer. For DNA 
conjugates, 20 µl of 17 mM activated polymer stock solution was diluted with 1960 µl of MilliQ water and 20 µl of 2 
µM DNA from Herring sperm were added and the mixture was gently mixed by pipetting and immediately 
































Figure S4: Representative dynamic light scattering data for P1(1)85(2)15 in the absence and presence of dsDNA (Herring 
DNA). A) Autocorrelation function (ACF) curves and B) intensity distributions measured in milliQ water. [activated 
polymer] = 17 !M. C) Diameter and D) "-potential for representative activated polymer P1(1)85(2)15 = 3 !M at increasing 
molar fractions of isovaleraldehyde (!2 = 0-1). 
Evaluation of Transport Across Model Membranes: Vesicle Experiments 
• Preparation of Large Unilamellar Vesicles (LUV) 
A thin lipid film was prepared by evaporating a solution of EYPC (25 mg) in MeOH/CHCl3 (1:1, 1 mL) on 
a rotary evaporator (at rt) and then in vacuo overnight. The resulting film was hydrated with 1.0 mL buffer (5 mM 
HPTS, 16.5 mM DPX, 10 mM Tris, 72 mM NaCl, pH 7.4) for more than 30 min, subjected to freeze-thaw cycles 
(5 x) and extrusions (15 x) through a polycarbonate membrane (pore size 100 nm). Extravesicular components 
were removed by gel filtration (Sephadex G-50) with 10 mM Tris, 107 mM NaCl, pH 7.4. Final conditions: ~5 
mM EYPC; inside: 5 mM HPTS, 16.5 mM DPX, 10 mM Tris, 72 mM NaCl, pH 7.4; outside: 10 mM Tris, 107 
mM NaCl, pH 7.4. 
P1(1)85(2)15
P1(1)85(2)15 + DNA





















Time / ms size / nm
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• Evaluation of Transport of Nucleic Acids across EYPC-LUV 
EYPC-LUV stock solutions (5 µl) were diluted with buffer (10 mM Tris, 107 mM NaCl, pH 7.4), placed in 
a thermostated fluorescence cuvette (25 °C) and gently stirred (total volume ~2000 µl; final lipid concentration 
~13 µM). HPTS efflux was monitored at λ 511 nm (λex 413 nm) as a function of time after addition of activated 
polymer (20 µl in DMSO/AcOH buffer, t = 25 s), nucleic acid (NA, 20 µl of 2 µM stock solution in buffer, t = 50 
s) and aqueous triton X-100 (1.2%, 40 µl, 370 µM final concentration, t = 225 s). Total experiment time = 250 s. 
Fluorescence intensities were normalized to fractional emission intensity I(t) using Equation S1. 
Equation S1: !! ! = (!! − !!)/(!! − !!) 
where I0 = It at NA addition, I∞ = It at saturation after lysis. Effective concentration for activated polymer or 
NA - EC50 - and Hill coefficient - n - were determined by plotting the fractional activity Y ( = I(t) at saturation just 
before lysis, t = 200 s) as a function of activated polymer or NA concentration [Analyte] and fitting them to the 
Hill equation (Equation S2). 
Equation S2: ! = !! + (!!"# − !!)/ 1 + !"!"[!"#$%&']
!
 
where Y0 is Y without NA (or activated polymer), Ymax is Y with an excess of activated polymer (or NA) at 
saturation, EC50 is the concentration of NA (or activated polymer) required to reach 50% activity and n is the Hill 
coefficient (Figure S5 and Table S2). 
 
Figure S5: A) Changes to fractional emission intensity I(t) for EYPC-LUVs⊃HPTS/DPX after the addition of activated 
polymer (17 µM, χ1: 0.85 and χ5: 0.15) at t = 25 sec, Herring DNA (5 µM-0.15 nM final concentrations) at t = 50 sec and 
Triton-X (370 µM final concentration) at t = 225 sec. B) Dose response curve obtained from the plot of fractional activity vs 
activated polymer concentration and fitting to the Hill equation (Equation S2) YMAX = 51.10 ± 2.3%, EC50 = 0.33 ± 0.3 µM, n 























Y (%) Y (%)
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Figure S6: Changes to fractional emission intensity I(t) and dose-response curve for the transport of Herring DNA (2 µM) in 
EYPC-LUVs⊃HPTS/DPX in the presence of activated polymer (17 µM, χ1: 0.75 and χHydrophobic: 0.25). A) 
χHydrophobic = Benzaldehyde and in B) χHydrophobic = isovaleraldehyde (2). The increase in fluorescence observed 
immediately after the addition of activated polymer depicts membrane disruption profiles when using molar fractions of 0.25 


















Fuorescence increase after addition of only Activated Polymer (25-50 sec) suggests detergent and 











Figure S7: A) Changes to fractional emission intensity I(t) for the transport of Herring DNA (2 µM) in EYPC-
LUVs⊃HPTS/DPX in the presence of activated polymer (17 µM) prepared from χ2 (0.9-0.1) in the absence of cationic 
aldehyde (χ1 = 0). B) Same plot for activated polymers (17 µM) prepared with higher molar fractions of 2 (χ2 = 0.5, 0.75 or 











































































































































Figure S8: Changes to fractional emission intensity I(t) (A) and dose-response curve (B) for the transport of Herring DNA (2 














































Table S2: EC50 (µM), YMAX (%) and n for the transport of Herring DNA (125 µM) in EYPC-LUVs⊃HPTS/DPX with 
increasing concentrations of activated polymer P1(1)85(n)15 prepared from 15% of hydrophobic aldehyde (2-18) and 85% of 
1. All experiments were done in triplicate. P1(1)85(n)15 stands for P1: Polymer 1; (1)85: guanidinium aldehyde at a χ1 = 0.85; 
(n)15: hydrophobic aldehyde at a χn = 0.15.  
Polymer Aldehyde Number Aldehyde EC50 (µM) Ymax (%) n 
P1(1)85(2)15 2  5.73 ± 2.36 35.94 ± 7.80 1.47 ± 0.61 
P1(1)85(3)15 3  2.95 ± 2.25 28.00 ± 8.4 1.04 ± 0.57 
P1(1)85(4)15 4 
 
0.81 ± 0.05 53.50 ± 2.70 3.91 ± 0.94 
P1(1)85(5)15 5 
 
4.10 ± 0.74 56.00 ± 5.00 2.92 ± 1.48 
P1(1)85(12)15 12 
 
5.10 ± 1.40 23.10 ± 2.30 2.80 ± 0.17 
P1(1)85(13)15 13 
 
3.01 ± 0.61 17.74 ± 1.68 1.64 ± 0.50 
P1(1)85(14)15 14 
 
0.98 ± 0.17 26.71 ± 1.51 2.37 ± 0.89 
P1(1)85(15)15 15 
 
1.21 ± 0.08 48.80 ± 1.90 4.60 ± 1.19 
P1(1)85(16)15 16 
 
0.46 ± 0.05 50.9 ± 2.60 3.13 ± 1.02 
P1(1)85(17)15 17 
 
4.83 ± 3.30 17.58 ± 4.10 0.96 ± 0.39 
P1(1)85(18)15 18 
 




Cells Lines and Culture 
HeLa cells stably expressing enhanced green fluorescent protein (HeLa-EGFP) were maintained in 
Dulbecco´s Modified Eagle´s Medium from Life TechnologiesTM (DMEM, high glucose, GlutaMAXTM, pyruvate) 
supplemented with 10% (v/v) of fetal bovine serum (FBS) from HycloneTM (Thermo Fisher Scientific Inc) and 
500 µg·mL-1 of Geneticin® (Life TechnologiesTM). Transfection of HeLa-EGFP was performed in the same 
medium, free of serum and antibiotics. Cells incubations were performed in a water-jacketed 37 ºC/5% CO2 
incubator. 
• In Vitro Screening for siRNA Delivery  
Activated polymer stock solutions were prepared in DMSO/AcOHaq (v/v) as described above and diluted 
with DMSO to afford a range of stock solutions concentrations of (3-0.1 mM). These stock solutions were then 
sequentially diluted with DMEM medium free of serum and antibiotics to afford the final concentration in cells 
(17-0.3 µM). The solutions of siRNA/ activated polymer polyplexes were freshly prepared prior to the 
transfection experiments. 10 µl of the siRNA solution (1 µM in DMEM) and 8 µl of activated polymer solution at 
variable concentrations in DMEM, high Glucose, GlutaMAXTM, 10% (v/v) DMSO, were added to 190 µl DMEM, 
high glucose, GlutaMAXTM, and the mixture was homogenized by pipetting. Then, cell medium was aspirated 
from 96-well plate and 50 µl of the mixture was added in each well. The final concentration of DMSO in each 
well was 0.125% (v/v). After 4 hours of transfection the medium was aspirated and replaced by 100 µl of fresh 
DMEM, high glucose, GlutaMAXTM, pyruvate, supplemented with 10% (v/v) FBS. The total fluorescence 
knockdown was quantified after 72 hours in a microwell plate reader (Infinite F2000pro Tecan). For the best 
performing activated polymers, at the most efficient and less toxic concentration, siRNA solutions were prepared 
at different concentrations (Table S3). For control and normalization experiments forward transfection with 




Table S3: Conditions employed in the optimization of the transfection experiments. All experiments were done at a final 
concentration of activated polymer P1(1)!!1(2)!2 of 4 µM. 
χ2 a [siRNA] (nM)b siRNA (pmol) 








0.3 14 1.5 
0.4 14 1.5 
a Molar fraction of χ1 = 1 - χ2. b[siRNA] refers to the final concentration of siRNA. 
• Transfection in HeLa-EGFP 
HeLa-EGFP were transfected either with Ambion® Silencer® GFP (EGFP) siRNA (siEGFP) from Life 
Technologies™ or scramble RNA (siMock, All Star Negative Control) from Qiagen. 72 h post siRNA 
transfection, cell supernatant was removed and EGFP expression was measured by fluorimetry (λex 489nm; λem 
509nm). The percentage of EGFP knockdown was calculated as the percentage of fluorescence decrease observed 
in cells transfected with siEGFP compared to transfection with siMock with the same reagents at the same 
conditions. Percentage of cell viability was calculated as the percentage of remaining fluorescence in samples 
transfected with siMock compared to non-transfected cells in DMEM, high glucose, GlutaMAX™ and pyruvate, 
supplemented with 0.125% (v/v) DMSO. 
Lipofectamine® RNAiMAX was used as a positive control of siRNA transfection in the in vitro screening 
of activated polymers in HeLa-EGFP. The quality of the transfection experiments was assessed calculating the Z-
factor using Equation S3, 
Equation S3: !– !"#$%& = 1 − !(!!!!!)!!!!!  
In where µ stands for the mean value and σ for the corresponding standard deviation of relative 
fluorescence units (RFU) of both the positive (p = cells transfected with mixture of siEGFP and activated 
polymers or Lipofectamine® RNAiMAX) and negative (n = non-transfected cells in medium supplemented with 
0.125% (v/v) DMSO) controls (µp, σp, and µn, σn). A Z-factor between 0.5 and 1.0 indicates an excellent assay, 
0.5 is equivalent to a separation of 12 standard deviations between µp and µn (Figure S9). 
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Figure S9: RFUs and Z-factor for the knock-down of EGFP in HeLa-EGFP with activated polymer (χ1: 0.85 and 
χHydrophobic: 0.15) or Lipofectamine® RNAiMAX. 
 




Figure S11: Relative fluorescent units (RFUs) for the siRNA transfection experiments. In all cases and in all concentrations, 
transfection experiments were performed with siRNA (red) and siMock (negative control experiment in blue). In all cases the 
molar fractions were χ1 = 0.85 and χHydrophobic = 0.15. a) Hexanal (3), P1(1)85(3)15, b) Naphthaldehyde (4), P1(1)85(4)15, 
c) Benzaldehyde (5), P1(1)85(5)15, d) Knock-down of EGFP in HeLa-EGFP is only observed for isovaleraldehyde (2), 
P1(1)85(2)15. A satisfactory Z factor was obtained for the different concentrations: 0.3 µM: 0.91, 1 µM: 0.89, 2 µM: 0.65, 4 
µM: 0.46; 8 µM: 0.79, 17 µM: 0.88. 
To optimize the concentration of activated polymer, HeLa-EGFP were treated with siEGFP/ activated 






Figure S12: A) Transfection efficiency in HeLa-EGFP at a constant siRNA concentration (14 nM) and increasing 
concentrations of activated polymer (χ1 = 0.85 and χHydrophobic = 0.15). B) Transfection efficiency in HeLa-EGFP at a 
constant siRNA concentration (14 nM) and constant concentration of activated polymer (4 µM) prepared from different 
molar fractions of 2 (χ1 = 1- χ2). 
To optimize the concentration of siRNA, HeLa-EGFP were treated with siEGFP/ activated polymer 
polyplexes, at a constant activated polymer concentration (12.25 µM) and with variable siEGFP concentrations 
(Figure S13). 
 
Figure S13: Transfection efficiency in HeLa-EGFP at a constant concentration of activated polymer (4 µM, χ1 = 0.85 and 
χHydrophobic = 0.15) and decreasing concentrations of siEGFP. 
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Figure S14: Transfection efficiency in HeLa-EGFP at a constant concentration of activated polymer (4 !M, !1 = 0.85 and 




















Polymer = 0.09 ng/ml




• Cell viability: MTT AssayS4 
 Cell viability was established by a standard MTT assay (Fig. S15).S4 One day before the assay, a 
suspension of HeLa-EGFP cells was plated in 96-well tissue culture plates (Costar 96 Flat Bottom Transparent 
Polystyrol) by adding 100 µl (∼30.000 cells) per well. The next day, the medium was aspirated and cells were 
incubated in DMEM containing 10% Fetal Bovine Serum (FBS) in the presence of activated polymer (50 
µl/well). After 4 h of incubation at 37ºC, the medium was aspirated and replaced by fresh medium (DMEM) 
containing 10% FBS (100 µl). Control cells were incubated with cell culture medium (100 µl final medium). The 
viability was measured by quantifying the cellular ability to reduce the water-soluble tetrazolium dye 3-4,5-
dimethylthiazole-2,5-diphenyl tetrazolium bromide (MTT) to its insoluble formazan salt as follows. At 72 h, 
MTT (5 mg/ml in PBS, 10 µl/well) was added to the wells and the cells were further incubated for 4 h. The 
supernatant was carefully removed and the water-insoluble formazan salt was dissolved in DMSO (100 µl/well). 
The absorbance at 560 nm was measured. Data points were collected in triplicate and expressed as normalized 
values for untreated control cells (100%). 
 
Figure S15: Cell viability from MTT assay in HeLa-EGFP cells at a constant siRNA concentration (14 nM). A) Increasing 
concentrations of activated polymer (χ1 = 0.85 and χHydrophobic = 0.15). B) Constant concentration of activated 




To further investigate cell viability in the presence of the parent polymer P1, the activated polymer P1(1)85(2)15 
and the Lipofectamine® RNAiMAX we performed additional viability experiments (in HeLa cells) at the working 
concentrations of the transfection experiments. Following the same protocol described above, but without medium 
replacement after the initial 4 hours, cells were incubated in the presence of either Lipofectamine® RNAiMAX P1, 
the activated polymer P1(1)85(2)15 (Figure S16). 
 
Figure S16: Comparison of cell viability (MTT assay in HeLa cells) at the working concentrations of the transfection 
experiments for the polymer and for the Lipofectamine® RNAiMAX (A), P1 (B) and Activated polymer = P1(1)85(2)15 (C). In all 
cases [siRNA] = 14 nM. 
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Characterization of Polyplexes 
• Hydrodynamic Radius and !-potential 
10 !l of activated polymer’s stock solutions were diluted in MilliQ water to afford the desired final 
concentrations (67-4 !M) and were mixed with a solution of siRNA (10 nM, 995 !l in MilliQ water) before 
measuring. To measure activated polymer alone, the 995 !l of siRNA solution was replaced by the same amount 
of bi-distilled water. Bi-distilled water was filtered through a nylon syringe filter (0.45 !m) before use. All 
experiments were performed at 25 ºC and the mean values and standard deviations obtained from triplicates. 
 
Figure S17: Diameter (A) and "-potential (B) for representative siMock/Activated polymer polyplexes. [siMock] = 14 nM. 
Activated polymer (!1 = 0.85 and !2 = 0.15). 
• Gel Retardation Assay 
Pre-mixed siRNA/Activated polymer polyplexes (3 pmol) were loaded onto a 2% agarose gel. The gels 
were run at 100 V for 60 min in TAE buffer (40 mM Tris, 20 mM acetic acid, and 1 mM EDTA) (Figure S18). 
 
Figure S18: Gel retardation assay. siMock (lane 1) and siMock/Activated polymer polyplexes with molar ratios of of 2 (lane 
2), 4.3 (lane 3), 8.3 (lane 4), 16.7 (lane 5), 33.3 (lane 6) and 66.7 (lane 7) were loaded. [siRNA] = 14 nM in all cases. 
[Activated polymer] = [P1(1)85(2)15] = 28 nM (lane 2), 60 nM (lane 3), 0.12 !M (lane 4), 0.23 !M (lane 5), 0.46 !M (lane 6), 




















Figure S20: RP-HPLC [Nucleosil 100-7 C18, H2O (0.1% TFA)/CH3CN (0.1% TFA) 100:0 (0!10 min), 100:0!75:35 






































Figure S22: RP-HPLC [Nucleosil 100-7 C18, H2O (0.1% TFA)/CH3CN (0.1% TFA) 100:0→80:20 (5→35 min), 0:100 (>35 
min)] for the reaction of 1 with benzyl hydroxylamine. The chromatogram after oxime formation shows the presence of the 
final compound 9 and the excess of hydroxylamine. 
  
Figure S23: RP-HPLC [Nucleosil 100-7 C18, H2O (0.1% TFA)/CH3CN (0.1% TFA) 100:0 (0→5 min), 100:0→35:75 
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Conclusions 
 In this thesis, a case has been made regarding the usefulness of polymer 
scaffolds as tools for the synthesis of functional polymers. The argument was that 
functional polymers, derived from a polymer scaffold, require the synthesis of one 
monomer and only one subsequent polymerisation. As such, all functional polymers 
derived would have the same degree of polymerisation, reducing the number of 
characterisation steps required. Furthermore, complex functional groups could be 
introduced onto polymers in situations where the corresponding functionalised 
monomer would be difficult to polymerise using existing techniques. It has been 
argued that polyhydrazides could be useful scaffolds towards the synthesis of 
functional polymers for biological applications. Hydrazides react readily with 
aldehydes, which are commercially available with a diversity of functional groups. 
The reaction between hydrazides and aldehydes can be carried out in a variety of 
solvents including aqueous conditions and DMSO, with water as the byproduct of the 
reaction. This was argued to be advantageous for testing polymers for biomedical 
applications, as scaffolds could be functionalised and tested “in-situ” without the 
necessity of first isolating and purifying the product. This should eventually lead to a 
faster identification of suitable functional polymer targets with useful biological 
properties. 
 Towards this goal, several polyhydrazide scaffolds were synthesised, 
characterised and their functionalisation with aldehydes explored. Poly(acryloyl 
hydrazide) was successfully synthesised via the RAFT polymerisation of tert-butyl 
2-acryloylhydrazine-1-carboxylate and subsequent deprotection. Different molecular 
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weight samples were synthesised and characterised by 1H and 13C NMR, UV-Vis 
spectroscopies and SEC/GPC, and the functionalisation with aldehydes was 
investigated by 1H NMR spectroscopy in biologically compatible solvents (i.e. 
aqueous conditions or mixtures of aqueous solvent and DMSO). Solvent mixtures 
with 95% DMSO and 5% aqueous solution (5% AcOH in H2O) were found to provide 
a suitable percentage functionalisation (i.e. ~70% when 1 equivalent aldehyde was 
used per hydrazide side-chain) and accommodate for most of the aldehydes’ and the 
resulting polymers’ poor solubility in water. It was also found that the percentage 
functionalisation could be increased by using an excess of aldehyde, while using a 
polymer scaffold with a larger degree of polymerisation generally resulted to a small 
decrease. This was attributed to increased steric hinderance and unavailability of the 
side-chains to react. Hydrazone reduction was explored as a tool to permanently 
immobilise aldehydes to the scaffold, and a combination of borane-pyridine was 
found to be a suitable mild reducing agent. The carboxylic acid terminus of the 
poly(acryloyl hydrazide) scaffold was modified with a diamine to serve as an anchor 
for labelling with fluorescent tags (i.e. fluorescein-5-isothiocyanate) with a view to 
synthesise a fluorescent polymer scaffold towards libraries of fluorescent functional 
polymers.  
 Poly(4-ethynylbenzohydrazide) was synthesised via the rhodium catalysed 
polymerisation of tert-butyl 2-(4-ethynylbenzoyl)hydrazine-1-carboxylate and isolated 
as the polymer⋅TFA salt after deprotection. This scaffold was synthesised due to the 
helical nature of the backbone of poly(phenyl acetylenes), which could be used for 
the synthesis of functional polymers that mimic naturally occurring helical moieties. 
Stability studies via SEC/GPC and fluorescence spectroscopy showed that 
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isomerisation from cis-transoid to trans-transoid likely occurs in solution at room 
temperature. Synthesis of poly(4-ethynylbenzohydrazide) via the deprotected 
monomer, as well as the neutralisation of the polymer⋅TFA salt resulted in a insoluble 
polymer, believed to be due to extensive hydrogen bonded networks between the 
hydrazide side-chains. Functionalisation studies with the polymer⋅TFA salt and 
aldehydes revealed that fast, almost complete coupling was occurring followed by a 
slow equilibration over several days, in which aldehyde was regenerated. Solubility of 
the scaffold was problematic however, as in aqueous conditions the scaffold was 
insoluble and moderately successful dissolution in DMSO was achieved only after 
heating. As a consequence, poly(prop-2-yn-1-yl hydrazine carboxylate) was 
synthesised via the metal catalysed polymerisation of 1-(tert-butyl) 2-(prop-2-yn-1-yl) 
hydrazine-1,2-dicarboxylate and subsequent deprotection. Due to solubility problems 
with the neutral scaffold associated with extensive hydrogen bonded networks 
between the hydrazide side-chains, the polymer was isolated as the acetate salt. 
Functionalisation of the polymer with aldehydes revealed that high percentage 
loading could be achieved, but in a solvent dependent manner, which defeated the 
purpose of a polymer scaffold useful for fast screening. 
 To demonstrate the potential of the “in-situ” aspect of polyhydrazide scaffolds, 
poly(acryloyl hydrazide) was functionalised with a cationic guanidinium aldehyde and 
with diverse hydrophobic aldehydes to form functional amphiphilic polymers. The 
biological activity of these polymers was tested, by complexing siRNA without the 
necessity for purification and isolation of the target compounds. The biological activity 
of these complexes was tested on GFP-HeLA cells, which allowed the identification 
of a target functional polymer with potent activity.  
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Future plans 
 The methodology developed for the functionalisation and testing of polymers 
derived from poly(acryloyl hydrazide) is being used to further explore the delivery of 
useful biological cargo such as siRNA and plasmids. Because of the significant size 
difference of a siRNA strand compared to a plasmid, poly(acryloyl hydrazide)s of 
different molecular weights are being tested to identify suitable combinations of 
aldehydes and relationships between polymer size and biological activity. Other 
applications currently being explored using poly(acryloyl hydrazide) scaffolds involve 
the clustering of bacteria using functional polymers, but further opportunities exist in 
the development of novel mimics of antimicrobial peptides, formation of antifouling 
surfaces and chelators for metal ions. 
 The development of fluorescent poly(acryloyl hydrazide) is being continued 
towards the synthesis of a tool towards libraries of fluorescent functional polymers, 
which could be exploited in identifying a variety of biological mechanisms (e.g. 
membrane transport pathway), as well as potentially monitoring the biological 
distribution of functional polymers in a system (e.g. targeted drug delivery). 
 Despite the solubility issues of poly(4-ethynylbenzohydrazide), there is scope 
to improve this polymer by copolymerising with phenyl acetylenes bearing functional 
groups that do not participate in hydrogen bonding and that could potentially improve 
the water solubility of the polymer. This could lead to a helical polyhydrazide scaffold 
that would have interesting applications in the development of functional polymers, 
which mimic the function of naturally occurring helical biological molecules.
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